SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mimedx Group, Inc. – ‘10-K’ for 12/31/12 – ‘EX-101.INS’

On:  Friday, 3/15/13, at 5:14pm ET   ·   For:  12/31/12   ·   Accession #:  1140361-13-12765   ·   File #:  0-52491

Previous ‘10-K’:  ‘10-K/A’ on 6/21/12 for 12/31/11   ·   Next:  ‘10-K’ on 3/4/14 for 12/31/13   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/15/13  Mimedx Group, Inc.                10-K       12/31/12   70:10M                                    Broadridge Fin’l So… Inc

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Mimedx Group Inc 10-K 12-31-2012                    HTML   1.04M 
 2: EX-10.54    Material Contract                                   HTML     39K 
 3: EX-10.55    Material Contract                                   HTML     27K 
 4: EX-10.56    Material Contract                                   HTML     96K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML     19K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
47: R1          Document and Entity Information                     HTML     48K 
37: R2          Consolidated Balance Sheets                         HTML    126K 
45: R3          Consolidated Balance Sheets (Parenthetical)         HTML     56K 
49: R4          Consolidated Statements of Operations               HTML     70K 
64: R5          Consolidated Statements of Stockholders' Equity     HTML    130K 
39: R6          Consolidated Statements of Stockholders' Equity     HTML     22K 
                (Parenthetical)                                                  
44: R7          Consolidated Statements of Cash Flows               HTML    150K 
34: R8          Consolidated Statements of Cash Flows               HTML     76K 
                (Parenthetical)                                                  
26: R9          Nature of Business                                  HTML     24K 
66: R10         Significant Accounting Policies                     HTML    124K 
51: R11         Liquidity and Management's Plans                    HTML     22K 
50: R12         Acquisition of Surgical Biologics, LLC              HTML     85K 
55: R13         Inventories                                         HTML     33K 
56: R14         Property and Equipment                              HTML     36K 
54: R15         Intangible Assets and Royalty Agreement             HTML     96K 
57: R16         Accrued Expenses                                    HTML     30K 
46: R17         Long-Term Debt                                      HTML     54K 
48: R18         Common Stock Placements                             HTML     36K 
53: R19         Equity                                              HTML    185K 
70: R20         Income Taxes                                        HTML     58K 
60: R21         Related Party Transactions                          HTML     38K 
41: R22         401k Plan                                           HTML     30K 
52: R23         Commitments                                         HTML     30K 
43: R24         Subsequent Events                                   HTML     24K 
20: R25         Significant Accounting Policies (Policies)          HTML    222K 
61: R26         Significant Accounting Policies (Tables)            HTML     65K 
67: R27         Acquisition of Surgical Biologics, LLC (Tables)     HTML     72K 
30: R28         Inventories (Tables)                                HTML     30K 
29: R29         Property and Equipment (Tables)                     HTML     33K 
32: R30         Intangible Assets and Royalty Agreement (Tables)    HTML     96K 
33: R31         Accrued Expenses (Tables)                           HTML     27K 
35: R32         Long-Term Debt (Tables)                             HTML     47K 
19: R33         Equity (Tables)                                     HTML    182K 
58: R34         Income Taxes (Tables)                               HTML     50K 
40: R35         Related Party Transactions (Tables)                 HTML     33K 
42: R36         Commitments (Tables)                                HTML     25K 
23: R37         Nature of Business (Details)                        HTML     21K 
69: R38         Significant Accounting Policies (Details)           HTML    157K 
16: R39         Liquidity and Management's Plans (Details)          HTML     31K 
36: R40         Acquisition of Surgical Biologics, LLC (Details)    HTML    177K 
63: R41         Inventories (Details)                               HTML     38K 
22: R42         Property and Equipment (Details)                    HTML     34K 
28: R43         Intangible Assets and Royalty Agreement (Details)   HTML    122K 
31: R44         Accrued Expenses (Details)                          HTML     31K 
38: R45         Long-Term Debt (Details)                            HTML    116K 
18: R46         Common Stock Placements (Details)                   HTML     70K 
25: R47         Equity (Details)                                    HTML    285K 
17: R48         Income Taxes (Details)                              HTML     95K 
62: R49         Related Party Transactions (Details)                HTML     31K 
21: R50         401k Plan (Details)                                 HTML     32K 
59: R51         Commitments (Details)                               HTML     28K 
24: R52         Subsequent Events (Details)                         HTML     37K 
68: XML         IDEA XML File -- Filing Summary                      XML     94K 
27: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.52M 
10: EX-101.INS  XBRL Instance -- mdxg-20121231                       XML   2.21M 
12: EX-101.CAL  XBRL Calculations -- mdxg-20121231_cal               XML    193K 
13: EX-101.DEF  XBRL Definitions -- mdxg-20121231_def                XML    640K 
14: EX-101.LAB  XBRL Labels -- mdxg-20121231_lab                     XML   2.22M 
15: EX-101.PRE  XBRL Presentations -- mdxg-20121231_pre              XML   1.17M 
11: EX-101.SCH  XBRL Schema -- mdxg-20121231                         XSD    203K 
65: ZIP         XBRL Zipped Folder -- 0001140361-13-012765-xbrl      Zip    225K

‘EX-101.INS’   —   XBRL Instance — mdxg-20121231

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Generated by Disclosure Solutions PROFILE 1.2.0.0 Copyright 1995 - 2013 Thomson Reuters Accelus. All rights reserved. -->
<xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:invest="http://xbrl.sec.gov/invest/2012-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:country="http://xbrl.sec.gov/country/2012-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2012-01-31" xmlns:mdxg="http://mimedx.com/20121231" xmlns="http://www.xbrl.org/2003/instance">
<link:schemaRef xlink:type="simple" xlink:href="mdxg-20121231.xsd"/>
<xbrli:context id="c20120101to20121231">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120630">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-06-30 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20130215">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2013-02-15 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20101231_StatementEquityComponentsAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2010-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20101231_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2010-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20101231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2010-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20101231_StatementEquityComponentsAxis_TreasuryStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2010-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20101231_StatementEquityComponentsAxis_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2010-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20101231">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2010-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_StatementEquityComponentsAxis_TreasuryStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_StatementEquityComponentsAxis_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_StatementEquityComponentsAxis_TreasuryStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_StatementEquityComponentsAxis_TreasuryStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_StatementEquityComponentsAxis_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_StatementEquityComponentsAxis_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_StatementEquityComponentsAxis_TreasuryStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_StatementEquityComponentsAxis_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_IncomeStatementLocationAxis_CostOfSalesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis"> us-gaap:CostOfSalesMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_IncomeStatementLocationAxis_CostOfSalesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis"> us-gaap:CostOfSalesMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis"> us-gaap:ResearchAndDevelopmentExpenseMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis"> us-gaap:ResearchAndDevelopmentExpenseMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_IncomeStatementLocationAxis_SellingGeneralAndAdministrativeExpensesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis"> us-gaap:SellingGeneralAndAdministrativeExpensesMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_IncomeStatementLocationAxis_SellingGeneralAndAdministrativeExpensesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis"> us-gaap:SellingGeneralAndAdministrativeExpensesMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20100731">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2010-07-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueGoodsNetMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueGoodsNetMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueGoodsNetMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember_ConcentrationRiskByTypeAxis_FirstCustomerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueGoodsNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> mdxg:FirstCustomerMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember_ConcentrationRiskByTypeAxis_SecondCustomerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueGoodsNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> mdxg:SecondCustomerMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueGoodsNetMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember_ConcentrationRiskByTypeAxis_FirstCustomerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueGoodsNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> mdxg:FirstCustomerMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember_ConcentrationRiskByTypeAxis_SecondCustomerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueGoodsNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> mdxg:SecondCustomerMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_ConcentrationRiskByTypeAxis_FirstCustomerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> mdxg:FirstCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_ConcentrationRiskByTypeAxis_SecondCustomerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> mdxg:SecondCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_ConcentrationRiskByTypeAxis_FirstCustomerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> mdxg:FirstCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_ConcentrationRiskByTypeAxis_SecondCustomerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> mdxg:SecondCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MinimumMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MaximumMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_StockOptionsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:StockOptionsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_StockOptionsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:StockOptionsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleNotesPayableMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:ConvertibleNotesPayableMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleNotesPayableMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:ConvertibleNotesPayableMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RevolvingCreditFacilityMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RevolvingCreditFacilityMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleDebtMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleDebtMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110104to20110105">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-04 </xbrli:startDate>
<xbrli:endDate> 2011-01-05 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110105">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-01-05 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120731">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-07-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120401to20120430">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-04-01 </xbrli:startDate>
<xbrli:endDate> 2012-04-30 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120701to20120731">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-07-01 </xbrli:startDate>
<xbrli:endDate> 2012-07-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110105_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:CustomerRelationshipsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-01-05 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110105_FiniteLivedIntangibleAssetsByMajorClassAxis_SupplierRelationshipsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:SupplierRelationshipsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-01-05 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110105_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:PatentsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-01-05 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110105_FiniteLivedIntangibleAssetsByMajorClassAxis_LicensingAgreementsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:LicensingAgreementsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-01-05 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:CustomerRelationshipsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_SupplierRelationshipsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:SupplierRelationshipsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:PatentsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_LicensingAgreementsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:LicensingAgreementsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110105_IndefiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesAndTrademarksMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:TradeNamesAndTrademarksMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-01-05 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110105_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentLiquidMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:InProcessResearchAndDevelopmentLiquidMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-01-05 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110105_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentOtherMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:InProcessResearchAndDevelopmentOtherMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-01-05 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesAndTrademarksMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:TradeNamesAndTrademarksMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentLiquidMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:InProcessResearchAndDevelopmentLiquidMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentOtherMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:InProcessResearchAndDevelopmentOtherMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:LeaseholdImprovementsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:LeaseholdImprovementsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:EquipmentMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:EquipmentMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:FurnitureAndFixturesMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:FurnitureAndFixturesMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_PropertyPlantAndEquipmentByTypeAxis_ConstructionInProgressMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:ConstructionInProgressMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_PropertyPlantAndEquipmentByTypeAxis_ConstructionInProgressMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:ConstructionInProgressMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-ShrinersHspForChildrenUsfResearchMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:License-ShrinersHspForChildrenUsfResearchMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-SalumedicaLlcSpineRepairMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:License-SalumedicaLlcSpineRepairMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-PolyvinylAlcoholCryogelMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:License-PolyvinylAlcoholCryogelMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_MicronizedProcessingKnow-HowMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:MicronizedProcessingKnow-HowMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-ShrinersHspForChildrenUsfResearchMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:License-ShrinersHspForChildrenUsfResearchMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-SalumedicaLlcSpineRepairMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:License-SalumedicaLlcSpineRepairMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-PolyvinylAlcoholCryogelMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:License-PolyvinylAlcoholCryogelMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:CustomerRelationshipsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_SupplierRelationshipsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:SupplierRelationshipsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:PatentsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_MicronizedProcessingKnow-HowMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:MicronizedProcessingKnow-HowMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_LicensingAgreementsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:LicensingAgreementsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-ShrinersHspForChildrenUsfResearchMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:License-ShrinersHspForChildrenUsfResearchMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-SalumedicaLlcSpineRepairMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:License-SalumedicaLlcSpineRepairMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-PolyvinylAlcoholCryogelMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:License-PolyvinylAlcoholCryogelMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:CustomerRelationshipsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_SupplierRelationshipsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:SupplierRelationshipsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:PatentsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_MicronizedProcessingKnow-HowMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:MicronizedProcessingKnow-HowMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_LicensingAgreementsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:LicensingAgreementsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesAndTrademarksMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:TradeNamesAndTrademarksMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentOtherMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:InProcessResearchAndDevelopmentOtherMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesAndTrademarksMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:TradeNamesAndTrademarksMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentOtherMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> mdxg:InProcessResearchAndDevelopmentOtherMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> mdxg:FivePercentConvertibleSeniorSecuredPromissoryNoteMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> mdxg:FivePercentConvertibleSeniorSecuredPromissoryNoteMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_CreditFacilityAxis_RevolvingCreditFacilityMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_CreditFacilityAxis_RevolvingCreditFacilityMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_DebtInstrumentAxis_ConvertibleDebtMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_DebtInstrumentAxis_ConvertibleDebtMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> mdxg:FivePercentConvertibleSeniorSecuredPromissoryNoteMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_CreditFacilityAxis_RevolvingCreditFacilityMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_DebtInstrumentAxis_ConvertibleDebtMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_CreditFacilityAxis_RevolvingCreditFacilityMember_LineOfCreditFacilityAxis_BoardOfDirectorsChairmanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> us-gaap:BoardOfDirectorsChairmanMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_CreditFacilityAxis_RevolvingCreditFacilityMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_DebtInstrumentAxis_ConvertibleDebtMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> us-gaap:ConvertibleDebtMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_FirstContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:FirstContingentWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> mdxg:FivePercentConvertibleSeniorSecuredPromissoryNoteMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_SecondContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> mdxg:FivePercentConvertibleSeniorSecuredPromissoryNoteMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:SecondContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120301to20120331_ClassOfWarrantOrRightAxis_FirstContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:FirstContingentWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> mdxg:FivePercentConvertibleSeniorSecuredPromissoryNoteMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-03-01 </xbrli:startDate>
<xbrli:endDate> 2012-03-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120301to20120331_ClassOfWarrantOrRightAxis_FirstContingentWarrantsMember_CreditFacilityAxis_RevolvingCreditFacilityMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:FirstContingentWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-03-01 </xbrli:startDate>
<xbrli:endDate> 2012-03-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120701to20120731_ClassOfWarrantOrRightAxis_SecondContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> mdxg:FivePercentConvertibleSeniorSecuredPromissoryNoteMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:SecondContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-07-01 </xbrli:startDate>
<xbrli:endDate> 2012-07-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120701to20120731_ClassOfWarrantOrRightAxis_SecondContingentWarrantsMember_CreditFacilityAxis_RevolvingCreditFacilityMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:SecondContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-07-01 </xbrli:startDate>
<xbrli:endDate> 2012-07-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120702to20120703_ClassOfWarrantOrRightAxis_SecondContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> mdxg:FivePercentConvertibleSeniorSecuredPromissoryNoteMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:SecondContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-07-02 </xbrli:startDate>
<xbrli:endDate> 2012-07-03 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_FirstContingentWarrantsMember_CreditFacilityAxis_RevolvingCreditFacilityMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:FirstContingentWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> mdxg:FivePercentConvertibleSeniorSecuredPromissoryNoteMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember_LineOfCreditFacilityAxis_BoardOfDirectorsChairmanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> mdxg:FivePercentConvertibleSeniorSecuredPromissoryNoteMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> us-gaap:BoardOfDirectorsChairmanMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20130101to20130228_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> mdxg:FivePercentConvertibleSeniorSecuredPromissoryNoteMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2013-01-01 </xbrli:startDate>
<xbrli:endDate> 2013-02-28 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20130101to20130228_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember_LineOfCreditFacilityAxis_BoardOfDirectorsChairmanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> mdxg:FivePercentConvertibleSeniorSecuredPromissoryNoteMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> us-gaap:BoardOfDirectorsChairmanMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2013-01-01 </xbrli:startDate>
<xbrli:endDate> 2013-02-28 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20120630_StatementEquityComponentsAxis_FirstContingentWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxg:FirstContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-06-30 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120702to20120703_StatementEquityComponentsAxis_SecondContingentWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxg:SecondContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-07-02 </xbrli:startDate>
<xbrli:endDate> 2012-07-03 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120630_StatementEquityComponentsAxis_FirstContingentWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxg:FirstContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-06-30 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_SaleOfStockAndWarrantsEntityAxis_BoardOfDirectorsChairmanMember_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:SaleOfStockAndWarrantsEntityAxis"> us-gaap:BoardOfDirectorsChairmanMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120731_SaleOfStockAndWarrantsEntityAxis_BoardOfDirectorsChairmanMember_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:SaleOfStockAndWarrantsEntityAxis"> us-gaap:BoardOfDirectorsChairmanMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-07-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_StatementEquityComponentsAxis_FirstContingentWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxg:FirstContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120701to20120731_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-07-01 </xbrli:startDate>
<xbrli:endDate> 2012-07-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20120630_SaleOfStockAndWarrantsEntityAxis_BoardOfDirectorsChairmanMember_StatementEquityComponentsAxis_FirstContingentWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:SaleOfStockAndWarrantsEntityAxis"> us-gaap:BoardOfDirectorsChairmanMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxg:FirstContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-06-30 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange065To100Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange065To100Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange104To180Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange104To180Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050To076Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange050To076Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange087To135Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange087To135Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange140To218Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange140To218Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange229To347Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange229To347Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange349To385Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange349To385Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange050Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange240Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange240Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange050Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange065To100Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange065To100Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange104To180Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange104To180Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange240Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange240Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050To076Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange050To076Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange087To135Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange087To135Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange140To218Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange140To218Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange229To347Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange229To347Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange349To385Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"> mdxg:PriceRange349To385Member </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20101231_ClassOfWarrantOrRightAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2010-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20101231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2010-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsIssuedInConnectionWithPrivatePlacementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsIssuedInConnectionWithPrivatePlacementMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithConvertiblePromissoryNotesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsIssuedInConnectionWithConvertiblePromissoryNotesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithConvertiblePromissoryNotesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsIssuedInConnectionWithConvertiblePromissoryNotesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithSeniorSecuredPromissoryNotesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsIssuedInConnectionWithSeniorSecuredPromissoryNotesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithSeniorSecuredPromissoryNotesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsIssuedInConnectionWithSeniorSecuredPromissoryNotesMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> us-gaap:PrivatePlacementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> us-gaap:PrivatePlacementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsIssuedInConnectionWithPrivatePlacementMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsIssuedInConnectionWithPrivatePlacementMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_ContingentWarrantsRelatedToConvertibleNoteMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:ContingentWarrantsRelatedToConvertibleNoteMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_ContingentWarrantsRelatedToConvertibleNoteMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:ContingentWarrantsRelatedToConvertibleNoteMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_CallableWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:CallableWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_CallableWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:CallableWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_EquitySecuritiesOtherMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> us-gaap:EquitySecuritiesOtherMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_EquitySecuritiesOtherMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> us-gaap:EquitySecuritiesOtherMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsRedeemedForCashlessExercisesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsRedeemedForCashlessExercisesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_RepurchaseOfCallableWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:RepurchaseOfCallableWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsRedeemedForCashlessExercisesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsRedeemedForCashlessExercisesMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_RepurchaseOfCallableWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:RepurchaseOfCallableWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsExpiredMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsExpiredMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsExpiredMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="mdxg:WarrantEventAxis"> mdxg:WarrantsExpiredMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_ClassOfWarrantOrRightAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2011-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_ClassOfWarrantOrRightAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> us-gaap:WarrantMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> mdxg:ContingentWarrantsMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_PropertyPlantAndEquipmentByTypeAxis_OfficeSpaceLeaseMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> mdxg:OfficeSpaceLeaseMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_PropertyPlantAndEquipmentByTypeAxis_OfficeSpaceLeaseMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> mdxg:OfficeSpaceLeaseMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_PropertyPlantAndEquipmentByTypeAxis_Z3721">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> sic:Z3721 </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_PropertyPlantAndEquipmentByTypeAxis_Z3721">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> sic:Z3721 </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_LongtermDebtTypeAxis_HybridDebtInstrumentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> mdxg:HybridDebtInstrumentMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_LongtermDebtTypeAxis_HybridDebtInstrumentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> mdxg:HybridDebtInstrumentMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_LongtermDebtTypeAxis_LineOfCreditMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_LongtermDebtTypeAxis_LineOfCreditMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_LongtermDebtTypeAxis_ConvertibleSeniorSecuredPromissoryNotesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> mdxg:ConvertibleSeniorSecuredPromissoryNotesMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20110101to20111231_LongtermDebtTypeAxis_ConvertibleSeniorSecuredPromissoryNotesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> mdxg:ConvertibleSeniorSecuredPromissoryNotesMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2011-01-01 </xbrli:startDate>
<xbrli:endDate> 2011-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20130131_SubsequentEventTypeAxis_SubsequentEventMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2013-01-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_SubsequentEventTypeAxis_SubsequentEventMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20121231_SubsequentEventTypeAxis_SubsequentEventMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant> 2012-12-31 </xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20120101to20121231_FinancingAxis_IssuanceOfEquityMember_SubsequentEventTypeAxis_SubsequentEventMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancingAxis"> us-gaap:IssuanceOfEquityMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2012-01-01 </xbrli:startDate>
<xbrli:endDate> 2012-12-31 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20130101to20130228_FinancingAxis_IssuanceOfEquityMember_RelatedPartyTransactionsByRelatedPartyAxis_BoardOfDirectorsChairmanMember_SubsequentEventTypeAxis_SubsequentEventMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancingAxis"> us-gaap:IssuanceOfEquityMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> us-gaap:BoardOfDirectorsChairmanMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2013-01-01 </xbrli:startDate>
<xbrli:endDate> 2013-02-28 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="c20130101to20130228_FinancingAxis_IssuanceOfEquityMember_SubsequentEventTypeAxis_SubsequentEventMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001376339 </xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancingAxis"> us-gaap:IssuanceOfEquityMember </xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate> 2013-01-01 </xbrli:startDate>
<xbrli:endDate> 2013-02-28 </xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:unit id="U001">
<xbrli:measure> iso4217:USD </xbrli:measure>
</xbrli:unit>
<xbrli:unit id="U002">
<xbrli:measure> xbrli:shares </xbrli:measure>
</xbrli:unit>
<xbrli:unit id="U003">
<xbrli:divide>
<xbrli:unitNumerator>
<xbrli:measure> iso4217:USD </xbrli:measure>
</xbrli:unitNumerator>
<xbrli:unitDenominator>
<xbrli:measure> xbrli:shares </xbrli:measure>
</xbrli:unitDenominator>
</xbrli:divide>
</xbrli:unit>
<xbrli:unit id="U004">
<xbrli:measure> mdxg:Businesssegments </xbrli:measure>
</xbrli:unit>
<xbrli:unit id="U005">
<xbrli:measure> xbrli:pure </xbrli:measure>
</xbrli:unit>
<xbrli:unit id="U006">
<xbrli:measure> mdxg:Plans </xbrli:measure>
</xbrli:unit>
<xbrli:unit id="U007">
<xbrli:measure> utr:sqft </xbrli:measure>
</xbrli:unit>
<!-- Amendment Flag -->
<dei:AmendmentFlag contextRef="c20120101to20121231"> false </dei:AmendmentFlag>
<!-- Current Fiscal Year End Date -->
<dei:CurrentFiscalYearEndDate contextRef="c20120101to20121231"> --12-31 </dei:CurrentFiscalYearEndDate>
<!-- Document Period End Date -->
<dei:DocumentPeriodEndDate contextRef="c20120101to20121231"> 2012-12-31 </dei:DocumentPeriodEndDate>
<!-- Entity Well-known Seasoned Issuer -->
<dei:EntityWellKnownSeasonedIssuer contextRef="c20120101to20121231"> No </dei:EntityWellKnownSeasonedIssuer>
<!-- Entity Voluntary Filers -->
<dei:EntityVoluntaryFilers contextRef="c20120101to20121231"> No </dei:EntityVoluntaryFilers>
<!-- Entity Current Reporting Status -->
<dei:EntityCurrentReportingStatus contextRef="c20120101to20121231"> Yes </dei:EntityCurrentReportingStatus>
<!-- Entity Filer Category -->
<dei:EntityFilerCategory contextRef="c20120101to20121231"> Smaller Reporting Company </dei:EntityFilerCategory>
<!-- Entity Public Float -->
<dei:EntityPublicFloat contextRef="c20120630" unitRef="U001" decimals="0"> 142370000 </dei:EntityPublicFloat>
<!-- Entity Registrant Name -->
<dei:EntityRegistrantName contextRef="c20120101to20121231"> MIMEDX GROUP, INC. </dei:EntityRegistrantName>
<!-- Entity Central Index Key -->
<dei:EntityCentralIndexKey contextRef="c20120101to20121231"> 0001376339 </dei:EntityCentralIndexKey>
<!-- Entity Common Stock, Shares Outstanding -->
<dei:EntityCommonStockSharesOutstanding contextRef="c20130215" unitRef="U002" decimals="0"> 93748564 </dei:EntityCommonStockSharesOutstanding>
<!-- Document Fiscal Year Focus -->
<dei:DocumentFiscalYearFocus contextRef="c20120101to20121231"> 2012 </dei:DocumentFiscalYearFocus>
<!-- Document Fiscal Period Focus -->
<dei:DocumentFiscalPeriodFocus contextRef="c20120101to20121231"> FY </dei:DocumentFiscalPeriodFocus>
<!-- Document Type -->
<dei:DocumentType contextRef="c20120101to20121231"> 10-K </dei:DocumentType>
<!-- Square feet of office the company will lease-Subsequent Event [Member] -->
<us-gaap:AreaOfRealEstateProperty contextRef="c20130131_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U007" decimals="0"> 80000 </us-gaap:AreaOfRealEstateProperty>
<!-- Accrued Expenses -->
<us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c20120101to20121231">
<div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"><div style="text-indent: 0pt; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">8.</div></td><td><div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Accrued Expenses</div></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div><div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">  <div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Accrued Expenses consist of the following as of December 31, 2012 and December 31, 2011:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="6" valign="bottom" style="width: 22%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Accrued Personnel Related Costs</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,761,760</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">311,849</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Accrued Commissions</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,469,925</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">112,905</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Other Accrued Expenses</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">512,249</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">358,435</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Total Accrued Expenses</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">3,743,934</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">783,189</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><div><div style="text-align: center; width: 1899px; font-family: 'Times New Roman'; font-size: 8pt;"></div></div></div></div></div></div></div>
</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
<!-- Accounts receivable, net -->
<us-gaap:AccountsReceivableNetCurrent contextRef="c20121231" unitRef="U001" decimals="0"> 7653561 </us-gaap:AccountsReceivableNetCurrent>
<!-- Accounts receivable, net -->
<us-gaap:AccountsReceivableNetCurrent contextRef="c20111231" unitRef="U001" decimals="0"> 1891919 </us-gaap:AccountsReceivableNetCurrent>
<!-- Accounts Payable -->
<us-gaap:AccountsPayableCurrentAndNoncurrent contextRef="c20121231" unitRef="U001" decimals="0"> 1251684 </us-gaap:AccountsPayableCurrentAndNoncurrent>
<!-- Accounts Payable -->
<us-gaap:AccountsPayableCurrentAndNoncurrent contextRef="c20111231" unitRef="U001" decimals="0"> 1517449 </us-gaap:AccountsPayableCurrentAndNoncurrent>
<!-- Accrued Commissions -->
<us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes contextRef="c20121231" unitRef="U001" decimals="0"> 1469925 </us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes>
<!-- Accrued Commissions -->
<us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes contextRef="c20111231" unitRef="U001" decimals="0"> 112905 </us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes>
<!-- Accrued expenses -->
<us-gaap:AccruedLiabilitiesCurrent contextRef="c20121231" unitRef="U001" decimals="0"> 3743934 </us-gaap:AccruedLiabilitiesCurrent>
<!-- Accrued expenses -->
<us-gaap:AccruedLiabilitiesCurrent contextRef="c20111231" unitRef="U001" decimals="0"> 783189 </us-gaap:AccruedLiabilitiesCurrent>
<!-- Property and equipment, net of accumulated depreciation -->
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c20121231" unitRef="U001" decimals="0"> 2279840 </us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<!-- Property and equipment, net of accumulated depreciation -->
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c20111231" unitRef="U001" decimals="0"> 1814473 </us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<!-- Acquired Indefinite-lived Intangible Asset, Amount-Trade names and trademarks [Member] -->
<us-gaap:AcquiredIndefiniteLivedIntangibleAssetAmount contextRef="c20110105_IndefiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesAndTrademarksMember" unitRef="U001" decimals="0"> 1008000 </us-gaap:AcquiredIndefiniteLivedIntangibleAssetAmount>
<!-- Acquired Indefinite-lived Intangible Asset, Amount-In process research and development, liquid [Member] -->
<us-gaap:AcquiredIndefiniteLivedIntangibleAssetAmount contextRef="c20110105_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentLiquidMember" unitRef="U001" decimals="0"> 2160000 </us-gaap:AcquiredIndefiniteLivedIntangibleAssetAmount>
<!-- Acquired Indefinite-lived Intangible Asset, Amount-In process research and development, other [Member] -->
<us-gaap:AcquiredIndefiniteLivedIntangibleAssetAmount contextRef="c20110105_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentOtherMember" unitRef="U001" decimals="0"> 25000 </us-gaap:AcquiredIndefiniteLivedIntangibleAssetAmount>
<!-- Estimated useful life (in years)-Customer Relationships [Member] -->
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"> P14Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<!-- Estimated useful life (in years)-Supplier Relationships [Member] -->
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_SupplierRelationshipsMember"> P14Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<!-- Estimated useful life (in years)-Patents [Member] -->
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember"> P14Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<!-- Estimated useful life (in years)-Licensing Agreements [Member] -->
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_LicensingAgreementsMember"> P3Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<!-- Estimated useful life (in years)-License-Shriners Hsp for Children & USF Research [Member] -->
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-ShrinersHspForChildrenUsfResearchMember"> P10Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<!-- Estimated useful life (in years)-License - SaluMedica LLC Spine Repair [Member] -->
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-SalumedicaLlcSpineRepairMember"> P10Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<!-- Estimated useful life (in years)-License - Polyvinyl Alcohol Cryogel [Member] -->
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-PolyvinylAlcoholCryogelMember"> P10Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<!-- Estimated useful life (in years)-Customer Relationships [Member] --> <!-- Estimated useful life (in years)-Supplier Relationships [Member] --> <!-- Estimated useful life (in years)-Patents [Member] --> <!-- Estimated useful life (in years)-Micronized Processing Know-How [Member] -->
<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c20120101to20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_MicronizedProcessingKnow-HowMember"> P14Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
<!-- Estimated useful life (in years)-Licensing Agreements [Member] --> <!-- Acquired intangible assets-Customer Relationships [Member] -->
<us-gaap:AcquiredFiniteLivedIntangibleAssetAmount contextRef="c20110105_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="0"> 3520000 </us-gaap:AcquiredFiniteLivedIntangibleAssetAmount>
<!-- Acquired intangible assets-Supplier Relationships [Member] -->
<us-gaap:AcquiredFiniteLivedIntangibleAssetAmount contextRef="c20110105_FiniteLivedIntangibleAssetsByMajorClassAxis_SupplierRelationshipsMember" unitRef="U001" decimals="0"> 241000 </us-gaap:AcquiredFiniteLivedIntangibleAssetAmount>
<!-- Acquired intangible assets-Patents [Member] -->
<us-gaap:AcquiredFiniteLivedIntangibleAssetAmount contextRef="c20110105_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember" unitRef="U001" decimals="0"> 5530000 </us-gaap:AcquiredFiniteLivedIntangibleAssetAmount>
<!-- Acquired intangible assets-Licensing Agreements [Member] -->
<us-gaap:AcquiredFiniteLivedIntangibleAssetAmount contextRef="c20110105_FiniteLivedIntangibleAssetsByMajorClassAxis_LicensingAgreementsMember" unitRef="U001" decimals="0"> 13000 </us-gaap:AcquiredFiniteLivedIntangibleAssetAmount>
<!-- Additional paid-in capital -->
<us-gaap:AdditionalPaidInCapital contextRef="c20121231" unitRef="U001" decimals="0"> 89627601 </us-gaap:AdditionalPaidInCapital>
<!-- Additional paid-in capital -->
<us-gaap:AdditionalPaidInCapital contextRef="c20111231" unitRef="U001" decimals="0"> 73868604 </us-gaap:AdditionalPaidInCapital>
<!-- Beneficial conversion feature recognized on convertible debt-Series A Preferred Stock [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
<!-- Beneficial conversion feature recognized on convertible debt-Common Stock [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
<!-- Beneficial conversion feature recognized on convertible debt-Additional Paid-in Capital [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt contextRef="c20110101to20111231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 2715552 </us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
<!-- Beneficial conversion feature recognized on convertible debt-Treasury Stock [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt contextRef="c20110101to20111231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
<!-- Beneficial conversion feature recognized on convertible debt-Accumulated Deficit [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt contextRef="c20110101to20111231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
<!-- Beneficial conversion feature recognized on convertible debt -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 2715552 </us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
<!-- Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 47733 </us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
<!-- Warrants issued in conjunction with convertible promissory notes-Series A Preferred Stock [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<!-- Warrants issued in conjunction with convertible promissory notes-Common Stock [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<!-- Warrants issued in conjunction with convertible promissory notes-Additional Paid-in Capital [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c20110101to20111231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 14885 </us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<!-- Warrants issued in conjunction with convertible promissory notes-Treasury Stock [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c20110101to20111231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<!-- Warrants issued in conjunction with convertible promissory notes-Accumulated Deficit [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c20110101to20111231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<!-- Warrants issued in conjunction with convertible promissory notes -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 14885 </us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<!-- Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Series A Preferred Stock [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<!-- Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Series A Preferred Stock [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<!-- Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Common Stock [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<!-- Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Common Stock [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<!-- Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Additional Paid-in Capital [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20110101to20111231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 1307869 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<!-- Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Additional Paid-in Capital [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20120101to20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 2075680 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<!-- Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Treasury Stock [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20110101to20111231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<!-- Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Treasury Stock [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20120101to20121231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<!-- Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Accumulated Deficit [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20110101to20111231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<!-- Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Accumulated Deficit [Member] -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20120101to20121231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<!-- Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 1307869 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<!-- Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition -->
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 2075680 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<!-- Share-based compensation expense-Cost of Products Sold [Member] -->
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="c20120101to20121231_IncomeStatementLocationAxis_CostOfSalesMember" unitRef="U001" decimals="0"> 97970 </us-gaap:AllocatedShareBasedCompensationExpense>
<!-- Share-based compensation expense-Cost of Products Sold [Member] -->
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="c20110101to20111231_IncomeStatementLocationAxis_CostOfSalesMember" unitRef="U001" decimals="0"> 98366 </us-gaap:AllocatedShareBasedCompensationExpense>
<!-- Share-based compensation expense-Research and Development [Member] -->
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="c20120101to20121231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U001" decimals="0"> 289341 </us-gaap:AllocatedShareBasedCompensationExpense>
<!-- Share-based compensation expense-Research and Development [Member] -->
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="c20110101to20111231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U001" decimals="0"> 254997 </us-gaap:AllocatedShareBasedCompensationExpense>
<!-- Share-based compensation expense-Administrative Expenses [Member] -->
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="c20120101to20121231_IncomeStatementLocationAxis_SellingGeneralAndAdministrativeExpensesMember" unitRef="U001" decimals="0"> 2151410 </us-gaap:AllocatedShareBasedCompensationExpense>
<!-- Share-based compensation expense-Administrative Expenses [Member] -->
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="c20110101to20111231_IncomeStatementLocationAxis_SellingGeneralAndAdministrativeExpensesMember" unitRef="U001" decimals="0"> 1305720 </us-gaap:AllocatedShareBasedCompensationExpense>
<!-- Share-based compensation expense -->
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 2538721 </us-gaap:AllocatedShareBasedCompensationExpense>
<!-- Share-based compensation expense -->
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 1659083 </us-gaap:AllocatedShareBasedCompensationExpense>
<!-- Allowance for doubtful accounts -->
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c20121231" unitRef="U001" decimals="0"> 49400 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<!-- Allowance for doubtful accounts -->
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c20111231" unitRef="U001" decimals="0"> 19500 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<!-- Accounts receivable charge-offs -->
<us-gaap:AllowanceForDoubtfulAccountsReceivableChargeOffs contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 27000 </us-gaap:AllowanceForDoubtfulAccountsReceivableChargeOffs>
<!-- Accounts receivable charge-offs -->
<us-gaap:AllowanceForDoubtfulAccountsReceivableChargeOffs contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 60000 </us-gaap:AllowanceForDoubtfulAccountsReceivableChargeOffs>
<!-- Amortization of intangible assets -->
<us-gaap:AmortizationOfIntangibleAssets contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 1380241 </us-gaap:AmortizationOfIntangibleAssets>
<!-- Amortization of intangible assets -->
<us-gaap:AmortizationOfIntangibleAssets contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 1335908 </us-gaap:AmortizationOfIntangibleAssets>
<!-- Amortization of debt discount and deferred financing costs -->
<us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 1714101 </us-gaap:AmortizationOfFinancingCostsAndDiscounts>
<!-- Amortization of debt discount and deferred financing costs -->
<us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 315152 </us-gaap:AmortizationOfFinancingCostsAndDiscounts>
<!-- Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Stock Options [Member] -->
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c20120101to20121231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_StockOptionsMember" unitRef="U002" decimals="0"> 13614135 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<!-- Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Stock Options [Member] -->
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c20110101to20111231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_StockOptionsMember" unitRef="U002" decimals="0"> 10333583 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<!-- Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Callable Warrants [Member] -->
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c20120101to20121231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U002" decimals="0"> 3129168 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<!-- Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Callable Warrants [Member] -->
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c20110101to20111231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U002" decimals="0"> 9388817 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<!-- Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Convertible Notes Payable [Member] -->
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c20120101to20121231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleNotesPayableMember" unitRef="U002" decimals="0"> 5313645 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<!-- Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Convertible Notes Payable [Member] -->
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c20110101to20111231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleNotesPayableMember" unitRef="U002" decimals="0"> 5007732 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<!-- Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Revolving Credit Facility [Member] -->
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c20120101to20121231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="0"> 0 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<!-- Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Revolving Credit Facility [Member] -->
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c20110101to20111231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="0"> 1342726 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<!-- Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-4% Convertible Debt [Member] -->
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c20120101to20121231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleDebtMember" unitRef="U002" decimals="0"> 0 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<!-- Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-4% Convertible Debt [Member] -->
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c20110101to20111231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleDebtMember" unitRef="U002" decimals="0"> 1299315 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<!-- Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount -->
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 22056948 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<!-- Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount -->
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c20110101to20111231" unitRef="U002" decimals="0"> 27372173 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<!-- Assets, Current -->
<us-gaap:AssetsCurrent contextRef="c20121231" unitRef="U001" decimals="0"> 18088791 </us-gaap:AssetsCurrent>
<!-- Assets, Current -->
<us-gaap:AssetsCurrent contextRef="c20111231" unitRef="U001" decimals="0"> 6881511 </us-gaap:AssetsCurrent>
<!-- Assets -->
<us-gaap:Assets contextRef="c20121231" unitRef="U001" decimals="0"> 35182608 </us-gaap:Assets>
<!-- Assets -->
<us-gaap:Assets contextRef="c20111231" unitRef="U001" decimals="0"> 27096192 </us-gaap:Assets>
<!-- Business Acquisition, Purchase Price Allocation, Current Liabilities, Accounts Payable -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayable contextRef="c20110105" unitRef="U001" decimals="0"> 196101 </us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayable>
<!-- Business Acquisition, Contingent Consideration, Shares Issuable -->
<us-gaap:BusinessAcquisitionContingentConsiderationSharesIssuable contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 600000 </us-gaap:BusinessAcquisitionContingentConsiderationSharesIssuable>
<!-- Prepaid Expenses -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets contextRef="c20110105" unitRef="U001" decimals="0"> 2738 </us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets>
<!-- Business Acquisition, Cost of Acquired Entity, Cash Paid -->
<us-gaap:BusinessAcquisitionCostOfAcquiredEntityCashPaid contextRef="c20110105" unitRef="U001" decimals="0"> 350000 </us-gaap:BusinessAcquisitionCostOfAcquiredEntityCashPaid>
<!-- Business Acquisition, Purchase Price Allocation, Net Tangible Assets -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets contextRef="c20110105" unitRef="U001" decimals="0"> 745131 </us-gaap:BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets>
<!-- Business Acquisition, Contingent Consideration, at Fair Value -->
<us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue contextRef="c20110105" unitRef="U001" decimals="0"> -7404700 </us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue>
<!-- Business Acquisition, Purchase Price Allocation, Goodwill Amount -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount contextRef="c20110105" unitRef="U001" decimals="0"> 3182846 </us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount>
<!-- Business Acquisition, Purchase Price Allocation, Current Liabilities, Deferred Revenue -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesDeferredRevenue contextRef="c20110105" unitRef="U001" decimals="0"> 36533 </us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesDeferredRevenue>
<!-- Business Acquisition, Purchase Price Allocation, Current Liabilities, Long-term Debt -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesLongTermDebt contextRef="c20110105" unitRef="U001" decimals="0"> 62590 </us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesLongTermDebt>
<!-- Business Acquisition, Contingent Consideration, Potential Cash Payment -->
<us-gaap:BusinessAcquisitionContingentConsiderationPotentialCashPayment contextRef="c20121231" unitRef="U001" decimals="0"> 200000 </us-gaap:BusinessAcquisitionContingentConsiderationPotentialCashPayment>
<!-- Other assets, net -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherAssets contextRef="c20110105" unitRef="U001" decimals="0"> 385 </us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherAssets>
<!-- Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet contextRef="c20110105" unitRef="U001" decimals="0"> 16424977 </us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet>
<!-- Cash -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents contextRef="c20110105" unitRef="U001" decimals="0"> 33583 </us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents>
<!-- Common Stock issued (in shares) -->
<us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="c20110104to20110105" unitRef="U002" decimals="0"> 5250000 </us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
<!-- Common Stock issued (in shares) -->
<us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="c20120401to20120430" unitRef="U002" decimals="0"> 2632576 </us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
<!-- Business Acquisition, Purchase Price Allocation, Liabilities Assumed -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed contextRef="c20110105" unitRef="U001" decimals="0"> -182777 </us-gaap:BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed>
<!-- Business Combination, Liabilities Arising from Contingencies, Amount Recognized -->
<us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized contextRef="c20111231" unitRef="U001" decimals="0"> 7410503 </us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
<!-- Business Combination, Liabilities Arising from Contingencies, Amount Recognized -->
<us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized contextRef="c20101231" unitRef="U001" decimals="0"> 0 </us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
<!-- Business Combination, Liabilities Arising from Contingencies, Amount Recognized -->
<us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized contextRef="c20121231" unitRef="U001" decimals="0"> 5792330 </us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
<!-- Inventory -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsInventory contextRef="c20110105" unitRef="U001" decimals="0"> 347106 </us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsInventory>
<!-- Business Acquisition, Purchase Price Allocation, Intangible Assets Other than Goodwill -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill contextRef="c20110105" unitRef="U001" decimals="0"> 12497000 </us-gaap:BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill>
<!-- Common Stock valued -->
<us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="c20110105" unitRef="U001" decimals="0"> 7087500 </us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
<!-- Common Stock valued -->
<us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="c20120731" unitRef="U001" decimals="0"> 893267 </us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
<!-- Business Acquisition, Cost of Acquired Entity, Equity Interests Issued and Issuable -->
<us-gaap:BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable contextRef="c20110105" unitRef="U001" decimals="0"> 7087500 </us-gaap:BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable>
<!-- Business Acquisition, Purchase Price Allocation, Current Assets, Receivables -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsReceivables contextRef="c20110105" unitRef="U001" decimals="0"> 181087 </us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsReceivables>
<!-- Business Acquisition, Cost of Acquired Entity, Purchase Price -->
<us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice contextRef="c20110105" unitRef="U001" decimals="0"> 16424977 </us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice>
<!-- Property, plant and equipment -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment contextRef="c20110105" unitRef="U001" decimals="0"> 72866 </us-gaap:BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment>
<!-- Business Combination Disclosure [Text Block] -->
<us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c20120101to20121231">
<div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"><div style="text-indent: 0pt; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">4.</div></td><td><div style="text-align: left; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Acquisition of Surgical Biologics, LLC</div></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div><div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">  <div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">On December 21, 2010, we entered into an Agreement and Plan of Merger ("the Merger Agreement") with Membrane Products Holdings, LLC and OnRamp Capital Investments, LLC, the owners of Surgical Biologics, LLC ("Surgical Biologics"), a privately held company headquartered in Kennesaw, Georgia.  This transaction closed on January 5, 2011 and as a result we acquired all of the outstanding shares of Surgical Biologics in exchange for $500,000 cash, a total of $1,250,000 in 4% Convertible Secured Promissory Notes, and $7,087,500 in stock, represented by 5,250,000 shares of our common stock (525,000 of which were held in escrow for the purpose of securing the indemnification obligations outlined in the Merger Agreement).  Contingent consideration shall be payable in a formula determined by sales for the years 2011 and 2012.  The significant unobservable inputs used in the fair value measurement of contingent consideration related to the acquisitions are annualized revenue forecasts developed by the Company's management and the probability of achievement of those revenue forecasts.  The contingent consideration was initially valued at $7,404,700 and is shown in the schedule below as fair value of earn-out (level 3 input under the valuation hierarchy).  We completed the acquisition of Surgical Biologics in an effort to extend our biomaterials product lines.  As of December 31, 2011, the Company evaluated the contingent liability based on operating results for the year, and adjusted the earn-out liability to $7,410,503.  On April 30, 2012, the Company issued 2,632,576 shares of its Common Stock valued at $3,185,223 in payment of the 2011 earn-out.  As of December 31, 2012, the Company evaluated the 2012 contingent liability based on operating results for the year ended December 31, 2012, and adjusted the 2012 earn-out liability to $5,792,330.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;"> </div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Accrued Earn - Out Acquisition Consideration</div><div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> </div></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Beginning balance at January 1,</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">7,410,503</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Valuation at acquisition date</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">7,404,700</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Remeasurement adjustments</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,567,050</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,803</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Common stock issued on earn - out</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(3,185,223</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Ending balance at December 31,</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">5,792,330</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">7,410,503</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">In total, the 4% Convertible Promissory Notes were convertible into up to 1,250,000 shares of the Company's common stock at $1.00 per share (a) at any time upon the election of the holder of the Convertible Notes; or (b) at the election of the Company, at any such time as the closing price per share of the Company's common stock (as reported by the OTCBB or on any national securities exchange on which the Company's shares may be listed, as the case may be) closes at no less than $1.75 per share for not less than 20 consecutive trading days in any period prior to the maturity date.  The 4% Convertible Promissory Notes matured in eighteen (18) months and earned interest at 4% per annum on the outstanding principal amount payable in cash on the maturity date or convertible into shares of common stock of the Company as provided for above.  The 4% Convertible Promissory Notes were secured by a security interest in the Intellectual Property, including the Patents and know-how and trade secrets related thereto, owned by, or exclusively licensed to, Surgical Biologics, LLC. In July, 2012, the Company settled the Convertible Promissory Notes by paying approximately $177,000 in cash and issuing 893,267 shares of MiMedx common stock.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company has evaluated the contingent consideration for accounting purposes under GAAP and has determined that the contingent consideration is within the scope of ASC 480 Distinguishing Liabilities from Equity whereby a financial instrument other than an outstanding share, that embodies a conditional obligation that the issuer may settle by issuing a variable number of its equity shares, shall be classified as a liability if, at inception, the monetary value of the obligation is based solely or predominantly on variations in something other than the fair value of the issuer's equity shares.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The actual purchase price was based on cash paid, the fair value of our stock on the date of the Surgical Biologics acquisition, and direct costs associated with the combination.  The actual purchase price was allocated as follows:</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Value of 5,250,000 shares issued at $1.35 per share</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">7,087,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cash paid at closing</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">350,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cash retained for working capital</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">150,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Assumed Debt</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">182,777</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Convertible Secured Promissory Note</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,250,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Fair value of earn-out</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">7,404,700</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Total fair value of purchase price</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">16,424,977</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Assets purchased:</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Tangible assets:</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Debt-free working capital</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">671,880</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Other assets, net</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">385</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Property, plant and equipment</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">72,866</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">745,131</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Intangible assets:</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Customer relationships</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3,520,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Supplier relationships</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">241,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Patents and know-how</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,530,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Trade names and trademarks</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,008,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">In-process research and development – liquid</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">2,160,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">In-process research and development – other</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">25,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Licenses and permits</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">13,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">12,497,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Goodwill</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">3,182,846</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Total Assets Purchased</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">16,424,977</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Working capital and other assets were composed of the following:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Working capital:</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Cash</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">33,583</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Prepaid Expenses</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">2,738</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Accounts Receivable</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">181,087</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">License Receivable</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">340,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Inventory</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">347,106</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Accounts payable and accrued expenses</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(196,101</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Deferred rent and customer deposits</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(36,533</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Debt-free working capital</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">671,880</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Current portion of debt</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(62,590</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Long-term debt</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(21,187</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Line of credit</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(99,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Net working capital</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">489,103</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Deposits</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">16,582</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Deferred rent (non-current)</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(16,197</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="padding-bottom: 4px; width: 68%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">385</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The combination was accounted for as a purchase business combination as defined by ASC Topic 805 – Business Combinations.  The allocation of the purchase price to the assets acquired and liabilities assumed was based on an independent valuation report obtained by us.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The values assigned to intangible assets are subject to amortization.  The intangible assets were assigned the following lives for amortization purposes:</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 70%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="top" style="width: 40%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="top" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Estimated useful</div></td></tr><tr><td align="left" valign="middle" style="padding-bottom: 2px; width: 40%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Intangible asset:</div></td><td valign="top" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">     life (in years)</div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Customer relationships</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14</div></td></tr><tr bgcolor="white"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Supplier relationships</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14</div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Patents and know-how</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14</div></td></tr><tr bgcolor="white"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Trade names and trademarks</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">indefinite</div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">In-process research and development – liquid</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">indefinite(a)</div></td></tr><tr bgcolor="white"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">In-process research and development – other</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">indefinite</div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Licenses and permits</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">3</div></td></tr></table></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(a)AmnioFix<font style="display: inline; font-size: 10pt;">®</font> injectable was launched in 2012 with amortization recorded over its expected useful life.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Goodwill consists of the excess of the purchase price paid over the identifiable net assets and liabilities acquired at fair value.  Goodwill was determined using the residual method based on an independent appraisal of the assets and liabilities acquired in the transaction.  Goodwill is tested for impairment as defined by ASC Topic 350 – Intangibles – Goodwill and Other.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div></div></div></div></div>
</us-gaap:BusinessCombinationDisclosureTextBlock>
<!-- Business Acquisition, Purchase Price Allocation, Noncurrent Liabilities, Long-term Debt -->
<us-gaap:BusinessAcquisitionPurchasePriceAllocationNoncurrentLiabilitiesLongTermDebt contextRef="c20110105" unitRef="U001" decimals="0"> 21187 </us-gaap:BusinessAcquisitionPurchasePriceAllocationNoncurrentLiabilitiesLongTermDebt>
<!-- Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low -->
<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow contextRef="c20111231" unitRef="U001" decimals="0"> 0 </us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow>
<!-- Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low -->
<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow contextRef="c20110105" unitRef="U001" decimals="0"> 7404700 </us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow>
<!-- Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability -->
<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 1567050 </us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
<!-- Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability -->
<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 5803 </us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
<!-- Equipment purchased under capital lease -->
<us-gaap:CapitalLeaseObligationsIncurred contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 84650 </us-gaap:CapitalLeaseObligationsIncurred>
<!-- Cash and cash equivalents -->
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c20121231" unitRef="U001" decimals="0"> 6754485 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<!-- Cash and cash equivalents -->
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c20111231" unitRef="U001" decimals="0"> 4112326 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<!-- Cash and cash equivalents -->
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c20101231" unitRef="U001" decimals="0"> 1340922 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<!-- Acquisition, cash acquired -->
<us-gaap:CashAcquiredFromAcquisition contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 33583 </us-gaap:CashAcquiredFromAcquisition>
<!-- Cash and Cash Equivalents, Policy [Policy Text Block] -->
<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Cash and Cash Equivalents</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Cash and cash equivalents include all highly liquid investments with an original maturity of three months or less.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div></div>
</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
<!-- Cash and Cash Equivalents, Period Increase (Decrease) -->
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 2642159 </us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<!-- Cash and Cash Equivalents, Period Increase (Decrease) -->
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 2771404 </us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<!-- FDIC insured amount -->
<us-gaap:CashFDICInsuredAmount contextRef="c20100731" unitRef="U001" decimals="0"> 250000 </us-gaap:CashFDICInsuredAmount>
<!-- FDIC insured amount -->
<us-gaap:CashFDICInsuredAmount contextRef="c20121231" unitRef="U001" decimals="0"> 250000 </us-gaap:CashFDICInsuredAmount>
<!-- Cash, Uninsured Amount -->
<us-gaap:CashUninsuredAmount contextRef="c20121231" unitRef="U001" decimals="0"> 6254000 </us-gaap:CashUninsuredAmount>
<!-- Class of Warrant or Right, Outstanding-Callable Warrants [Member] -->
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c20101231_ClassOfWarrantOrRightAxis_WarrantMember" unitRef="U002" decimals="0"> 6003924 </us-gaap:ClassOfWarrantOrRightOutstanding>
<!-- Class of Warrant or Right, Outstanding-Contingent Warrants [Member] -->
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c20101231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember" unitRef="U002" decimals="0"> 1252990 </us-gaap:ClassOfWarrantOrRightOutstanding>
<!-- Class of Warrant or Right, Outstanding-Callable Warrants [Member] -->
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c20111231_ClassOfWarrantOrRightAxis_WarrantMember" unitRef="U002" decimals="0"> 9388817 </us-gaap:ClassOfWarrantOrRightOutstanding>
<!-- Class of Warrant or Right, Outstanding-Contingent Warrants [Member] -->
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember" unitRef="U002" decimals="0"> 5245484 </us-gaap:ClassOfWarrantOrRightOutstanding>
<!-- Class of Warrant or Right, Outstanding-Callable Warrants [Member] -->
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c20121231_ClassOfWarrantOrRightAxis_WarrantMember" unitRef="U002" decimals="0"> 3129168 </us-gaap:ClassOfWarrantOrRightOutstanding>
<!-- Class of Warrant or Right, Outstanding-Contingent Warrants [Member] -->
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember" unitRef="U002" decimals="0"> 0 </us-gaap:ClassOfWarrantOrRightOutstanding>
<!-- Class of Warrant or Right, Exercise Price of Warrants or Rights-Callable Warrants [Member] -->
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="c20101231_ClassOfWarrantOrRightAxis_WarrantMember" unitRef="U003" decimals="2"> 1.21 </us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
<!-- Class of Warrant or Right, Exercise Price of Warrants or Rights-Contingent Warrants [Member] -->
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="c20101231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember" unitRef="U003" decimals="2"> 0.01 </us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
<!-- Class of Warrant or Right, Exercise Price of Warrants or Rights-Callable Warrants [Member] -->
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="c20111231_ClassOfWarrantOrRightAxis_WarrantMember" unitRef="U003" decimals="2"> 1.00 </us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
<!-- Class of Warrant or Right, Exercise Price of Warrants or Rights-Contingent Warrants [Member] -->
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="c20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember" unitRef="U003" decimals="2"> 0.01 </us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
<!-- Class of Warrant or Right, Exercise Price of Warrants or Rights-Callable Warrants [Member] -->
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="c20121231_ClassOfWarrantOrRightAxis_WarrantMember" unitRef="U003" decimals="2"> 1.04 </us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
<!-- Class of Warrant or Right, Exercise Price of Warrants or Rights-Contingent Warrants [Member] -->
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="c20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember" unitRef="U003" decimals="0"> 0 </us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
<!-- Number of warrants called (in shares) -->
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c20120731" unitRef="U002" decimals="0"> 3345000 </us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<!-- Commitments and Contingencies Disclosure [Text Block] -->
<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">15.   Commitments</div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-align: left; font-style: italic; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Contractual Arrangements</div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">  <div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company has entered into operating lease agreements for facility space and equipment, and employment agreements with our Vice President of Sales for Europe, Middle East and Africa and for some key employees acquired with Surgical Biologics.  In addition, the Company has minimum royalty payments due in conjunction with one of its licenses.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The estimated annual lease, royalty, and employment agreement expenses are as follows:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; padding-left: 0pt; margin-left: 9pt;"><div style="text-align: center; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 54pt; font-size: 10pt; margin-right: 0pt;">Year ended December 31,</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2013</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">423,206</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2014</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">204,700</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Thereafter</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">542,021</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 4px; width: 68%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,169,927</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Rent expense on all operating leases for the years ended December 31, 2012 and 2011, respectively, was approximately $528,000 and $533,000.</div></div></div>
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
<!-- Commitments and contingencies (Notes 14 and 15) -->
<us-gaap:CommitmentsAndContingencies contextRef="c20121231" unitRef="U001" xsi:nil="true"/>
<!-- Commitments and contingencies (Notes 14 and 15) -->
<us-gaap:CommitmentsAndContingencies contextRef="c20111231" unitRef="U001" xsi:nil="true"/>
<!-- Common stock, shares outstanding (in shares) -->
<us-gaap:CommonStockSharesOutstanding contextRef="c20121231" unitRef="U002" decimals="0"> 88373169 </us-gaap:CommonStockSharesOutstanding>
<!-- Common stock, shares outstanding (in shares) -->
<us-gaap:CommonStockSharesOutstanding contextRef="c20111231" unitRef="U002" decimals="0"> 74256895 </us-gaap:CommonStockSharesOutstanding>
<!-- Common stock; $.001 par value; 130,000,000 shares authorized; 88,423,169 issued and 88,373,169 outstanding for 2012 and 74,306,895 issued and 74,256,895 outstanding for 2011 -->
<us-gaap:CommonStockValue contextRef="c20121231" unitRef="U001" decimals="0"> 88423 </us-gaap:CommonStockValue>
<!-- Common stock; $.001 par value; 130,000,000 shares authorized; 88,423,169 issued and 88,373,169 outstanding for 2012 and 74,306,895 issued and 74,256,895 outstanding for 2011 -->
<us-gaap:CommonStockValue contextRef="c20111231" unitRef="U001" decimals="0"> 74307 </us-gaap:CommonStockValue>
<!-- Common stock, shares issued (in shares) -->
<us-gaap:CommonStockSharesIssued contextRef="c20121231" unitRef="U002" decimals="0"> 88423169 </us-gaap:CommonStockSharesIssued>
<!-- Common stock, shares issued (in shares) -->
<us-gaap:CommonStockSharesIssued contextRef="c20111231" unitRef="U002" decimals="0"> 74306895 </us-gaap:CommonStockSharesIssued>
<!-- Common stock, shares issued (in shares) -->
<us-gaap:CommonStockSharesIssued contextRef="c20120731" unitRef="U002" decimals="0"> 3289000 </us-gaap:CommonStockSharesIssued>
<!-- Common stock, par value (in dollars per share) -->
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="c20121231" unitRef="U003" decimals="3"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare>
<!-- Common stock, par value (in dollars per share) -->
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="c20111231" unitRef="U003" decimals="3"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare>
<!-- Common stock, shares authorized (in shares) -->
<us-gaap:CommonStockSharesAuthorized contextRef="c20121231" unitRef="U002" decimals="0"> 130000000 </us-gaap:CommonStockSharesAuthorized>
<!-- Common stock, shares authorized (in shares) -->
<us-gaap:CommonStockSharesAuthorized contextRef="c20111231" unitRef="U002" decimals="0"> 130000000 </us-gaap:CommonStockSharesAuthorized>
<!-- Market Concentrations and Credit Risk -->
<us-gaap:ConcentrationRiskCreditRisk contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Market Concentrations and Credit Risk</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company places its cash and cash equivalents on deposit with financial institutions in the United States.  In July 2010, the Federal Deposit Insurance Corporation ("FDIC") increased coverage to $250,000 for substantially all depository accounts and temporarily provides unlimited coverage for certain qualifying and participating non-interest bearing transaction accounts.  The temporary unlimited coverage expired on December 31, 2012, at which time the amounts insured by the FDIC returned to $250,000. As of January 1, 2013, the Company had cash and cash equivalents of approximately $6,254,000 in excess of these insured amounts.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company's principal market concentration of risk is related to its limited distribution channels.  Three customers accounted for approximately 68% of revenues for the year ended December 31, 2012, including one customer who represented 40% and another customer which represented 21% of total revenue.  Two customers accounted for approximately 37% of the revenues for the year ended December 31, 2011, including one customer who represented 19% and another customer which represented 18% of total revenue.  The Company's accounts receivable are derived from customers primarily located in the United States of America.  As of December 31, 2012 two customers accounted for 78% of total accounts receivable, 53% and 25% respectively compared to December 31, 2011 when two customers accounted for 43% of total accounts receivable, 33% and 10%, respectively.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div></div>
</us-gaap:ConcentrationRiskCreditRisk>
<!-- Concentration of risk (in hundredths)-Revenue [Member] -->
<us-gaap:ConcentrationRiskPercentage1 contextRef="c20120101to20121231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember" unitRef="U005" decimals="2"> 0.68 </us-gaap:ConcentrationRiskPercentage1>
<!-- Concentration of risk (in hundredths)-Revenue [Member]-First Customer [Member] -->
<us-gaap:ConcentrationRiskPercentage1 contextRef="c20120101to20121231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember_ConcentrationRiskByTypeAxis_FirstCustomerMember" unitRef="U005" decimals="1"> 0.4 </us-gaap:ConcentrationRiskPercentage1>
<!-- Concentration of risk (in hundredths)-Revenue [Member]-Second Customer [Member] -->
<us-gaap:ConcentrationRiskPercentage1 contextRef="c20120101to20121231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember_ConcentrationRiskByTypeAxis_SecondCustomerMember" unitRef="U005" decimals="2"> 0.21 </us-gaap:ConcentrationRiskPercentage1>
<!-- Concentration of risk (in hundredths)-Revenue [Member] -->
<us-gaap:ConcentrationRiskPercentage1 contextRef="c20110101to20111231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember" unitRef="U005" decimals="2"> 0.37 </us-gaap:ConcentrationRiskPercentage1>
<!-- Concentration of risk (in hundredths)-Revenue [Member]-First Customer [Member] -->
<us-gaap:ConcentrationRiskPercentage1 contextRef="c20110101to20111231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember_ConcentrationRiskByTypeAxis_FirstCustomerMember" unitRef="U005" decimals="2"> 0.19 </us-gaap:ConcentrationRiskPercentage1>
<!-- Concentration of risk (in hundredths)-Revenue [Member]-Second Customer [Member] -->
<us-gaap:ConcentrationRiskPercentage1 contextRef="c20110101to20111231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember_ConcentrationRiskByTypeAxis_SecondCustomerMember" unitRef="U005" decimals="2"> 0.18 </us-gaap:ConcentrationRiskPercentage1>
<!-- Concentration of risk (in hundredths)-Accounts Receivable [Member] -->
<us-gaap:ConcentrationRiskPercentage1 contextRef="c20120101to20121231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember" unitRef="U005" decimals="2"> 0.78 </us-gaap:ConcentrationRiskPercentage1>
<!-- Concentration of risk (in hundredths)-First Customer [Member]-Accounts Receivable [Member] -->
<us-gaap:ConcentrationRiskPercentage1 contextRef="c20120101to20121231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_ConcentrationRiskByTypeAxis_FirstCustomerMember" unitRef="U005" decimals="2"> 0.53 </us-gaap:ConcentrationRiskPercentage1>
<!-- Concentration of risk (in hundredths)-Second Customer [Member]-Accounts Receivable [Member] -->
<us-gaap:ConcentrationRiskPercentage1 contextRef="c20120101to20121231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_ConcentrationRiskByTypeAxis_SecondCustomerMember" unitRef="U005" decimals="2"> 0.25 </us-gaap:ConcentrationRiskPercentage1>
<!-- Concentration of risk (in hundredths)-Accounts Receivable [Member] -->
<us-gaap:ConcentrationRiskPercentage1 contextRef="c20110101to20111231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember" unitRef="U005" decimals="2"> 0.43 </us-gaap:ConcentrationRiskPercentage1>
<!-- Concentration of risk (in hundredths)-First Customer [Member]-Accounts Receivable [Member] -->
<us-gaap:ConcentrationRiskPercentage1 contextRef="c20110101to20111231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_ConcentrationRiskByTypeAxis_FirstCustomerMember" unitRef="U005" decimals="2"> 0.33 </us-gaap:ConcentrationRiskPercentage1>
<!-- Concentration of risk (in hundredths)-Second Customer [Member]-Accounts Receivable [Member] -->
<us-gaap:ConcentrationRiskPercentage1 contextRef="c20110101to20111231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_ConcentrationRiskByTypeAxis_SecondCustomerMember" unitRef="U005" decimals="1"> 0.1 </us-gaap:ConcentrationRiskPercentage1>
<!-- Consolidation, Policy [Policy Text Block] -->
<us-gaap:ConsolidationPolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Principles of Consolidation</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The accompanying financial statements include the accounts of MiMedx Group, Inc. and its wholly-owned subsidiaries MiMedx, Inc., SpineMedica, LLC., and Surgical Biologics, LLC. All significant inter-company balances and transactions have been eliminated</div></div>
</us-gaap:ConsolidationPolicyTextBlock>
<!-- Contractual Obligation, Due in Second Year -->
<us-gaap:ContractualObligationDueInSecondYear contextRef="c20121231" unitRef="U001" decimals="0"> 423206 </us-gaap:ContractualObligationDueInSecondYear>
<!-- Estimated annual lease, royalty, and employment agreement expenses -->
<us-gaap:ContractualObligationFiscalYearMaturityScheduleTableTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The estimated annual lease, royalty, and employment agreement expenses are as follows:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; padding-left: 0pt; margin-left: 9pt;"><div style="text-align: center; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 54pt; font-size: 10pt; margin-right: 0pt;">Year ended December 31,</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2013</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">423,206</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2014</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">204,700</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Thereafter</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">542,021</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 4px; width: 68%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,169,927</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div>
</us-gaap:ContractualObligationFiscalYearMaturityScheduleTableTextBlock>
<!-- Contractual Obligation, Due in Third Year -->
<us-gaap:ContractualObligationDueInThirdYear contextRef="c20121231" unitRef="U001" decimals="0"> 204700 </us-gaap:ContractualObligationDueInThirdYear>
<!-- Contractual Obligation -->
<us-gaap:ContractualObligation contextRef="c20121231" unitRef="U001" decimals="0"> 1169927 </us-gaap:ContractualObligation>
<!-- Outstanding convertible debt and accrued interest (in shares) -->
<us-gaap:ConversionOfStockSharesIssued1 contextRef="c20110101to20111231" unitRef="U002" decimals="0"> 406664 </us-gaap:ConversionOfStockSharesIssued1>
<!-- Convertible Senior Secured Promissory Notes -->
<us-gaap:ConvertibleLongTermNotesPayable contextRef="c20121231" unitRef="U001" decimals="0"> 4012442 </us-gaap:ConvertibleLongTermNotesPayable>
<!-- Convertible Senior Secured Promissory Notes -->
<us-gaap:ConvertibleLongTermNotesPayable contextRef="c20111231" unitRef="U001" decimals="0"> 2744587 </us-gaap:ConvertibleLongTermNotesPayable>
<!-- Cost of products sold -->
<us-gaap:CostOfGoodsSold contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 5188378 </us-gaap:CostOfGoodsSold>
<!-- Cost of products sold -->
<us-gaap:CostOfGoodsSold contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 3357909 </us-gaap:CostOfGoodsSold>
<!-- Debt Conversion, Converted Instrument, Amount-Subsequent Event [Member]-Issuance of Equity [Member] -->
<us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c20120101to20121231_FinancingAxis_IssuanceOfEquityMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="0"> 5271963 </us-gaap:DebtConversionConvertedInstrumentAmount1>
<!-- Total debt-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<us-gaap:DebtInstrumentCarryingAmount contextRef="c20121231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U001" decimals="0" id="Item-1"> 5313645 </us-gaap:DebtInstrumentCarryingAmount>
<!-- Total debt-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<us-gaap:DebtInstrumentCarryingAmount contextRef="c20111231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U001" decimals="0" id="Item-2"> 5007732 </us-gaap:DebtInstrumentCarryingAmount>
<!-- Total debt-Revolving Credit Facility [Member] -->
<us-gaap:DebtInstrumentCarryingAmount contextRef="c20121231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="0" id="Item-3"> 0 </us-gaap:DebtInstrumentCarryingAmount>
<!-- Total debt-Revolving Credit Facility [Member] -->
<us-gaap:DebtInstrumentCarryingAmount contextRef="c20111231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="0" id="Item-4"> 1342726 </us-gaap:DebtInstrumentCarryingAmount>
<!-- Total debt-4% Convertible Debt [Member] -->
<us-gaap:DebtInstrumentCarryingAmount contextRef="c20121231_DebtInstrumentAxis_ConvertibleDebtMember" unitRef="U001" decimals="0"> 0 </us-gaap:DebtInstrumentCarryingAmount>
<!-- Total debt-4% Convertible Debt [Member] -->
<us-gaap:DebtInstrumentCarryingAmount contextRef="c20111231_DebtInstrumentAxis_ConvertibleDebtMember" unitRef="U001" decimals="0"> 1299315 </us-gaap:DebtInstrumentCarryingAmount>
<!-- Total debt -->
<us-gaap:DebtInstrumentCarryingAmount contextRef="c20121231" unitRef="U001" decimals="0"> 5313645 </us-gaap:DebtInstrumentCarryingAmount>
<!-- Total debt -->
<us-gaap:DebtInstrumentCarryingAmount contextRef="c20111231" unitRef="U001" decimals="0"> 7649773 </us-gaap:DebtInstrumentCarryingAmount>
<!-- Convertible promissory note, stock price trigger (in dollars per share) -->
<us-gaap:DebtInstrumentConvertibleStockPriceTrigger contextRef="c20120101to20121231" unitRef="U003" decimals="2"> 1.75 </us-gaap:DebtInstrumentConvertibleStockPriceTrigger>
<!-- Fair value of short term and long term convertible debt -->
<us-gaap:DebtInstrumentFairValue contextRef="c20121231" unitRef="U001" decimals="0"> 5169000 </us-gaap:DebtInstrumentFairValue>
<!-- Debt Disclosure [Text Block] -->
<us-gaap:DebtDisclosureTextBlock contextRef="c20120101to20121231">
<div><div><div><div><div style="text-align: left;"><div>  <div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"><div style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9.</div></td><td><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Long-Term Debt</div></td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The following table summarizes our long-term debt:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="6" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; text-indent: 0pt; width: 76%; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">$5M Convertible Senior Secured Promissory Notes including  interest at 5% per annum payable quarterly through December 31, 2013, and an additional one time 5% interest charge payable on January 15, 2013 if not repaid by December 31, 2012, collateralized by a first priority lien shared equally with holder of the Convertible Line of Credit with Related Party in all of the patents and intellectual property owned by the Company subordinated to the Convertible Debt related to acquisition for Surgical Biologics intellectual property until repaid. (a)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,313,645</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,007,732</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 76%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; text-indent: 0pt; width: 76%; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Convertible Line of Credit with Related Party with 5% interest; principal and interest payable in full December 31, 2012 collateralized by a first priority lien shared equally with holders of Convertible Senior Secured Promissory Notes in all patents and intellectual property of the Company subordinated to the Convertible debt related to the acquisition for Surgical Biologics intellectual property until repaid. (b)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,342,726</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 76%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; text-indent: 0pt; width: 76%; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Convertible debt related to acquisition with 4% interest; principal and interest payable in full on July 5, 2012, collateralized by a first priority lien in all the intellectual property owned by Surgical Biologics immediately after the closing. (c)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,299,315</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 2px; width: 76%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Total debt</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,313,645</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">7,649,773</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 76%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Less unamortized debt discount</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(1,301,203</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(2,480,400</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td valign="bottom" style="width: 76%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Less current portion</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(2,424,786</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td valign="bottom" style="width: 76%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Long-term portion</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">4,012,442</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">2,744,587</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">(a) </font><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Investors received First Contingent Warrants (25% of amount invested) and Second Contingent Warrants (25% of amount invested) at an exercise price of $.01 per share. In March 2012 a total of 1,250,000 First Contingent Warrants were vested. In July 2012, a total of 1,250,000 Second Contingent Warrants were voided due to the Company share price trading at or above $1.75 for ten consecutive trading days. The additional interest resulting from the beneficial conversion feature, inclusive of the First Contingent Warrants, totaled $2,278,052 which has been recorded as a debt discount that has been and will continue to be charged to interest expense using the effective interest rate over the life of the note.</font></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">(b) </font><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">The same terms offered to the Senior Secured Promissory note with regard to Contingent Warrants applied to the Convertible Line of Credit. In March 2012 a total of 325,000 First Contingent Warrants vested. In July 2012, a total of 325,000 Second Contingent Warrants were voided. The additional interest related to the beneficial conversion feature totaled $594,456 and was recorded as a debt discount and charged to interest expense using the effective interest rate over the life of the note. On December 7, 2012, the Chairman and CEO elected to convert his note and accrued interest resulting in the issuance of 1,403,630 shares of MiMedx common stock.</font></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">(c) </font><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Additional financing expense of $437,500 was recorded for the beneficial conversion feature of the convertible notes over the term of the note. In July, 2012, the Company settled the Convertible Promissory Notes by paying approximately $177,000 in cash and issuing 893,267 shares of MiMedx common stock.</font></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: bold italic 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: bold italic 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Convertible Line of Credit with related party</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">On March 31, 2011, the Company and its Chairman of the Board and CEO ("the Lender") entered into a Subscription Agreement for a 5% Convertible Senior Secured Promissory Note ("Subscription Agreement") and, in connection therewith, agreed to issue a 5% Convertible Senior Secured Promissory Note ("Note") in the amount borrowed by the Company.  At the option of the Lender, the Note was convertible into the number of shares of common stock of the Company equal to the quotient of the outstanding principal amount and accrued interest of the Note as of the date of such election divided by $1.00 per share.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: bold italic 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Senior Secured Promissory Notes</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">From December 27 to December 31, 2011, the Company sold 5% Convertible Senior Secured Promissory Notes (the "Notes") to individual accredited investors for aggregate proceeds of $5,000,000.  The aggregate proceeds included $500,000 of Notes sold to the Company's Chairman of the Board and CEO.  In total, the principal of the Notes is convertible into up to 5,000,000 shares of common stock of the Company ("Common Stock") plus accrued but unpaid interest at $1.00 per share at any time upon the election of the holder of the note.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">As of December 31, 2012 the Company had not repaid the Notes in full and as a result requires the Company to pay each lender an additional interest payment in the amount of five percent (5%) of the aggregate outstanding principal amount of such lender's Notes as of December 31, 2012.  The additional interest was accrued on a monthly basis during the year.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">In conjunction with the sale of the Convertible Senior Secured Promissory notes, the Company incurred a placement fee of $32,800 and issued 42,400 common stock warrants to the placement agents at an exercise price of $1.09 per share.  The warrants expire in five years.  The fair value of the warrants was determined to be approximately $15,000 using the Black-Scholes-Merton valuation technique.  The total direct costs of approximately $47,800 are recorded as deferred financing costs and are being amortized over the term of the Senior Notes using the effective interest method.  Further, the placement agent warrants are classified in stockholders' equity because they achieved all of the requisite conditions for equity classification in accordance with GAAP.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">In January and February of 2013 all note holders elected to convert their notes including the Company's Chairman and CEO, resulting in the issuance of 5,271,963 shares of common stock which represents the face value of their respective notes plus accrued but unpaid interest.  The Company's Chairman and CEO received 532,260 shares of common stock upon conversion of his note.  This will also result in the acceleration of amortization of debt discount of $1,301,000 in the same period.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div></div></div></div></div></div></div>
</us-gaap:DebtDisclosureTextBlock>
<!-- Conversion of Convertible Secured Promissory Notes related to the acquisition of Surgical Biologics (in shares) -->
<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 893267 </us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
<!-- Conversion of Convertible Secured Promissory Notes related to the acquisition of Surgical Biologics (in shares)-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="c20130101to20130228_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U002" decimals="0"> 5271963 </us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
<!-- Conversion of Convertible Secured Promissory Notes related to the acquisition of Surgical Biologics (in shares)-Five Percent Convertible Senior Secured Promissory Note [Member]-Chairman and CEO [Member] -->
<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="c20130101to20130228_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember_LineOfCreditFacilityAxis_BoardOfDirectorsChairmanMember" unitRef="U002" decimals="0"> 532260 </us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
<!-- Conversion of Convertible Secured Promissory Notes related to the acquisition of Surgical Biologics (in shares)-Subsequent Event [Member]-Issuance of Equity [Member]-Chairman and CEO [Member] -->
<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="c20130101to20130228_FinancingAxis_IssuanceOfEquityMember_RelatedPartyTransactionsByRelatedPartyAxis_BoardOfDirectorsChairmanMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U002" decimals="0"> 532260 </us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
<!-- Conversion of Convertible Secured Promissory Notes related to the acquisition of Surgical Biologics (in shares)-Subsequent Event [Member]-Issuance of Equity [Member] -->
<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="c20130101to20130228_FinancingAxis_IssuanceOfEquityMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U002" decimals="0"> 5271963 </us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
<!-- Convertible Promissory Note, conversion price (in dollars per share) -->
<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="c20121231" unitRef="U003" decimals="2"> 1.00 </us-gaap:DebtInstrumentConvertibleConversionPrice1>
<!-- Debt Instrument, Convertible, Beneficial Conversion Feature -->
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 80000 </us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<!-- Debt Instrument, Convertible, Beneficial Conversion Feature -->
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 514456 </us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<!-- Debt Instrument, Convertible, Number of Equity Instruments-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments contextRef="c20110101to20111231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U005" decimals="0"> 5000000 </us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
<!-- Direct costs of sale of notes-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<us-gaap:DebtIssuanceCosts contextRef="c20120101to20121231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U001" decimals="0"> 47800 </us-gaap:DebtIssuanceCosts>
<!-- Debt, Policy [Policy Text Block] -->
<us-gaap:DebtPolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Debt Instruments with Detachable Warrants and Beneficial Conversion Features</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">According to ASC-470 Debt Instruments with Detachable Warrants, proceeds from the sale of convertible debt instruments with stock purchase warrants (detachable call options) shall be allocated to the two elements based upon the relative fair values of the debt instrument without the warrants and of the warrants themselves at the time of issuance.  The portion of the proceeds so allocated to the warrants shall be accounted for as paid-in capital.  The remainder of the proceeds shall be allocated to the debt instrument portion of the transaction.  Also, the embedded beneficial conversion feature present in the convertible instrument shall be recognized separately at issuance by allocating a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div></div>
</us-gaap:DebtPolicyTextBlock>
<!-- Debt Instrument, Maturity Date-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<us-gaap:DebtInstrumentMaturityDate contextRef="c20120101to20121231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember"> 2013-12-31 </us-gaap:DebtInstrumentMaturityDate>
<!-- Debt Instrument, Maturity Date-Revolving Credit Facility [Member] -->
<us-gaap:DebtInstrumentMaturityDate contextRef="c20110101to20111231_CreditFacilityAxis_RevolvingCreditFacilityMember"> 2012-12-31 </us-gaap:DebtInstrumentMaturityDate>
<!-- Debt Instrument, Maturity Date-4% Convertible Debt [Member] -->
<us-gaap:DebtInstrumentMaturityDate contextRef="c20110101to20111231_DebtInstrumentAxis_ConvertibleDebtMember"> 2012-07-05 </us-gaap:DebtInstrumentMaturityDate>
<!-- Debt Instrument, Unamortized Discount -->
<us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c20121231" unitRef="U001" decimals="0"> 1301203 </us-gaap:DebtInstrumentUnamortizedDiscount>
<!-- Debt Instrument, Unamortized Discount -->
<us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c20111231" unitRef="U001" decimals="0"> 2480400 </us-gaap:DebtInstrumentUnamortizedDiscount>
<!-- Convertible Promissory Notes, interest rate (in hundredths) -->
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c20110105" unitRef="U005" decimals="2"> 0.04 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<!-- Convertible Promissory Notes, interest rate (in hundredths)-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c20121231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U005" decimals="2"> 0.05 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<!-- Convertible Promissory Notes, interest rate (in hundredths)-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c20111231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U005" decimals="2"> 0.05 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<!-- Convertible Promissory Notes, interest rate (in hundredths)-Revolving Credit Facility [Member] -->
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c20111231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U005" decimals="2"> 0.05 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<!-- Convertible Promissory Notes, interest rate (in hundredths)-4% Convertible Debt [Member] -->
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c20111231_DebtInstrumentAxis_ConvertibleDebtMember" unitRef="U005" decimals="2"> 0.04 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<!-- Deferred Tax Assets, Property, Plant and Equipment -->
<us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c20121231" unitRef="U001" decimals="0"> 89000 </us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
<!-- Intangible assets -->
<us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c20121231" unitRef="U001" decimals="0"> 1117000 </us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
<!-- Intangible assets -->
<us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c20111231" unitRef="U001" decimals="0"> 249000 </us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
<!-- Additional financing expense -->
<us-gaap:DeferredFinanceCostsGross contextRef="c20121231" unitRef="U001" decimals="0"> 437500 </us-gaap:DeferredFinanceCostsGross>
<!-- Deferred Tax Assets, Net of Valuation Allowance -->
<us-gaap:DeferredTaxAssetsNet contextRef="c20121231" unitRef="U001" decimals="0"> 0 </us-gaap:DeferredTaxAssetsNet>
<!-- Deferred Tax Assets, Net of Valuation Allowance -->
<us-gaap:DeferredTaxAssetsNet contextRef="c20111231" unitRef="U001" decimals="0"> 0 </us-gaap:DeferredTaxAssetsNet>
<!-- Deferred Tax Assets, Net -->
<us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c20121231" unitRef="U001" decimals="0"> 18368303 </us-gaap:DeferredTaxAssetsLiabilitiesNet>
<!-- Deferred Tax Assets, Net -->
<us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c20111231" unitRef="U001" decimals="0"> 15453000 </us-gaap:DeferredTaxAssetsLiabilitiesNet>
<!-- Charitable Contributions -->
<us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards contextRef="c20121231" unitRef="U001" decimals="0"> 3000 </us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
<!-- Charitable Contributions -->
<us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards contextRef="c20111231" unitRef="U001" decimals="0"> 0 </us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
<!-- Net operating loss -->
<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c20121231" unitRef="U001" decimals="0"> 15487000 </us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
<!-- Net operating loss -->
<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c20111231" unitRef="U001" decimals="0"> 15524000 </us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
<!-- R&D tax credit carryforwards -->
<us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c20121231" unitRef="U001" decimals="0"> 1407356 </us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
<!-- R&D tax credit carryforwards -->
<us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c20111231" unitRef="U001" decimals="0"> 157500 </us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
<!-- Accrued liabilities -->
<us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c20111231" unitRef="U001" decimals="0"> 131000 </us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
<!-- Stock Compensation -->
<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c20121231" unitRef="U001" decimals="0"> 213000 </us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
<!-- Stock Compensation -->
<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c20111231" unitRef="U001" decimals="0"> 0 </us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
<!-- Deferred Tax Assets, Valuation Allowance -->
<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c20121231" unitRef="U001" decimals="0"> 18368303 </us-gaap:DeferredTaxAssetsValuationAllowance>
<!-- Deferred Tax Assets, Valuation Allowance -->
<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c20111231" unitRef="U001" decimals="0"> 15453000 </us-gaap:DeferredTaxAssetsValuationAllowance>
<!-- Deferred Tax Liabilities, Property, Plant and Equipment -->
<us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c20111231" unitRef="U001" decimals="0"> 18000 </us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
<!-- Employer matching contribution (in hundredths) -->
<us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent contextRef="c20120101to20121231" unitRef="U005" decimals="2"> 0.06 </us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
<!-- Depreciation -->
<us-gaap:Depreciation contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 465367 </us-gaap:Depreciation>
<!-- Depreciation -->
<us-gaap:Depreciation contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 446502 </us-gaap:Depreciation>
<!-- Depreciation-Cost of Products Sold [Member] -->
<us-gaap:Depreciation contextRef="c20120101to20121231_IncomeStatementLocationAxis_CostOfSalesMember" unitRef="U001" decimals="0"> 155987 </us-gaap:Depreciation>
<!-- Depreciation-Cost of Products Sold [Member] -->
<us-gaap:Depreciation contextRef="c20110101to20111231_IncomeStatementLocationAxis_CostOfSalesMember" unitRef="U001" decimals="0"> 104950 </us-gaap:Depreciation>
<!-- Depreciation-Research and Development [Member] -->
<us-gaap:Depreciation contextRef="c20120101to20121231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U001" decimals="0"> 120260 </us-gaap:Depreciation>
<!-- Depreciation-Research and Development [Member] -->
<us-gaap:Depreciation contextRef="c20110101to20111231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U001" decimals="0"> 118565 </us-gaap:Depreciation>
<!-- Depreciation-Administrative Expenses [Member] -->
<us-gaap:Depreciation contextRef="c20120101to20121231_IncomeStatementLocationAxis_SellingGeneralAndAdministrativeExpensesMember" unitRef="U001" decimals="0"> 189120 </us-gaap:Depreciation>
<!-- Depreciation-Administrative Expenses [Member] -->
<us-gaap:Depreciation contextRef="c20110101to20111231_IncomeStatementLocationAxis_SellingGeneralAndAdministrativeExpensesMember" unitRef="U001" decimals="0"> 222987 </us-gaap:Depreciation>
<!-- Disclosure of Compensation Related Costs, Share-based Payments [Text Block] -->
<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c20120101to20121231">
<div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 10pt;"><tr valign="top"><td style="width: 13.5pt;"><div style="display: inline; font-family: Times New Roman; font-size: 10pt;"></div></td><td><div style="text-align: left; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">11.  Equity</div></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-align: left; font-style: italic; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Stock Incentive Plan</div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">  <div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company has three share-based compensation plans, the MiMedx Group, Inc. Assumed 2006 Stock Incentive Plan (the "2006 Plan"), the MiMedx Inc. 2007 Assumed Stock Plan (the "Assumed 2007 Plan") and the MiMedx Group Inc. Amended and Restated Assumed 2005 Stock Plan (the "Assumed 2005 Plan") which provide for the granting of qualified incentive and non-qualified stock options, stock appreciation awards and restricted stock awards to employees, directors, consultants and advisors.  The awards are subject to a vesting schedule as set forth in each individual agreement.  The Company intends to use only the 2006 Plan to make future grants.  The number of assumed options under the Assumed 2005 Plan and Assumed 2007 Plan outstanding at December 31, 2012 and December 31, 2011 totaled 375,000.  The maximum number of shares of common stock which can be issued under the 2006 Plan is 16,500,000 at December 31, 2012 and 12,500,000 at December 31, 2011, with an increase of 4,000,000 shares in May 2012.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Activity with respect to the stock options is summarized as follows:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number of</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Shares</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Price</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Remaining</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Contractual</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Term</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">(in years)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Aggregate</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Intrinsic</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Outstanding at January 1, 2011</div></td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">8,257,650</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.20</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Granted</div></td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">3,918,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Exercised</div></td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">(490,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">0.60</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Unvested options forfeited</div></td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">(217,252</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.10</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Vested options expired</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(1,135,315</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.70</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Outstanding at December 31, 2011</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">10,333,583</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">7.1</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,457,218</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Vested or expected to vest at December 31, 2011</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">10,283,583</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5.7</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,395,223</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 52%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Outstanding at January 1, 2012</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">10,333,583</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Granted</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,307,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.90</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Exercised</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(843,862</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.25</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Unvested options forfeited</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(387,171</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Vested options expired</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(795,915</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.55</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Outstanding at December 31, 2012</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">13,614,135</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.42</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">8.0</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">32,924,881</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Vested or expected to vest at December 31, 2012</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">13,367,278</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.41</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">7.9</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">32,490,930</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The intrinsic value of options exercised during the year ended December 31, 2012, was approximately $718,978 and was $258,000 for the year ended December 31, 2011.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The following is a summary of stock options outstanding for years ended December 31, 2012 and 2011, respectively:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><div style="text-align: left;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 30%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="10" valign="bottom" style="width: 42%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 11%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 30%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="10" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Options Outstanding</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Options Exercisable</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Range of Exercise Prices</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number outstanding</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Remaining</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Contractual</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Term</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">(in years)</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise Price</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number Exercisable</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise Price</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$0.50 - $0.76</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2,372,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">5.3</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">0.66</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2,372,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.66</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$0.87 - $1.35</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">7,048,668</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">8.6</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1.15</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1,674,638</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.15</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$1.40 - $2.18</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1,958,467</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">6.8</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1.68</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1,189,459</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.68</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$2.29 - $3.47</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2,177,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">9.7</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$3.49 - $3.85</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">57,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 15%; font-family: 'times new roman'; font-size: 10pt;">10.0</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 10%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 9%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 30%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">13,614,135</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 15%; font-family: 'times new roman'; font-size: 10pt;">8.0</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1.42</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">5,236,597</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.05</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div> </div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr bgcolor="white"><td valign="bottom" style="text-align: right; width: 30%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 10%;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 15%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">2011</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="10" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Options Outstanding</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Options Exercisable</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="white"><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Range of Exercise Prices</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number outstanding</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Remaining</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Contractual</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Term</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">(in years)</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise Price</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number Exercisable</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise Price</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$0.50</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">587,250</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">2.9</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">0.50</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">513,268</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.50</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$0.65 - $1.00</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2,967,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">5.7</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">0.79</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2,730,224</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.79</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$1.04 - $1.80</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">6,228,833</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">8.8</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1.30</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2,207,005</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.45</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$2.40</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">550,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 15%; font-family: 'times new roman'; font-size: 10pt;">0.7</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2.40</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">550,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 9%; font-family: 'times new roman'; font-size: 10pt;">2.40</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 30%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">10,333,583</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 15%; font-family: 'times new roman'; font-size: 10pt;">7.1</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">6,000,497</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.16</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">A summary of the status of the Company's unvested stock options as of December 31, 2012 and December 31, 2011 is presented below:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Unvested Stock Options</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="width: 10%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number of</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Shares</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="width: 10%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Grant Date Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Unvested at January 1, 2012</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">4,333,086</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.72</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Granted</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,307,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.90</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cancelled/expired</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(387,171</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Vested</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(875,877</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.05</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Unvested at December 31, 2012</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">8,377,538</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">0.96</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div> </div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Unvested Stock Options</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="width: 10%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number of</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Shares</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="width: 10%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Grant Date Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Unvested at January 1, 2011</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">2,679,787</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.87</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Granted</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3,918,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.63</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cancelled/expired</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(1,352,567</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.59</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Vested</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(912,634</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">0.81</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Unvested at December 31, 2011</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">4,333,086</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">0.72</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Total unrecognized compensation expense at December 31, 2012, was approximately $6,151,000 and will be charged to expense through December 2015.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The fair value of the options granted was estimated on the date of grant using the Black-Scholes-Merton option-pricing model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate.  Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the options.  The term of employee options granted is derived using the "simplified method" which computes expected term as the average of the sum of the vesting term plus the contract term.  The simplified method was used due to the Company's lack of sufficient historical data to provide a reasonable basis upon which to estimate the expected term due to the limited period of time its equity shares have been publically traded.  The term for non-employee options is generally based upon the contractual term of the option.  The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term or contractual term as described.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The assumptions used in calculating the fair value of options using the Black-Scholes-Merton option-pricing model are set forth in the following table:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" nowrap="nowrap" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Year ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Expected volatility</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">45.7-64.3</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">57.3-58.1</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Expected life (in years)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">6</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">6</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Expected dividend yield</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Risk-free interest rate</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">.62%-1.77</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.86% - 2.24</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The weighted-average grant date fair value for options granted during the year ended December 31, 2012, was approximately $1.07 and $.63 for 2011.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Warrants</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company grants common stock warrants in connection with equity share purchases by investors as an additional incentive for providing long-term equity capital to the Company and as additional compensation to consultants and advisors.  The warrants are granted at negotiated prices in connection with the equity share purchases and at the market price of the common stock in other instances.  The warrants have been issued for terms of five years.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Common Stock warrants activity and resulting balances for the years ended December 31, 2012 and 2011, are as follows:</div><div style="text-align: center; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number of</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Warrants</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise Price per Warrant</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number of</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Contingent Warrants</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise Price per Contingent Warrant</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants outstanding at January 1, 2011</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">6,003,924</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.21</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,252,990</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Issued in connection with private placement of common stock</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,889,161</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.50</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,889,162</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Issued in connection with convertible promissory notes</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">203,332</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.50</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">203,332</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Issued in connection with line of credit with related party</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">650,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Issued in connection with Senior Secured Promissory Notes</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,250,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,250,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Placement agent</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">42,400</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.09</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants outstanding at December 31, 2011</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">9,388,817</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.00</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">5,245,484</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants issued:</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Vested contingent warrants related to private placement of common stock</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,672,743</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(1,672,743</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Vested contingent warrants related to line of credit with related party</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">325,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(325,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Contingent warrants voided</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(3,247,741</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants exercised:</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Contingent warrants related to convertible note</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(1,249,750</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Contingent warrants related to private placement of common stock</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(1,608,802</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Contingent warrants related to line of credit with related party</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(325,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Callable warrants</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(3,288,733</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.50</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Other</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(1,703,568</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.63</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants expired</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(10,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.00</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants redeemed for cashless exercises</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(14,789</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.53</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Repurchased callable warrants (a)</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(56,750</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.50</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants outstanding at December 31, 2012</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">3,129,168</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.04</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"><div style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"> </div></td><td style="width: 18pt;"><div style="text-indent: 0pt; font-family: 'Times New Roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">(a)</div></td><td><div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Company repurchased the callable warrants at $0.01 per share.</div></td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Warrants may be exercised in whole or in part by:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"><div style="text-indent: 0pt; font-family: 'Times New Roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">•</div></td><td><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Notice given by the holder accompanied by payment of an amount equal to the warrant exercise price multiplied by the number of warrant shares being purchased; or</div></td></tr></table></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"><div style="text-indent: 0pt; font-family: 'Times New Roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">•</div></td><td><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Election by the holder to exchange the warrant (or portion thereof) for that number of shares equal to the product of (a) the number of shares issuable upon exercise of the warrant (or portion) and (b) a fraction, (x) the numerator of which is the market price of the shares at the time of exercise minus the warrant exercise price per share at the time of exercise and (y) the denominator of which is the market price per share at the time of exercise.</div></td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">These warrants are not mandatorily redeemable, do not obligate the Company to repurchase its equity shares by transferring assets or issue a variable number of shares.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The warrants require that the Company deliver shares as part of a physical settlement or a net-share settlement, at the option of the holder, and do not provide for a net-cash settlement.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">All of our warrants are classified as equity as of December 31, 2012 and 2011.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div></div></div>
</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
<!-- Basic and diluted (in dollars per share) -->
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="c20120101to20121231" unitRef="U003" decimals="2"> -0.09 </us-gaap:EarningsPerShareBasicAndDiluted>
<!-- Basic and diluted (in dollars per share) -->
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="c20110101to20111231" unitRef="U003" decimals="2"> -0.14 </us-gaap:EarningsPerShareBasicAndDiluted>
<!-- Net loss Per Share -->
<us-gaap:EarningsPerSharePolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Net loss Per Share</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Basic net loss per common share is computed using the weighted-average number of common shares outstanding during the period.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">For all periods presented, diluted net loss per share is the same as basic net loss per share, as the inclusion of equivalent shares from outstanding common stock options, warrants, and convertible debt would be anti-dilutive.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The following table sets forth the computation of basic and diluted net loss per share for the fiscal years ended December 31, 2012 and 2011:</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="6" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Year ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Net loss</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(7,662,376</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(10,193,986</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Denominator for basic earnings per share - weighted </font><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">average shares</font></div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">81,646,295</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">72,450,337</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Effect of dilutive securities: Stock options and warrants outstanding and convertible debt (a)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Denominator for diluted earnings per share - weighted average shares adjusted for dilutive securities</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">81,646,295</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">72,450,337</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Loss per common share - basic and diluted</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(0.09</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(0.14</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr></table></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(a) Securities outstanding that were excluded from the computation, prior to the use of the treasury stock method, because they would have been anti-dilutive are as follows:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: right; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: right; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">December 31, 2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Outstanding Stock Options</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">13,614,135</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">10,333,583</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Outstanding Warrants</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3,129,168</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">9,388,817</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Convertible Debt, promissory notes</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,313,645</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,007,732</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Convertible Line of Credit with Related Party</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,342,726</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Convertible Debt, Acquisition</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,299,315</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 4px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">22,056,948</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">27,372,173</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The table above excludes all securities with contingencies including the earnout liability and contingent warrants.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div></div>
</us-gaap:EarningsPerSharePolicyTextBlock>
<!-- Effective Income Tax Rate, Continuing Operations -->
<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c20120101to20121231" unitRef="U005" decimals="0"> 0 </us-gaap:EffectiveIncomeTaxRateContinuingOperations>
<!-- Effective Income Tax Rate, Continuing Operations -->
<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c20110101to20111231" unitRef="U005" decimals="0"> 0 </us-gaap:EffectiveIncomeTaxRateContinuingOperations>
<!-- Federal statutory rate (in hundredths) -->
<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c20120101to20121231" unitRef="U005" decimals="2"> 0.34 </us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
<!-- Federal statutory rate (in hundredths) -->
<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c20110101to20111231" unitRef="U005" decimals="2"> 0.34 </us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
<!-- Permanent items & other (in hundredths) -->
<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="c20120101to20121231" unitRef="U005" decimals="4"> 0.0651 </us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
<!-- Permanent items & other (in hundredths) -->
<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="c20110101to20111231" unitRef="U005" decimals="3"> -0.113 </us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
<!-- State taxes, net of federal benefit (in hundredths) -->
<us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c20120101to20121231" unitRef="U005" decimals="3"> 0.034 </us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
<!-- State taxes, net of federal benefit (in hundredths) -->
<us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c20110101to20111231" unitRef="U005" decimals="4"> 0.0534 </us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
<!-- Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance -->
<us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c20120101to20121231" unitRef="U005" decimals="4"> -0.4391 </us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
<!-- Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance -->
<us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c20110101to20111231" unitRef="U005" decimals="4"> -0.2804 </us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
<!-- Accrued Personnel Related Costs -->
<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c20121231" unitRef="U001" decimals="0"> 1761760 </us-gaap:EmployeeRelatedLiabilitiesCurrent>
<!-- Accrued Personnel Related Costs -->
<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c20111231" unitRef="U001" decimals="0"> 311849 </us-gaap:EmployeeRelatedLiabilitiesCurrent>
<!-- Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options -->
<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c20121231" unitRef="U001" decimals="0"> 6151000 </us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
<!-- Fair Value Measurements -->
<us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Fair Value Measurements</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company records certain financial instruments at fair value, including: cash equivalents and contingent consideration.  The Company may make an irrevocable election to measure other financial instruments at fair value on an instrument-by-instrument basis; although as of December 31, 2012 the Company has not chosen to make any such elections.  Fair value financial instruments are recorded in accordance with the fair value measurement framework.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company also measures certain non-financial assets at fair value on a non-recurring basis.  These non-recurring valuations include evaluating assets such as long-lived assets, and non-amortizing intangible assets for impairment; allocating value to assets in an acquired asset group; and applying accounting for business combinations.  The Company uses the fair value measurement framework to value these assets and reports these fair values in the periods in which they are recorded or written down.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The fair value measurement framework includes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair values in their broad levels.  These levels from highest to lowest priority are as follows:</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"> </td><td align="right" style="width: 18pt;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: Symbol, serif; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">·</div></td><td align="left"><div style="text-align: left; font-style: italic; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: normal; margin-right: 0pt;">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities;</div></td></tr></table></div><div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"> </td><td align="right" style="width: 18pt;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: Symbol, serif; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">·</div></td><td align="left"><div style="text-align: left; font-style: italic; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: normal; margin-right: 0pt;">Level 2: Quoted prices in active markets for similar assets or liabilities or observable prices that are based on inputs not quoted on active markets, but corroborated by market data; and</div></td></tr></table></div><div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"> </td><td align="right" style="width: 18pt;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: Symbol, serif; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">·</div></td><td align="left"><div style="text-align: left; font-style: italic; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: normal; margin-right: 0pt;">Level 3: Unobservable inputs or valuation techniques that are used when little or no market data is available.</div></td></tr></table></div></div></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The determination of fair value and the assessment of a measurement's placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity.  Level 3 valuations may require the use of various cost, market, or income valuation methodologies applied to unobservable management estimates and assumptions.  Management's assumptions could vary depending on the asset or liability valued and the valuation method used.  Such assumptions could include: estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods.  The Company may also engage external advisors to assist it in determining fair value, as appropriate.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Although the Company believes that the recorded fair value of its financial instruments is appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div></div>
</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
<!-- Fair Value of Financial Instruments -->
<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Fair Value of Financial Instruments</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The carrying value of accounts payable and accrued expenses approximate their fair value due to the short-term nature of these liabilities.  The fair value of our convertible debt approximates $4,012,000 which represents the face value less the unamortized discount of any beneficial conversion feature plus accrued but unpaid interest at December 31, 2012, as compared to the fair value of our short term and long term convertible debt of approximately $5,169,000 which represented the face value less the unamortized discount of any beneficial conversion feature plus accrued but unpaid interest at December 31, 2011.  As of December 31, 2012, and December 31, 2011, the fair value of warrants issued in conjunction with placement fees was approximately $20,500  and $15,000, respectively, which represents the face value less the unamortized discount of any beneficial conversion feature.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div></div>
</us-gaap:FairValueOfFinancialInstrumentsPolicy>
<!-- 2016 -->
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c20121231" unitRef="U001" decimals="0"> 976998 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
<!-- Gross Carrying Value-License-Shriners Hsp for Children & USF Research [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-ShrinersHspForChildrenUsfResearchMember" unitRef="U001" decimals="0"> 996000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-License - SaluMedica LLC Spine Repair [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-SalumedicaLlcSpineRepairMember" unitRef="U001" decimals="0"> 2399000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-License - Polyvinyl Alcohol Cryogel [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-PolyvinylAlcoholCryogelMember" unitRef="U001" decimals="0"> 2667000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-Customer Relationships [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="0"> 3520000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-Supplier Relationships [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_SupplierRelationshipsMember" unitRef="U001" decimals="0"> 241000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-Patents [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember" unitRef="U001" decimals="0"> 5530000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-Micronized Processing Know-How [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_MicronizedProcessingKnow-HowMember" unitRef="U001" decimals="0"> 2160000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-Licensing Agreements [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_LicensingAgreementsMember" unitRef="U001" decimals="0"> 13000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20121231" unitRef="U001" decimals="0"> 17526000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-License-Shriners Hsp for Children & USF Research [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-ShrinersHspForChildrenUsfResearchMember" unitRef="U001" decimals="0"> 996000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-License - SaluMedica LLC Spine Repair [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-SalumedicaLlcSpineRepairMember" unitRef="U001" decimals="0"> 2399000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-License - Polyvinyl Alcohol Cryogel [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-PolyvinylAlcoholCryogelMember" unitRef="U001" decimals="0"> 2667000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-Customer Relationships [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="0"> 3520000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-Supplier Relationships [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_SupplierRelationshipsMember" unitRef="U001" decimals="0"> 241000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-Patents [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember" unitRef="U001" decimals="0"> 5530000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-Micronized Processing Know-How [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_MicronizedProcessingKnow-HowMember" unitRef="U001" decimals="0"> 2160000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value-Licensing Agreements [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_LicensingAgreementsMember" unitRef="U001" decimals="0"> 13000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- Gross Carrying Value -->
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c20111231" unitRef="U001" decimals="0"> 17526000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<!-- 2014 -->
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c20121231" unitRef="U001" decimals="0"> 1046047 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
<!-- Accumulated Amortization-License-Shriners Hsp for Children & USF Research [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-ShrinersHspForChildrenUsfResearchMember" unitRef="U001" decimals="0"> -587633 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-License - SaluMedica LLC Spine Repair [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-SalumedicaLlcSpineRepairMember" unitRef="U001" decimals="0"> -1547324 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-License - Polyvinyl Alcohol Cryogel [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-PolyvinylAlcoholCryogelMember" unitRef="U001" decimals="0"> -1223561 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-Customer Relationships [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="0"> -502857 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-Supplier Relationships [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_SupplierRelationshipsMember" unitRef="U001" decimals="0"> -34429 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-Patents [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember" unitRef="U001" decimals="0"> -790000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-Micronized Processing Know-How [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_MicronizedProcessingKnow-HowMember" unitRef="U001" decimals="0"> -154286 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-Licensing Agreements [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_LicensingAgreementsMember" unitRef="U001" decimals="0"> -8667 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20121231" unitRef="U001" decimals="0"> -4848756 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-License-Shriners Hsp for Children & USF Research [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-ShrinersHspForChildrenUsfResearchMember" unitRef="U001" decimals="0"> -488033 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-License - SaluMedica LLC Spine Repair [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-SalumedicaLlcSpineRepairMember" unitRef="U001" decimals="0"> -1313573 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-License - Polyvinyl Alcohol Cryogel [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-PolyvinylAlcoholCryogelMember" unitRef="U001" decimals="0"> -998932 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-Customer Relationships [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="0"> -251429 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-Supplier Relationships [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_SupplierRelationshipsMember" unitRef="U001" decimals="0"> -17215 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-Patents [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember" unitRef="U001" decimals="0"> -395000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-Micronized Processing Know-How [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_MicronizedProcessingKnow-HowMember" unitRef="U001" decimals="0"> 0 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization-Licensing Agreements [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_LicensingAgreementsMember" unitRef="U001" decimals="0"> -4333 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Accumulated Amortization -->
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20111231" unitRef="U001" decimals="0"> -3468515 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Thereafter -->
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c20121231" unitRef="U001" decimals="0"> 6782673 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
<!-- 2015 -->
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c20121231" unitRef="U001" decimals="0"> 1022651 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
<!-- 2013 -->
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c20121231" unitRef="U001" decimals="0"> 1050380 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
<!-- Net carrying value, Total-License-Shriners Hsp for Children & USF Research [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-ShrinersHspForChildrenUsfResearchMember" unitRef="U001" decimals="0"> 408367 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-License - SaluMedica LLC Spine Repair [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-SalumedicaLlcSpineRepairMember" unitRef="U001" decimals="0"> 0 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-License - Polyvinyl Alcohol Cryogel [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-PolyvinylAlcoholCryogelMember" unitRef="U001" decimals="0"> 496620 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-Customer Relationships [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="0"> 3017143 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-Supplier Relationships [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_SupplierRelationshipsMember" unitRef="U001" decimals="0"> 206571 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-Patents [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember" unitRef="U001" decimals="0"> 4740000 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-Micronized Processing Know-How [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_MicronizedProcessingKnow-HowMember" unitRef="U001" decimals="0"> 2005714 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-Licensing Agreements [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_LicensingAgreementsMember" unitRef="U001" decimals="0"> 4333 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20121231" unitRef="U001" decimals="0"> 10878749 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-License-Shriners Hsp for Children & USF Research [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-ShrinersHspForChildrenUsfResearchMember" unitRef="U001" decimals="0"> 507967 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-License - SaluMedica LLC Spine Repair [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-SalumedicaLlcSpineRepairMember" unitRef="U001" decimals="0"> 1085427 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-License - Polyvinyl Alcohol Cryogel [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-PolyvinylAlcoholCryogelMember" unitRef="U001" decimals="0"> 1668068 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-Customer Relationships [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="0"> 3268571 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-Supplier Relationships [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_SupplierRelationshipsMember" unitRef="U001" decimals="0"> 223785 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-Patents [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember" unitRef="U001" decimals="0"> 5135000 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-Micronized Processing Know-How [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_MicronizedProcessingKnow-HowMember" unitRef="U001" decimals="0"> 2160000 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total-Licensing Agreements [Member] -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20111231_FiniteLivedIntangibleAssetsByMajorClassAxis_LicensingAgreementsMember" unitRef="U001" decimals="0"> 8667 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Net carrying value, Total -->
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c20111231" unitRef="U001" decimals="0"> 14057485 </us-gaap:FiniteLivedIntangibleAssetsNet>
<!-- Goodwill -->
<us-gaap:Goodwill contextRef="c20121231" unitRef="U001" decimals="0"> 4040443 </us-gaap:Goodwill>
<!-- Goodwill -->
<us-gaap:Goodwill contextRef="c20111231" unitRef="U001" decimals="0"> 4040443 </us-gaap:Goodwill>
<!-- Goodwill and Purchased Intangible Assets -->
<us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Goodwill and Purchased Intangible Assets</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Goodwill and purchased intangible assets with indefinite useful lives are not amortized but are tested for impairment at least annually.  The Company reviews goodwill and purchased intangible assets with indefinite lives for impairment annually at the beginning of its fourth fiscal quarter and whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable.  For goodwill, the Company performs a two-step impairment test.  In the first step, the Company compares the fair value of the Company to its carrying value.  The Company determines the fair value utilizing the market approach.  Under the market approach, the Company uses its market capitalization which is calculated by taking the Company's share price times the number of outstanding shares.  If the fair value of the Company exceeds the carrying value of the net assets, goodwill is not impaired, and no further testing is required.  If the fair value of the Company is less than the carrying value, the Company must perform the second step of the impairment test to measure the amount of impairment loss, if any. In the second step, the Company's value is allocated to all of the assets and liabilities, including any unrecognized intangible assets, in a hypothetical analysis that calculates the implied fair value of goodwill in the same manner as if the Company was being acquired in a business combination.  If the implied fair value of the reporting unit's goodwill is less than the carrying value, the difference is recorded as an impairment loss.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company estimates the fair value of indefinite-lived purchased intangible assets using a market approach.  The Company recognizes an impairment loss when the estimated fair value of the indefinite-lived purchased intangible assets is less than the carrying value.  The Company reviews purchased intangible assets with finite lives for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable.  Recoverability of these intangible assets is assessed based on the undiscounted future cash flows expected to result from the use of the asset.  If the undiscounted future cash flows are less than the carrying value, the purchased intangible assets with finite lives are considered to be impaired.  The amount of the impairment loss, if any, is measured as the difference between the carrying amount of these assets and the fair value based on a discounted cash flow approach or, when available and appropriate, to comparable market values.  The Company amortizes purchased intangible assets with finite lives using the straight-line method over the estimated economic lives of the assets.  Intangible assets with finite useful lives are amortized into Selling, General and Administrative Expenses in the consolidated statement of operations using the straight-line method over various periods depending upon the specific asset.</div></div>
</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
<!-- Impairment of Goodwill -->
<us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Impairment of Goodwill</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">We tested for impairment of the Intangible Assets related to the Licenses for SaluMedica LLC, Spine Repair and Polyvinyl Alcohol Cryogel as of September 30, 2012 using an undiscounted cash flow methodology.  The impairment was the result of the HydroFix® product line experiencing slower than projected growth in each of its markets.  Our test indicated that the carrying value of the assets related to HydroFix® exceeded its fair value, an impairment loss of approximately $1,798,000 was recognized and the intangible asset carrying amount was adjusted to its new basis.  The impairment was reported as a separate line item in the Consolidated Statement of Operations and included in the Loss From Operations.</div></div>
</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
<!-- Impairment loss -->
<us-gaap:GoodwillImpairmentLoss contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 1798000 </us-gaap:GoodwillImpairmentLoss>
<!-- Impairment of Long-lived Assets -->
<us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Impairment of Long-<font style="font-weight: normal;">lived</font> Assets</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company evaluates the recoverability of its long-lived assets (property and equipment) whenever adverse events or changes in business climate indicate that the expected undiscounted future cash flows from the related assets may be less than previously anticipated.  If the net book value of the related assets exceeds the expected undiscounted future cash flows of the assets, the carrying amount would be reduced to the present value of their expected future cash flows and an impairment loss would be recognized.</div></div>
</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
<!-- Impairment of intangible assets -->
<us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 1799000 </us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
<!-- Income Tax Disclosure [Text Block] -->
<us-gaap:IncomeTaxDisclosureTextBlock contextRef="c20120101to20121231">
<div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 10pt;"><tr valign="top"><td style="width: 13.5pt;"><div style="display: inline; font-family: Times New Roman; font-size: 10pt;"></div></td><td><div style="text-align: left; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">12.  Income Taxes</div></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div><div><div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">  <div style="text-align: left; text-transform: none; text-indent: 0pt; display: block; font: 10pt 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; display: block; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; display: block; font: 10pt 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company files income tax returns in the U.S. federal jurisdiction and various states.  With few exceptions, the Company is subject to U.S. federal, state and local income tax examinations for the years 2009 through 2012.  However, certain returns from years prior to 2009, in which net operating losses and tax credits have arisen, are still open for examination by the tax authorities.</div><div style="text-transform: none; text-indent: 0pt; display: block; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div><div style="text-align: left; text-transform: none; text-indent: 0pt; display: block; font: 10pt 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Significant components of the Company's deferred tax assets and liabilities are as follows:</div><div style="text-transform: none; text-indent: 0pt; display: block; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="6" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center; width: 184px;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 16px; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td align="left" valign="bottom"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Deferred tax assets and liabilities:</div></td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 184px; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 16px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff" style="height: 17px;"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Accrued liabilities</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">(73,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">131,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Beneficial conversion feature on convertible financial instruments</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"><font style="font-weight: normal;">(449,000)</font></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"><font style="font-weight: normal;"> </font></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(927,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff" style="height: 12px;"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Intangible assets</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">1,117,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">249,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Property and equipment</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">89,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(18,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff" style="height: 14px;"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">R&D Credit Carryforward</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">1,407,356</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">494,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white" style="height: 18px;"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Stock Compensation</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">213,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Adjust accrued earn-out liability</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">567,947</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"><font style="display: inline; font-weight: bold;">—</font></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Charitable Contributions</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">3,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Patent fees</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">6,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Net operating loss</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; width: 166px; font-family: 'times new roman'; font-size: 10pt;">15,487,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">15,524,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Net deferred tax assets</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">18,368,303</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">15,453,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 76%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Valuation allowance</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; width: 166px; font-family: 'times new roman'; font-size: 10pt;">(18,368,303</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(15,453,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 4px; width: 76%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; width: 166px; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; display: block; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div></div><div><div style="text-align: left; text-transform: none; text-indent: 0pt; display: block; font: 10pt 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The reconciliation of the Federal statutory income tax rate of 34% to the effective rate is as follows:</div><div style="text-transform: none; text-indent: 0pt; display: block; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0px; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">12/31/2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">12/31/2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-left: 0pt; width: 76%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Federal statutory rate</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">34.00</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">34.00</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-left: 0pt; width: 76%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">State taxes, net of federal benefit</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3.40</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5.34</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-left: 0pt; width: 76%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Permanent items & other</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">6.51</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(11.30</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%)</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; padding-left: 0pt; width: 76%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Valuation allowance</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(43.91</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(28.04</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%)</td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="padding-bottom: 4px; width: 76%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td></tr></table></div></div><div style="text-transform: none; text-indent: 0pt; display: block; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; display: block; font: 10pt 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Income taxes are based on estimates of the annual effective tax rate and evaluations of possible future events and transactions and may be subject to subsequent refinement or revision.</div><div style="text-transform: none; text-indent: 0pt; display: block; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-transform: none; text-indent: 0pt; display: block; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; display: block; font: 10pt 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company has incurred net losses since its inception, and therefore, no current income tax liabilities have been incurred for the periods presented.  The amount of federal operating loss carryforwards was approximately $42,700,000 at December 31, 2012, and $41,400,000 at December 31, 2011.  The loss carryforwards will expire at various dates beginning in 2026 through 2032 if not utilized.  A valuation allowance is recorded to reduce the deferred tax assets reported if, based on the weight of the evidence, it is more likely than not that a portion or none of the deferred tax assets will be realized.  After consideration of all the evidence, including reversal of deferred tax liabilities, future taxable income and other factors, management has determined that a full valuation allowance is necessary as of December 31, 2012 and 2011.  Additionally, the Company has various tax credit carryforwards of approximately $1,400,000 as of December 31, 2012.  The tax credit carryforwards will expire at various dates beginning in 2025 through 2032 if not utilized.</div><div style="text-transform: none; text-indent: 0pt; display: block; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; display: block; font: 10pt 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company's net operating losses and credits could be subject to annual limitations due to ownership change limitations provided by Internal Revenue Code Section 382.  An annual limitation could result in the expiration of net operating losses and tax credit carryforward before utilization.  At this time the Company does not believe its carryforwards or credits will be materially impacted by such limitations.</div><div style="text-align: center; text-transform: none; text-indent: 0pt; display: block; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div></div></div></div></div></div>
</us-gaap:IncomeTaxDisclosureTextBlock>
<!-- Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest -->
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c20120101to20121231" unitRef="U001" decimals="0"> -7662376 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<!-- Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest -->
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c20110101to20111231" unitRef="U001" decimals="0"> -10193986 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<!-- Income Tax Expense (Benefit) -->
<us-gaap:IncomeTaxExpenseBenefit contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<!-- Income Tax Expense (Benefit) -->
<us-gaap:IncomeTaxExpenseBenefit contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<!-- Income Taxes Paid, Net -->
<us-gaap:IncomeTaxesPaidNet contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 0 </us-gaap:IncomeTaxesPaidNet>
<!-- Income Taxes Paid, Net -->
<us-gaap:IncomeTaxesPaidNet contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 0 </us-gaap:IncomeTaxesPaidNet>
<!-- Income Taxes -->
<us-gaap:IncomeTaxPolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Income Taxes</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that included the enactment date.  Valuation allowances are recorded for deferred tax assets when the recoverability of such assets is not deemed more likely than not.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div></div>
</us-gaap:IncomeTaxPolicyTextBlock>
<!-- Cash paid for income taxes -->
<us-gaap:IncomeTaxesPaid contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 0 </us-gaap:IncomeTaxesPaid>
<!-- Cash paid for income taxes -->
<us-gaap:IncomeTaxesPaid contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 0 </us-gaap:IncomeTaxesPaid>
<!-- Uncertain Tax Positions -->
<us-gaap:IncomeTaxUncertaintiesPolicy contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Uncertain Tax Positions</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Tax positions are evaluated in a two-step process.  The Company first determines whether it is more likely than not that a tax position will be sustained upon examination.  If a tax position meets the more-likely-than-not recognition threshold it is then measured to determine the amount of benefit to recognize in the financial statements.  The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.  The Company classifies gross interest and penalties and unrecognized tax benefits that are not expected to result in payment or receipt of cash within one year as non-current liabilities in the Consolidated Balance Sheets.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div></div>
</us-gaap:IncomeTaxUncertaintiesPolicy>
<!-- Accounts payable -->
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c20120101to20121231" unitRef="U001" decimals="0"> -81112 </us-gaap:IncreaseDecreaseInAccountsPayable>
<!-- Accounts payable -->
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 929039 </us-gaap:IncreaseDecreaseInAccountsPayable>
<!-- Increase (Decrease) in Accrued Liabilities -->
<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 2960744 </us-gaap:IncreaseDecreaseInAccruedLiabilities>
<!-- Increase (Decrease) in Accrued Liabilities -->
<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 327212 </us-gaap:IncreaseDecreaseInAccruedLiabilities>
<!-- Increase (Decrease) in Accounts Receivable -->
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 5761642 </us-gaap:IncreaseDecreaseInAccountsReceivable>
<!-- Increase (Decrease) in Accounts Receivable -->
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 1208456 </us-gaap:IncreaseDecreaseInAccountsReceivable>
<!-- Increase (Decrease) in Prepaid Expense and Other Assets -->
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 466060 </us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<!-- Increase (Decrease) in Prepaid Expense and Other Assets -->
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 70980 </us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<!-- Increase (Decrease) in Other Operating Assets -->
<us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c20120101to20121231" unitRef="U001" decimals="0"> -96657 </us-gaap:IncreaseDecreaseInOtherOperatingAssets>
<!-- Increase (Decrease) in Other Operating Assets -->
<us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 80375 </us-gaap:IncreaseDecreaseInOtherOperatingAssets>
<!-- Increase (Decrease) in Inventories -->
<us-gaap:IncreaseDecreaseInInventories contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 2310182 </us-gaap:IncreaseDecreaseInInventories>
<!-- Increase (Decrease) in Inventories -->
<us-gaap:IncreaseDecreaseInInventories contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 253942 </us-gaap:IncreaseDecreaseInInventories>
<!-- Accrued interest -->
<us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 387896 </us-gaap:IncreaseDecreaseInInterestPayableNet>
<!-- Accrued interest -->
<us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 107886 </us-gaap:IncreaseDecreaseInInterestPayableNet>
<!-- Other liabilities -->
<us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c20120101to20121231" unitRef="U001" decimals="0"> -12731 </us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
<!-- Other liabilities -->
<us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 16383 </us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
<!-- Indefinite-Lived Intangible Assets (Excluding Goodwill)-Trade names and trademarks [Member] -->
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c20121231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesAndTrademarksMember" unitRef="U001" decimals="0"> 1008000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<!-- Indefinite-Lived Intangible Assets (Excluding Goodwill)-In process research and development, other [Member] -->
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c20121231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentOtherMember" unitRef="U001" decimals="0"> 25000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<!-- Indefinite-Lived Intangible Assets (Excluding Goodwill)-Trade names and trademarks [Member] -->
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c20111231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesAndTrademarksMember" unitRef="U001" decimals="0"> 1008000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<!-- Indefinite-Lived Intangible Assets (Excluding Goodwill)-In process research and development, other [Member] -->
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c20111231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentOtherMember" unitRef="U001" decimals="0"> 25000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<!-- Intangible Assets Disclosure [Text Block] -->
<us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c20120101to20121231">
<div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"><div style="text-indent: 0pt; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">7.</div></td><td><div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Intangible Assets and Royalty Agreement</div></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">  <div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Intangible assets activity is summarized as follows:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 23%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="16" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="10" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31, 2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="text-align: center; width: 23%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Average</div></td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Gross</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Net</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Gross</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Net</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="text-align: center; width: 23%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Amortization</div></td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Carrying</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Impairment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Accumulated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Carrying</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Carrying</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Accumulated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Carrying</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="text-align: center; padding-bottom: 2px; width: 23%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Lives</div></td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Adjustment</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Amortization</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Amortization</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="width: 23%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 7%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">License-Shriners Hsp for Children & USF Research (a)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">10 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">996,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(587,633</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">408,367</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">996,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(488,033</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">507,967</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">License - SaluMedica LLC Spine Repair (b)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">10 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,399,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(851,676</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(1,547,324</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,399,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(1,313,573</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">1,085,427</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">License - Polyvinyl Alcohol Cryogel (c)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">10 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,667,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(946,819</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(1,223,561</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">496,620</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,667,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(998,932</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">1,668,068</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" nowrap="nowrap" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Customer Relationships (d)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">3,520,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(502,857</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">3,017,143</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">3,520,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(251,429</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">3,268,571</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Supplier Relationships (d)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">241,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(34,429</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">206,571</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">241,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(17,215</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">223,785</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Patents & Know-How (d)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">5,530,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(790,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">4,740,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">5,530,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(395,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">5,135,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Micronized Processing Know-How (d)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,160,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(154,286</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,005,714</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,160,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,160,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Licenses/Permits (d)</div></td><td valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">3 years</div></td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">13,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(8,667</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">4,333</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">13,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(4,333</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">8,667</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="width: 23%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 7%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">17,526,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(1,798,495</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(4,848,756</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">10,878,749</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">17,526,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(3,468,515</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">14,057,485</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 23%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 7%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Trade Names/Trademarks (d)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">indefinite</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">1,008,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">1,008,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">1,008,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">1,008,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">In-process Research & Development-Other (d)</div></td><td valign="bottom" style="padding-bottom: 2px; width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">indefinite</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">25,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">25,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">25,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">25,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="padding-bottom: 4px; width: 23%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 4px; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">18,559,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(1,798,495</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(4,848,756</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">11,911,749</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">18,559,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(3,468,515</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">15,090,485</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(a)    On January 29, 2007, the Company acquired a license from Shriners Hospitals for Children and University of South Florida Research Foundation, Inc.  Within 30 days after the receipt by the Company of approval by the FDA allowing the sale of the first licensed product, the Company is required to pay an additional $200,000 to the licensor.  Due to its contingent nature, this amount is not recorded as a liability. The Company will also be required to pay a royalty of 3% on all commercial sales revenue from the licensed products. The Company is also obligated to pay a $50,000 minimum annual royalty payment over the life of the license.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(b)    License from SaluMedica, LLC (SaluMedica) for the use of certain developed technologies related to spine repair. This license was acquired through the acquisition of SpineMedica Corp.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(c)    On March 31, 2008, the Company entered into a license agreement for the use of certain developed technologies related to surgical sheets made of polyvinyl alcohol cryogel.  The agreement also provides for the issuance of an additional 600,000 shares upon the Company meeting certain milestones related to future sales. On December 31, 2009 the Company completed the sale of its first commercial product and met its first milestone under this agreement. As a result the Company issued 100,000 shares of common stock to the licensor valued at $71,000. At December 31, 2012 or 2011, there are no additional amounts accrued for this obligation due to its contingent nature.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(d)    On January 5, 2011, the Company acquired Surgical Biologics, LLC.  As a result, the Company recorded intangible assets for customer and supplier relationships, patents and know-how, licenses/permits, trade names and trademarks and in-process research and development.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Expected future amortization of intangible assets is as follows:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="width: 10%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Estimated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="width: 10%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Amortization</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Year ending  December 31,</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Expense</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2013</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,050,380</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2014</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,046,047</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2015</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,022,651</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2016</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">976,998</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2017</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">886,927</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Thereafter</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,895,746</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">10,878,749</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><br class="Apple-interchange-newline" /></div></div></div>
</us-gaap:IntangibleAssetsDisclosureTextBlock>
<!-- Intangible assets, net of accumulated amortization of $4,848,756 and $3,468,515, respectively -->
<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c20121231" unitRef="U001" decimals="0"> 11911749 </us-gaap:IntangibleAssetsNetExcludingGoodwill>
<!-- Intangible assets, net of accumulated amortization of $4,848,756 and $3,468,515, respectively -->
<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c20111231" unitRef="U001" decimals="0"> 15090485 </us-gaap:IntangibleAssetsNetExcludingGoodwill>
<!-- Interest Expense -->
<us-gaap:InterestExpense contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 592892 </us-gaap:InterestExpense>
<!-- Interest Expense -->
<us-gaap:InterestExpense contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 117818 </us-gaap:InterestExpense>
<!-- Interest expense-Hybrid debt instrument [Member] -->
<us-gaap:InterestExpenseRelatedParty contextRef="c20120101to20121231_LongtermDebtTypeAxis_HybridDebtInstrumentMember" unitRef="U001" decimals="0" id="Item-5"> 0 </us-gaap:InterestExpenseRelatedParty>
<!-- Interest expense-Hybrid debt instrument [Member] -->
<us-gaap:InterestExpenseRelatedParty contextRef="c20110101to20111231_LongtermDebtTypeAxis_HybridDebtInstrumentMember" unitRef="U001" decimals="0" id="Item-6"> 3232 </us-gaap:InterestExpenseRelatedParty>
<!-- Interest expense-Line of Credit [Member] -->
<us-gaap:InterestExpenseRelatedParty contextRef="c20120101to20121231_LongtermDebtTypeAxis_LineOfCreditMember" unitRef="U001" decimals="0" id="Item-7"> 103630 </us-gaap:InterestExpenseRelatedParty>
<!-- Interest expense-Line of Credit [Member] -->
<us-gaap:InterestExpenseRelatedParty contextRef="c20110101to20111231_LongtermDebtTypeAxis_LineOfCreditMember" unitRef="U001" decimals="0" id="Item-8"> 42726 </us-gaap:InterestExpenseRelatedParty>
<!-- Interest expense-Convertible senior secured promissory notes [Member] -->
<us-gaap:InterestExpenseRelatedParty contextRef="c20120101to20121231_LongtermDebtTypeAxis_ConvertibleSeniorSecuredPromissoryNotesMember" unitRef="U001" decimals="0" id="Item-9"> 50000 </us-gaap:InterestExpenseRelatedParty>
<!-- Interest expense-Convertible senior secured promissory notes [Member] -->
<us-gaap:InterestExpenseRelatedParty contextRef="c20110101to20111231_LongtermDebtTypeAxis_ConvertibleSeniorSecuredPromissoryNotesMember" unitRef="U001" decimals="0" id="Item-10"> 4507 </us-gaap:InterestExpenseRelatedParty>
<!-- Cash paid for interest -->
<us-gaap:InterestPaid contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 13322 </us-gaap:InterestPaid>
<!-- Cash paid for interest -->
<us-gaap:InterestPaid contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 15456 </us-gaap:InterestPaid>
<!-- Inventories -->
<us-gaap:InventoryPolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Inventories</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Inventories are valued at the lower of cost or market, using the first–in, first-out (FIFO) method.  Inventory is tracked through Raw Material, WIP, and Finished Good stages as the product progresses through various production steps and stocking locations.  Within WIP labor and overhead costs are absorbed through the various production processes upon work order closes in our ERP (Enterprise Resource Planning) system.  Historical yields and normal capacities are utilized in the calculation of production overhead rates.  Reserves for inventory obsolescence are utilized to account for slow-moving inventory as well as inventory no longer needed due to diminished market demand.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div></div>
</us-gaap:InventoryPolicyTextBlock>
<!-- Inventory Valuation Reserves -->
<us-gaap:InventoryValuationReserves contextRef="c20121231" unitRef="U001" decimals="0"> 158622 </us-gaap:InventoryValuationReserves>
<!-- Inventory Valuation Reserves -->
<us-gaap:InventoryValuationReserves contextRef="c20111231" unitRef="U001" decimals="0"> 52456 </us-gaap:InventoryValuationReserves>
<!-- Inventory, Gross -->
<us-gaap:InventoryGross contextRef="c20121231" unitRef="U001" decimals="0"> 3181405 </us-gaap:InventoryGross>
<!-- Inventory, Gross -->
<us-gaap:InventoryGross contextRef="c20111231" unitRef="U001" decimals="0"> 765058 </us-gaap:InventoryGross>
<!-- Inventory Disclosure [Text Block] -->
<us-gaap:InventoryDisclosureTextBlock contextRef="c20120101to20121231">
<div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"><div style="text-indent: 0pt; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">5.</div></td><td><div style="text-align: left; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Inventories</div></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;"> Inventories consisted of the following items as of December 31, 2012 and 2011: <div style="text-align: center; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="6" valign="bottom" style="text-align: right; width: 21%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: right;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: right;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Raw materials</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">233,747</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">95,288</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Work in process</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,598,537</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">308,763</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Finished goods</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,349,121</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">361,007</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Inventory, gross</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3,181,405</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">765,058</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Reserve for obsolescence</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(158,621</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(52,456</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Inventory, net</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">3,022,784</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">712,602</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div></div></div></div>
</us-gaap:InventoryDisclosureTextBlock>
<!-- Finished goods -->
<us-gaap:InventoryFinishedGoods contextRef="c20121231" unitRef="U001" decimals="0"> 1349121 </us-gaap:InventoryFinishedGoods>
<!-- Finished goods -->
<us-gaap:InventoryFinishedGoods contextRef="c20111231" unitRef="U001" decimals="0"> 361007 </us-gaap:InventoryFinishedGoods>
<!-- Inventory, net -->
<us-gaap:InventoryNet contextRef="c20121231" unitRef="U001" decimals="0"> 3022784 </us-gaap:InventoryNet>
<!-- Inventory, net -->
<us-gaap:InventoryNet contextRef="c20111231" unitRef="U001" decimals="0"> 712602 </us-gaap:InventoryNet>
<!-- Raw materials -->
<us-gaap:InventoryRawMaterials contextRef="c20121231" unitRef="U001" decimals="0"> 233747 </us-gaap:InventoryRawMaterials>
<!-- Raw materials -->
<us-gaap:InventoryRawMaterials contextRef="c20111231" unitRef="U001" decimals="0"> 95288 </us-gaap:InventoryRawMaterials>
<!-- Work in process -->
<us-gaap:InventoryWorkInProcess contextRef="c20121231" unitRef="U001" decimals="0"> 1598537 </us-gaap:InventoryWorkInProcess>
<!-- Work in process -->
<us-gaap:InventoryWorkInProcess contextRef="c20111231" unitRef="U001" decimals="0"> 308763 </us-gaap:InventoryWorkInProcess>
<!-- Rent and operating leases expense -->
<us-gaap:LeaseAndRentalExpense contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 528000 </us-gaap:LeaseAndRentalExpense>
<!-- Rent and operating leases expense -->
<us-gaap:LeaseAndRentalExpense contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 533000 </us-gaap:LeaseAndRentalExpense>
<!-- Liabilities, Current -->
<us-gaap:LiabilitiesCurrent contextRef="c20121231" unitRef="U001" decimals="0"> 5070772 </us-gaap:LiabilitiesCurrent>
<!-- Liabilities, Current -->
<us-gaap:LiabilitiesCurrent contextRef="c20111231" unitRef="U001" decimals="0"> 4732044 </us-gaap:LiabilitiesCurrent>
<!-- Liabilities -->
<us-gaap:Liabilities contextRef="c20121231" unitRef="U001" decimals="0"> 15175306 </us-gaap:Liabilities>
<!-- Liabilities -->
<us-gaap:Liabilities contextRef="c20111231" unitRef="U001" decimals="0"> 15199627 </us-gaap:Liabilities>
<!-- Liabilities and Equity -->
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="c20121231" unitRef="U001" decimals="0"> 35182608 </us-gaap:LiabilitiesAndStockholdersEquity>
<!-- Liabilities and Equity -->
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="c20111231" unitRef="U001" decimals="0"> 27096192 </us-gaap:LiabilitiesAndStockholdersEquity>
<!-- Current portion of long term convertible debt related to acquisition -->
<us-gaap:LongTermDebtCurrent contextRef="c20121231" unitRef="U001" decimals="0"> 0 </us-gaap:LongTermDebtCurrent>
<!-- Current portion of long term convertible debt related to acquisition -->
<us-gaap:LongTermDebtCurrent contextRef="c20111231" unitRef="U001" decimals="0"> 1128806 </us-gaap:LongTermDebtCurrent>
<!-- Long-term portion -->
<us-gaap:LongTermDebtNoncurrent contextRef="c20121231" unitRef="U001" decimals="0"> 4012442 </us-gaap:LongTermDebtNoncurrent>
<!-- Long-term portion -->
<us-gaap:LongTermDebtNoncurrent contextRef="c20111231" unitRef="U001" decimals="0"> 2744587 </us-gaap:LongTermDebtNoncurrent>
<!-- Nature of Operations [Text Block] -->
<us-gaap:NatureOfOperations contextRef="c20120101to20121231">
<div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 10pt;"><tr valign="top"><td align="right" style="width: 18pt;"><div style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">1.  </div></td><td><div style="text-align: justify; text-indent: 0pt; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Nature of Business</div></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;"> MiMedx Group, Inc. ("MiMedx," "The Company," "we," or "us") operates in one business segment, Regenerative Biomaterials, which includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Orthopedics, Spine, Ophthalmic and Dental market categories.  Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix<font style="display: inline; font-size: 9px; vertical-align: text-top;">TM</font>, and our tissue technologies, AmnioFix® and EpiFix®. <div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 18pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company is focused primarily on the United States but will pursue other individual markets based upon the specific opportunity.  The adoption of the technologies may vary depending on each country's regulations, but the opportunities to help individuals in the different disease states remain similar and large.</div><br class="Apple-interchange-newline" /></div></div>
</us-gaap:NatureOfOperations>
<!-- Net Cash Provided by (Used in) Investing Activities -->
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c20120101to20121231" unitRef="U001" decimals="0"> -582931 </us-gaap:NetCashProvidedByUsedInInvestingActivities>
<!-- Net Cash Provided by (Used in) Investing Activities -->
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c20110101to20111231" unitRef="U001" decimals="0"> -702508 </us-gaap:NetCashProvidedByUsedInInvestingActivities>
<!-- Net Cash Provided by (Used in) Financing Activities -->
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 6609921 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<!-- Net Cash Provided by (Used in) Financing Activities -->
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 10138683 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<!-- Net loss -->
<us-gaap:NetIncomeLoss contextRef="c20120101to20121231" unitRef="U001" decimals="0"> -7662376 </us-gaap:NetIncomeLoss>
<!-- Net loss -->
<us-gaap:NetIncomeLoss contextRef="c20110101to20111231" unitRef="U001" decimals="0"> -10193986 </us-gaap:NetIncomeLoss>
<!-- Net loss-Series A Preferred Stock [Member] -->
<us-gaap:NetIncomeLoss contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:NetIncomeLoss>
<!-- Net loss-Series A Preferred Stock [Member] -->
<us-gaap:NetIncomeLoss contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:NetIncomeLoss>
<!-- Net loss-Common Stock [Member] -->
<us-gaap:NetIncomeLoss contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:NetIncomeLoss>
<!-- Net loss-Common Stock [Member] -->
<us-gaap:NetIncomeLoss contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:NetIncomeLoss>
<!-- Net loss-Additional Paid-in Capital [Member] -->
<us-gaap:NetIncomeLoss contextRef="c20110101to20111231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 0 </us-gaap:NetIncomeLoss>
<!-- Net loss-Additional Paid-in Capital [Member] -->
<us-gaap:NetIncomeLoss contextRef="c20120101to20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 0 </us-gaap:NetIncomeLoss>
<!-- Net loss-Treasury Stock [Member] -->
<us-gaap:NetIncomeLoss contextRef="c20110101to20111231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:NetIncomeLoss>
<!-- Net loss-Treasury Stock [Member] -->
<us-gaap:NetIncomeLoss contextRef="c20120101to20121231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:NetIncomeLoss>
<!-- Net loss-Accumulated Deficit [Member] -->
<us-gaap:NetIncomeLoss contextRef="c20110101to20111231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> -10193986 </us-gaap:NetIncomeLoss>
<!-- Net loss-Accumulated Deficit [Member] -->
<us-gaap:NetIncomeLoss contextRef="c20120101to20121231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> -7662376 </us-gaap:NetIncomeLoss>
<!-- Net Cash Provided by (Used in) Operating Activities -->
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c20120101to20121231" unitRef="U001" decimals="0"> -3384831 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<!-- Net Cash Provided by (Used in) Operating Activities -->
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c20110101to20111231" unitRef="U001" decimals="0"> -6664771 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<!-- New Accounting Pronouncements, Policy [Policy Text Block] -->
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: bold 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Recently Adopted Accounting Pronouncements</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">In January 2012 the Company adopted Accounting Standards Update ("ASU") 2011-04, Fair Value Measurement (Topic 820): <font style="font-style: italic; display: inline;"><font style="font-weight: bold;">Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs</font>,</font> which clarifies some existing concepts and expands the disclosures for fair value measurements that are estimated using significant unobservable (Level 3) inputs.  The adoption of ASU 2011-04 did not have a material effect on the Company's financial condition, profitability, and cash flows.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">In January 2012 the Company adopted ASU 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income.  The amendments to the Codification in this ASU will require companies to present the components of net income and other comprehensive income either as one continuous statement or as two consecutive statements.  It eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders' equity.  The standard does not change the items which must be reported in other comprehensive income, how such items are measured or when they must be reclassified to net income.  This standard is effective for interim and annual periods beginning after December 15, 2011.  Because this ASU impacts presentation only, it had no effect on our financial condition, results of operations or cash flows.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">In January 2012 the Company adopted ASU 2011-08, Intangibles-Goodwill and Other (Topic 350): <font style="font-style: italic; display: inline;"><font style="font-weight: bold;">Testing Goodwill for Impairment</font>,</font> which gives entities testing goodwill for impairment the option of performing a qualitative assessment before calculating the fair value of a reporting unit in step 1 of the goodwill impairment test.  The adoption of ASU 2011-08 did not have a material effect on the Company's financial condition, profitability, and cash flows.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">In July 2012, the FASB issued ASU No. 2012-02, which amends the guidance in ASC 350-30 on testing indefinite-lived intangible assets, other than goodwill, for impairment. Under the revised guidance, companies testing an indefinite-lived intangible asset for impairment have the option of performing a qualitative assessment before calculating the fair value of the asset (i.e. step 1 of the impairment test). If companies determine, on the basis of qualitative factors, that the fair value of the indefinite-lived intangible asset is more likely than not less than the carrying amount, the two-step impairment test would be required. This update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012, with early adoption permitted. The Company adopted the revised guidance, and it did not have a material impact on the Company's Consolidated Financial Statements.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div></div>
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<!-- Current portion of long term debt with related party -->
<us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="c20121231" unitRef="U001" decimals="0"> 0 </us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
<!-- Current portion of long term debt with related party -->
<us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="c20111231" unitRef="U001" decimals="0"> 1295980 </us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
<!-- Number of business segments -->
<us-gaap:NumberOfOperatingSegments contextRef="c20120101to20121231" unitRef="U004" decimals="0"> 1 </us-gaap:NumberOfOperatingSegments>
<!-- Operating Loss Carryforwards, Expiration Dates -->
<us-gaap:OperatingLossCarryforwardsExpirationDates contextRef="c20120101to20121231"> 2026 through 2032 </us-gaap:OperatingLossCarryforwardsExpirationDates>
<!-- Federal operating loss carryforwards -->
<us-gaap:OperatingLossCarryforwards contextRef="c20121231" unitRef="U001" decimals="0"> 42700000 </us-gaap:OperatingLossCarryforwards>
<!-- Federal operating loss carryforwards -->
<us-gaap:OperatingLossCarryforwards contextRef="c20111231" unitRef="U001" decimals="0"> 41400000 </us-gaap:OperatingLossCarryforwards>
<!-- Operating Income (Loss) -->
<us-gaap:OperatingIncomeLoss contextRef="c20120101to20121231" unitRef="U001" decimals="0"> -5355383 </us-gaap:OperatingIncomeLoss>
<!-- Operating Income (Loss) -->
<us-gaap:OperatingIncomeLoss contextRef="c20110101to20111231" unitRef="U001" decimals="0"> -9761016 </us-gaap:OperatingIncomeLoss>
<!-- Base rental payments-Subsequent Event [Member] -->
<us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="c20130131_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="0"> 7100000 </us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
<!-- Deposits and other long term assets -->
<us-gaap:OtherAssetsNoncurrent contextRef="c20121231" unitRef="U001" decimals="0"> 70000 </us-gaap:OtherAssetsNoncurrent>
<!-- Deposits and other long term assets -->
<us-gaap:OtherAssetsNoncurrent contextRef="c20111231" unitRef="U001" decimals="0"> 214342 </us-gaap:OtherAssetsNoncurrent>
<!-- Other current liabilities -->
<us-gaap:OtherLiabilitiesCurrent contextRef="c20121231" unitRef="U001" decimals="0"> 75154 </us-gaap:OtherLiabilitiesCurrent>
<!-- Other current liabilities -->
<us-gaap:OtherLiabilitiesCurrent contextRef="c20111231" unitRef="U001" decimals="0"> 6620 </us-gaap:OtherLiabilitiesCurrent>
<!-- Other Liabilities, Noncurrent -->
<us-gaap:OtherLiabilitiesNoncurrent contextRef="c20121231" unitRef="U001" decimals="0"> 299762 </us-gaap:OtherLiabilitiesNoncurrent>
<!-- Other Liabilities, Noncurrent -->
<us-gaap:OtherLiabilitiesNoncurrent contextRef="c20111231" unitRef="U001" decimals="0"> 312493 </us-gaap:OtherLiabilitiesNoncurrent>
<!-- Other Accrued Expenses -->
<us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c20121231" unitRef="U001" decimals="0"> 512249 </us-gaap:OtherAccruedLiabilitiesCurrent>
<!-- Other Accrued Expenses -->
<us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c20111231" unitRef="U001" decimals="0"> 358435 </us-gaap:OtherAccruedLiabilitiesCurrent>
<!-- Payments for Repurchase of Warrants -->
<us-gaap:PaymentsForRepurchaseOfWarrants contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 568 </us-gaap:PaymentsForRepurchaseOfWarrants>
<!-- Payments for Repurchase of Warrants -->
<us-gaap:PaymentsForRepurchaseOfWarrants contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 0 </us-gaap:PaymentsForRepurchaseOfWarrants>
<!-- Payments to Acquire Businesses, Net of Cash Acquired -->
<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 0 </us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
<!-- Payments to Acquire Businesses, Net of Cash Acquired -->
<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 466417 </us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
<!-- Payments to Acquire Intangible Assets -->
<us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 100000 </us-gaap:PaymentsToAcquireIntangibleAssets>
<!-- Cash Paid -->
<us-gaap:PaymentsToAcquireBusinessesGross contextRef="c20110104to20110105" unitRef="U001" decimals="0"> 500000 </us-gaap:PaymentsToAcquireBusinessesGross>
<!-- Payments to Acquire Equipment on Lease -->
<us-gaap:PaymentsToAcquireEquipmentOnLease contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 16116 </us-gaap:PaymentsToAcquireEquipmentOnLease>
<!-- Payments to Acquire Equipment on Lease -->
<us-gaap:PaymentsToAcquireEquipmentOnLease contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 0 </us-gaap:PaymentsToAcquireEquipmentOnLease>
<!-- Payments to Acquire Machinery and Equipment -->
<us-gaap:PaymentsToAcquireMachineryAndEquipment contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 582931 </us-gaap:PaymentsToAcquireMachineryAndEquipment>
<!-- Payments to Acquire Machinery and Equipment -->
<us-gaap:PaymentsToAcquireMachineryAndEquipment contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 486091 </us-gaap:PaymentsToAcquireMachineryAndEquipment>
<!-- Pension and Other Postretirement Benefits Disclosure [Text Block] -->
<us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">14.   401k Plan</div><div style="text-indent: 0pt; display: block;"> </div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;"><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company has a 401(k) plan (the "Plan") covering employees who have attained 21 years of age and have completed three months of service. Under the Plan, participants may defer up to 100% of their eligible wages to a maximum of $17,000 per year (annual limit for 2012). Employees age 50 or over in 2012 may make additional pre-tax contributions up to $5,500 above and beyond normal plan and legal limits.  Annually, the Company may elect to match employee contributions up to 6% of the employee's compensation.  Additionally, the Company may elect to make a discretionary contribution to the Plan. The Company did not provide matching contributions for the years ended December 31, 2012 and 2011.</div><br class="Apple-interchange-newline" /></div></div>
</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
<!-- Preferred stock; $.001 par value; 5,000,000 shares authorized and 0 shares issued and outstanding -->
<us-gaap:PreferredStockValue contextRef="c20121231" unitRef="U001" decimals="0"> 0 </us-gaap:PreferredStockValue>
<!-- Preferred stock; $.001 par value; 5,000,000 shares authorized and 0 shares issued and outstanding -->
<us-gaap:PreferredStockValue contextRef="c20111231" unitRef="U001" decimals="0"> 0 </us-gaap:PreferredStockValue>
<!-- Preferred stock, shares authorized (in shares) -->
<us-gaap:PreferredStockSharesAuthorized contextRef="c20121231" unitRef="U002" decimals="0"> 5000000 </us-gaap:PreferredStockSharesAuthorized>
<!-- Preferred stock, shares authorized (in shares) -->
<us-gaap:PreferredStockSharesAuthorized contextRef="c20111231" unitRef="U002" decimals="0"> 5000000 </us-gaap:PreferredStockSharesAuthorized>
<!-- Preferred stock, shares issued (in shares) -->
<us-gaap:PreferredStockSharesIssued contextRef="c20121231" unitRef="U002" decimals="0"> 0 </us-gaap:PreferredStockSharesIssued>
<!-- Preferred stock, shares issued (in shares) -->
<us-gaap:PreferredStockSharesIssued contextRef="c20111231" unitRef="U002" decimals="0"> 0 </us-gaap:PreferredStockSharesIssued>
<!-- Preferred stock, par value (in dollars per share) -->
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c20121231" unitRef="U003" decimals="3"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare>
<!-- Preferred stock, par value (in dollars per share) -->
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c20111231" unitRef="U003" decimals="3"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare>
<!-- Preferred stock, shares outstanding (in shares) -->
<us-gaap:PreferredStockSharesOutstanding contextRef="c20121231" unitRef="U002" decimals="0"> 0 </us-gaap:PreferredStockSharesOutstanding>
<!-- Preferred stock, shares outstanding (in shares) -->
<us-gaap:PreferredStockSharesOutstanding contextRef="c20111231" unitRef="U002" decimals="0"> 0 </us-gaap:PreferredStockSharesOutstanding>
<!-- Prepaid Expense and Other Assets, Current -->
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c20121231" unitRef="U001" decimals="0"> 657961 </us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<!-- Prepaid Expense and Other Assets, Current -->
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c20111231" unitRef="U001" decimals="0"> 164664 </us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<!-- Reclassifications -->
<us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Reclassifications</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Certain amounts in the prior year financial statements have been reclassified to conform to the current year financial statement presentation.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Historically, the Company has reported depreciation and share-based compensation expense as part of Selling, General and Administrative expense.  The Company decided to report these expenses in each functional area in order to more accurately present all of the costs attributable to each functional area. During the years ended December 31, 2012 and 2011, we recorded a total of approximately $465,000 and $447,000 in depreciation expense allocated to each functional area per the table below.  The overall $19,000 increase in depreciation was attributable to the purchase of additional production and office equipment and leasehold build-out to support our revenue growth and additional staff.  We depreciate our assets on a straight-line basis, principally over five to seven years.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The following table shows the allocation of depreciation for the years ended December 31, 2012 and 2011, to operating departments:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" valign="bottom" style="width: 22%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Depreciation expense included in:</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cost of products sold</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">155,987</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">104,950</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Research and development</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">120,260</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">118,565</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Selling, general and administrative</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">189,120</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">222,987</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">465,367</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">446,502</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Share-based compensation for the years ended December 31, 2012 and 2011, was approximately $2,539,000 and $1,659,000, respectively, an increase of approximately $880,000 or 53.0%. Increased employee stock option grants reflecting management's philosophy of aligning employee compensation with investor objectives and the increase in the market price of MiMedx common stock was the primary reason for the increase in expense.  The following table shows the allocation of share-based compensation for the years ended December 31, 2012 and 2011, to operating departments:</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" valign="bottom" style="width: 22%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Share-based compensation included in:</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cost of products sold</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">97,970</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">98,366</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Research and development</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">289,341</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">254,997</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Selling, General and administrative</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">2,151,410</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,305,720</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">2,538,721</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,659,083</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div>
</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
<!-- Proceeds from Issuance of Debt-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<us-gaap:ProceedsFromIssuanceOfDebt contextRef="c20110101to20111231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U001" decimals="0"> 5000000 </us-gaap:ProceedsFromIssuanceOfDebt>
<!-- Proceeds from Issuance of Debt-Five Percent Convertible Senior Secured Promissory Note [Member]-Chairman and CEO [Member] -->
<us-gaap:ProceedsFromIssuanceOfDebt contextRef="c20110101to20111231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember_LineOfCreditFacilityAxis_BoardOfDirectorsChairmanMember" unitRef="U001" decimals="0"> 500000 </us-gaap:ProceedsFromIssuanceOfDebt>
<!-- Proceeds from exercise of warrants -->
<us-gaap:ProceedsFromWarrantExercises contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 6001063 </us-gaap:ProceedsFromWarrantExercises>
<!-- Proceeds from exercise of warrants -->
<us-gaap:ProceedsFromWarrantExercises contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 0 </us-gaap:ProceedsFromWarrantExercises>
<!-- Proceeds from Issuance of Private Placement-Common Stock [Member] -->
<us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 3730587 </us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
<!-- Proceeds from issuance of Convertible Senior Secured Promissory Notes -->
<us-gaap:ProceedsFromIssuanceOfSecuredDebt contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 1250000 </us-gaap:ProceedsFromIssuanceOfSecuredDebt>
<!-- Proceeds from shares issued -->
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c20120701to20120731" unitRef="U001" decimals="0"> 4900000 </us-gaap:ProceedsFromIssuanceOfCommonStock>
<!-- Proceeds from sale of common stock and warrants and common stock with registration rights, net -->
<us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 0 </us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
<!-- Proceeds from sale of common stock and warrants and common stock with registration rights, net -->
<us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 3730587 </us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
<!-- Proceeds from exercise of stock options -->
<us-gaap:ProceedsFromStockOptionsExercised contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 1052668 </us-gaap:ProceedsFromStockOptionsExercised>
<!-- Proceeds from exercise of stock options -->
<us-gaap:ProceedsFromStockOptionsExercised contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 295753 </us-gaap:ProceedsFromStockOptionsExercised>
<!-- Proceeds from Senior Secured Promissory Notes -->
<us-gaap:ProceedsFromSecuredNotesPayable contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 0 </us-gaap:ProceedsFromSecuredNotesPayable>
<!-- Proceeds from Senior Secured Promissory Notes -->
<us-gaap:ProceedsFromSecuredNotesPayable contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 5000000 </us-gaap:ProceedsFromSecuredNotesPayable>
<!-- Property and equipment estimated useful life-Minimum [Member] -->
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c20120101to20121231_RangeAxis_MinimumMember"> P5Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<!-- Property and equipment estimated useful life-Maximum [Member] -->
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c20120101to20121231_RangeAxis_MaximumMember"> P7Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<!-- Property and Equipment -->
<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Property and Equipment</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Property and equipment are recorded at cost and depreciated on a straight-line basis over their estimated useful lives, principally five to seven years.  Leasehold improvements are depreciated on a straight-line basis over the lesser of the estimated useful lives or the life of the lease.</div></div>
</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
<!-- Property and equipment, net of accumulated depreciation of $2,279,840 and $1,814,473, respectively -->
<us-gaap:PropertyPlantAndEquipmentNet contextRef="c20121231" unitRef="U001" decimals="0"> 1071625 </us-gaap:PropertyPlantAndEquipmentNet>
<!-- Property and equipment, net of accumulated depreciation of $2,279,840 and $1,814,473, respectively -->
<us-gaap:PropertyPlantAndEquipmentNet contextRef="c20111231" unitRef="U001" decimals="0"> 869411 </us-gaap:PropertyPlantAndEquipmentNet>
<!-- Property, Plant and Equipment, Gross-Leasehold Improvements [Member] -->
<us-gaap:PropertyPlantAndEquipmentGross contextRef="c20121231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember" unitRef="U001" decimals="0"> 1022230 </us-gaap:PropertyPlantAndEquipmentGross>
<!-- Property, Plant and Equipment, Gross-Leasehold Improvements [Member] -->
<us-gaap:PropertyPlantAndEquipmentGross contextRef="c20111231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember" unitRef="U001" decimals="0"> 925086 </us-gaap:PropertyPlantAndEquipmentGross>
<!-- Property, Plant and Equipment, Gross-Equipment [Member] -->
<us-gaap:PropertyPlantAndEquipmentGross contextRef="c20121231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember" unitRef="U001" decimals="0"> 1887645 </us-gaap:PropertyPlantAndEquipmentGross>
<!-- Property, Plant and Equipment, Gross-Equipment [Member] -->
<us-gaap:PropertyPlantAndEquipmentGross contextRef="c20111231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember" unitRef="U001" decimals="0"> 1463144 </us-gaap:PropertyPlantAndEquipmentGross>
<!-- Property, Plant and Equipment, Gross-Furniture and Fixtures [Member] -->
<us-gaap:PropertyPlantAndEquipmentGross contextRef="c20121231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" unitRef="U001" decimals="0"> 431563 </us-gaap:PropertyPlantAndEquipmentGross>
<!-- Property, Plant and Equipment, Gross-Furniture and Fixtures [Member] -->
<us-gaap:PropertyPlantAndEquipmentGross contextRef="c20111231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" unitRef="U001" decimals="0"> 295654 </us-gaap:PropertyPlantAndEquipmentGross>
<!-- Property, Plant and Equipment, Gross-Construction in Progress [Member] -->
<us-gaap:PropertyPlantAndEquipmentGross contextRef="c20121231_PropertyPlantAndEquipmentByTypeAxis_ConstructionInProgressMember" unitRef="U001" decimals="0"> 10027 </us-gaap:PropertyPlantAndEquipmentGross>
<!-- Property, Plant and Equipment, Gross-Construction in Progress [Member] -->
<us-gaap:PropertyPlantAndEquipmentGross contextRef="c20111231_PropertyPlantAndEquipmentByTypeAxis_ConstructionInProgressMember" unitRef="U001" decimals="0"> 0 </us-gaap:PropertyPlantAndEquipmentGross>
<!-- Property, Plant and Equipment, Gross -->
<us-gaap:PropertyPlantAndEquipmentGross contextRef="c20121231" unitRef="U001" decimals="0"> 3351465 </us-gaap:PropertyPlantAndEquipmentGross>
<!-- Property, Plant and Equipment, Gross -->
<us-gaap:PropertyPlantAndEquipmentGross contextRef="c20111231" unitRef="U001" decimals="0"> 2683884 </us-gaap:PropertyPlantAndEquipmentGross>
<!-- Property, Plant and Equipment [Table Text Block] -->
<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Property and equipment consist of the following as of December 31, 2012 and 2011:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="6" valign="bottom" style="width: 22%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Leasehold improvements</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,022,230</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">925,086</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Lab and clean room equipment</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,887,645</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,463,144</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Furniture and equipment</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">431,563</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">295,654</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Construction in Progress</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">10,027</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Property, Equipment, gross</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3,351,465</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">2,683,884</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Less accumulated depreciation</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(2,279,840</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(1,814,473</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Property, Equipment, net</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,071,625</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">869,411</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div>
</us-gaap:PropertyPlantAndEquipmentTextBlock>
<!-- Property, Plant and Equipment Disclosure [Text Block] -->
<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c20120101to20121231">
<div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"><div style="text-indent: 0pt; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">6.</div></td><td><div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Property and Equipment</div></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">  <div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Property and equipment consist of the following as of December 31, 2012 and 2011:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="6" valign="bottom" style="width: 22%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Leasehold improvements</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,022,230</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">925,086</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Lab and clean room equipment</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,887,645</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,463,144</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Furniture and equipment</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">431,563</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">295,654</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Construction in Progress</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">10,027</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Property, Equipment, gross</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3,351,465</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">2,683,884</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Less accumulated depreciation</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(2,279,840</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(1,814,473</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Property, Equipment, net</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,071,625</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">869,411</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The table above includes reclassifications of production equipment previously included in the furniture and office equipment category.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><div><br class="Apple-interchange-newline" /></div></div></div></div></div>
</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
<!-- Provision for doubtful accounts -->
<us-gaap:ProvisionForDoubtfulAccounts contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 56900 </us-gaap:ProvisionForDoubtfulAccounts>
<!-- Provision for doubtful accounts -->
<us-gaap:ProvisionForDoubtfulAccounts contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 57900 </us-gaap:ProvisionForDoubtfulAccounts>
<!-- Accounts Receivable -->
<us-gaap:ReceivablesPolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Accounts Receivable</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Accounts receivable represent amounts due from customers for which revenue has been recognized.  Generally, the Company does not require collateral or any other security to support its receivables.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The allowance for doubtful accounts is the Company's best estimate of the amount of probable credit losses in the Company's existing receivables.  The Company determines the allowance based on factors such as historical collection experience, customer's current creditworthiness, customer concentration, age of accounts receivable balance and general economic conditions that may affect the customer's ability to pay.  As of December 31, 2012, and 2011, the Company has $49,400 and $19,500, respectively, in the allowance for doubtful accounts.  Actual customer collections could differ from estimates.  The approximate provision during the year ended December 31, 2012 was $56,900, with charge-offs of approximately $27,000 as compared to the approximate provision during the year ended December 31, 2011 of $57,900 with charge-offs of approximately $60,000.</div></div>
</us-gaap:ReceivablesPolicyTextBlock>
<!-- Related Party Transactions Disclosure [Text Block] -->
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c20120101to20121231">
<div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 10pt;"><tr valign="top"><td style="width: 13.5pt;"><div style="display: inline; font-family: Times New Roman; font-size: 10pt;"></div></td><td><div style="text-align: left; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">13.   Related Party Transactions</div></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">  <div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">  <div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company has related party expense as described in the following table:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Office space lease (a)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">48,182</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">41,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Aircraft use (b)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,100</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Hybrid debt instrument (c)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3,232</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Line of credit (d)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">103,630</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">42,726</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Convertible senior secured promissory notes (e)</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">50,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">4,507</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 4px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">201,812</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">92,565</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(a) payments related to the lease of office space from an entity owned by the Chairman of the Board and CEO for $48,182 for 2012 and $41,000 for 2011, respectively</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(b) payments related to aircraft use from an entity owned by the former Chairman of the Board and current member of the Board of Directors</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(c) interest of $3,232 related to convertible promissory notes issued in October 2010 to the Chairman of the Board and CEO and two other members of the Board of Directors</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(d) interest of $103,630 for 2012 and $42,726 for 2011, respectively related to a revolving secured line of credit with the Chairman of the Board and CEO dated March 31, 2011</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(e) interest of $50,000 for 2012 and $4,507 for 2011, respectively related to the convertible senior secured promissory notes with the Chairman of the Board and CEO during the fourth quarter of 2011</div></div></div></div></div>
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<!-- Related party expense-Office Space Lease [Member] -->
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="c20120101to20121231_PropertyPlantAndEquipmentByTypeAxis_OfficeSpaceLeaseMember" unitRef="U001" decimals="0" id="Item-11"> 48182 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<!-- Related party expense-Office Space Lease [Member] -->
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="c20110101to20111231_PropertyPlantAndEquipmentByTypeAxis_OfficeSpaceLeaseMember" unitRef="U001" decimals="0" id="Item-12"> 41000 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<!-- Related party expense-Aircraft Use [Member] -->
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="c20120101to20121231_PropertyPlantAndEquipmentByTypeAxis_Z3721" unitRef="U001" decimals="0" id="Item-13"> 0 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<!-- Related party expense-Aircraft Use [Member] -->
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="c20110101to20111231_PropertyPlantAndEquipmentByTypeAxis_Z3721" unitRef="U001" decimals="0" id="Item-14"> 1100 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<!-- Related party expense -->
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 201812 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<!-- Related party expense -->
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 92565 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<!-- Repayments of Lines of Credit -->
<us-gaap:RepaymentsOfLinesOfCredit contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 0 </us-gaap:RepaymentsOfLinesOfCredit>
<!-- Repayments of Lines of Credit -->
<us-gaap:RepaymentsOfLinesOfCredit contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 99000 </us-gaap:RepaymentsOfLinesOfCredit>
<!-- Repayments of Convertible Promissory Notes -->
<us-gaap:RepaymentsOfConvertibleDebt contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 427126 </us-gaap:RepaymentsOfConvertibleDebt>
<!-- Repayments of Convertible Promissory Notes -->
<us-gaap:RepaymentsOfConvertibleDebt contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 0 </us-gaap:RepaymentsOfConvertibleDebt>
<!-- Repayments of Convertible Promissory Notes -->
<us-gaap:RepaymentsOfConvertibleDebt contextRef="c20120701to20120731" unitRef="U001" decimals="0"> 177000 </us-gaap:RepaymentsOfConvertibleDebt>
<!-- Repayments of Convertible Promissory Notes-4% Convertible Debt [Member] -->
<us-gaap:RepaymentsOfConvertibleDebt contextRef="c20120101to20121231_DebtInstrumentAxis_ConvertibleDebtMember" unitRef="U001" decimals="0"> 177000 </us-gaap:RepaymentsOfConvertibleDebt>
<!-- Repayments of Notes Payable -->
<us-gaap:RepaymentsOfNotesPayable contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 0 </us-gaap:RepaymentsOfNotesPayable>
<!-- Repayments of Notes Payable -->
<us-gaap:RepaymentsOfNotesPayable contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 88657 </us-gaap:RepaymentsOfNotesPayable>
<!-- Research and development expenses -->
<us-gaap:ResearchAndDevelopmentExpense contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 2884546 </us-gaap:ResearchAndDevelopmentExpense>
<!-- Research and development expenses -->
<us-gaap:ResearchAndDevelopmentExpense contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 2976313 </us-gaap:ResearchAndDevelopmentExpense>
<!-- Research and Development Costs -->
<us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Research and Development Costs</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Research and development costs consist of direct and indirect costs associated with the development of the Company's technologies.  These costs are expensed as incurred.</div></div>
</us-gaap:ResearchAndDevelopmentExpensePolicy>
<!-- Retained Earnings (Accumulated Deficit) -->
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c20121231" unitRef="U001" decimals="0"> -69683722 </us-gaap:RetainedEarningsAccumulatedDeficit>
<!-- Retained Earnings (Accumulated Deficit) -->
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c20111231" unitRef="U001" decimals="0"> -62021346 </us-gaap:RetainedEarningsAccumulatedDeficit>
<!-- Revenue Recognition -->
<us-gaap:RevenueRecognitionSalesOfGoods contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Revenue Recognition</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company sells its products primarily through a combination of independent stocking distributors and representatives in the U.S. and independent distributors in international markets.  The Company recognizes revenue when title to the goods and risk of loss transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance.  In cases where the Company utilized distributors or ships products directly to the end user, it recognizes revenue according to the shipping terms of the agreement provided all revenue recognition criteria have been met.  A portion of the Company's revenue is generated from inventory maintained at hospitals or with field representatives.  For these products, revenue is recognized at the time the product has been used or implanted.  The Company records estimated sales returns, discounts and allowances as a reduction of net sales in the same period revenue is recognized.</div></div>
</us-gaap:RevenueRecognitionSalesOfGoods>
<!-- Revenue Recognition, Deferred Revenue [Policy Text Block] -->
<us-gaap:RevenueRecognitionDeferredRevenue contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Deferred Grant Income</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company received a Regional Economic Business Assistance ("REBA") grant in the amount of $250,000 from the State of Georgia to help the Company defray certain expenses and capital expenditures related to the Company's expansion of manufacturing activities in the State.  To retain the grant monies the Company must add a certain number of full time positions and spend a certain amount on capital and operations expenditures by December 31, 2014.  The Company recorded the grant monies received as Deferred Grant Income which is included in the Other Liabilities section of the balance sheet per ASC 450-30 Gain Contingencies where an existing condition, situation, or set of circumstances involving uncertainty as to possible gain will ultimately be resolved when one or more future events occur or fail to occur.  A contingency that might result in a gain should not be reflected in the financial statements because to do so might be to recognize the gain before its realization.  As part of the transaction, the Company sold and is leasing back $250,000 of the assets from the State for $100 payable at the time the performance standards are achieved or at the termination date of the lease whichever is earlier.  Once the Company has met the headcount and expenditure goals of the project the Company shall notify the State and pay the fixed rent amount of $100 at which time ownership of the equipment will transfer back to the Company.  The Company also entered into a Performance and Accountability Agreement with the State of Georgia which defines the performance standard that if the Company fails to reach by no later than December 31, 2014, the Company shall repay a portion of the Grant amount.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div></div>
</us-gaap:RevenueRecognitionDeferredRevenue>
<!-- Annual royalty payment -->
<us-gaap:RoyaltyExpense contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 50000 </us-gaap:RoyaltyExpense>
<!-- Outstanding Options, weighted average exercise price (in dollars per share)-Price Range 0.50 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050Member" unitRef="U003" decimals="2"> 0.50 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
<!-- Outstanding Options, weighted average exercise price (in dollars per share)-Price Range 0.65 to 1.00 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange065To100Member" unitRef="U003" decimals="2"> 0.79 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
<!-- Outstanding Options, weighted average exercise price (in dollars per share)-Price Range 1.04 to 1.80 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange104To180Member" unitRef="U003" decimals="2"> 1.30 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
<!-- Outstanding Options, weighted average exercise price (in dollars per share)-Price Range 2.40 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange240Member" unitRef="U003" decimals="2"> 2.40 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
<!-- Outstanding Options, weighted average exercise price (in dollars per share) -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="c20111231" unitRef="U003" decimals="2"> 1.17 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
<!-- Outstanding Options, weighted average exercise price (in dollars per share)-Price Range050 To076 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050To076Member" unitRef="U003" decimals="2"> 0.66 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
<!-- Outstanding Options, weighted average exercise price (in dollars per share)-$0.87-$1.35 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange087To135Member" unitRef="U003" decimals="2"> 1.15 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
<!-- Outstanding Options, weighted average exercise price (in dollars per share)-Price Range140 To218 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange140To218Member" unitRef="U003" decimals="2"> 1.68 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
<!-- Outstanding Options, weighted average exercise price (in dollars per share)-Price Range229 To347 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange229To347Member" unitRef="U003" decimals="0"> 0 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
<!-- Outstanding Options, weighted average exercise price (in dollars per share)-Price Range349 To385 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange349To385Member" unitRef="U003" decimals="0"> 0 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
<!-- Outstanding Options, weighted average exercise price (in dollars per share) -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="c20121231" unitRef="U003" decimals="2"> 1.42 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
<!-- Exercisable Options, weighted average exercise price (in dollars per share)-Price Range 0.50 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050Member" unitRef="U003" decimals="2"> 0.50 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
<!-- Exercisable Options, weighted average exercise price (in dollars per share)-Price Range 0.65 to 1.00 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange065To100Member" unitRef="U003" decimals="2"> 0.79 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
<!-- Exercisable Options, weighted average exercise price (in dollars per share)-Price Range 1.04 to 1.80 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange104To180Member" unitRef="U003" decimals="2"> 1.45 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
<!-- Exercisable Options, weighted average exercise price (in dollars per share)-Price Range 2.40 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange240Member" unitRef="U003" decimals="2"> 2.40 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
<!-- Exercisable Options, weighted average exercise price (in dollars per share) -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c20111231" unitRef="U003" decimals="2"> 1.16 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
<!-- Exercisable Options, weighted average exercise price (in dollars per share)-Price Range050 To076 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050To076Member" unitRef="U003" decimals="2"> 0.66 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
<!-- Exercisable Options, weighted average exercise price (in dollars per share)-$0.87-$1.35 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange087To135Member" unitRef="U003" decimals="2"> 1.15 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
<!-- Exercisable Options, weighted average exercise price (in dollars per share)-Price Range140 To218 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange140To218Member" unitRef="U003" decimals="2"> 1.68 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
<!-- Exercisable Options, weighted average exercise price (in dollars per share)-Price Range229 To347 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange229To347Member" unitRef="U003" decimals="0"> 0 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
<!-- Exercisable Options, weighted average exercise price (in dollars per share)-Price Range349 To385 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange349To385Member" unitRef="U003" decimals="0"> 0 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
<!-- Exercisable Options, weighted average exercise price (in dollars per share) -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c20121231" unitRef="U003" decimals="2"> 1.05 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
<!-- Vested and expected to vest, weighted average remaining contractual term -->
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c20110101to20111231"> P5Y8M12D </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
<!-- Vested and expected to vest, weighted average remaining contractual term -->
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c20120101to20121231"> P7Y10M24D </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
<!-- Expected life (in years) -->
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c20120101to20121231"> P6Y </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<!-- Expected life (in years) -->
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c20110101to20111231"> P6Y </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<!-- Outstanding, weighted average remaining contractual term -->
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c20110101to20111231"> P7Y1M6D </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
<!-- Outstanding, weighted average remaining contractual term -->
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c20120101to20121231"> P8Y </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
<!-- Outstanding Options, weighted average remaining contractual term-Price Range 0.50 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050Member"> P2Y10M24D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
<!-- Outstanding Options, weighted average remaining contractual term-Price Range 0.65 to 1.00 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange065To100Member"> P5Y8M12D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
<!-- Outstanding Options, weighted average remaining contractual term-Price Range 1.04 to 1.80 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange104To180Member"> P8Y9M18D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
<!-- Outstanding Options, weighted average remaining contractual term-Price Range 2.40 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange240Member"> P8M12D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
<!-- Outstanding Options, weighted average remaining contractual term -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c20110101to20111231"> P7Y1M6D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
<!-- Outstanding Options, weighted average remaining contractual term-Price Range050 To076 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050To076Member"> P5Y3M18D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
<!-- Outstanding Options, weighted average remaining contractual term-$0.87-$1.35 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange087To135Member"> P8Y7M6D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
<!-- Outstanding Options, weighted average remaining contractual term-Price Range140 To218 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange140To218Member"> P6Y9M18D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
<!-- Outstanding Options, weighted average remaining contractual term-Price Range229 To347 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange229To347Member"> P9Y8M12D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
<!-- Outstanding Options, weighted average remaining contractual term-Price Range349 To385 [Member] -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange349To385Member"> P10Y </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
<!-- Outstanding Options, weighted average remaining contractual term -->
<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c20120101to20121231"> P8Y </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
<!-- Estimated future amortization expense for intangible assets -->
<us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Expected future amortization of intangible assets is as follows:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="width: 10%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Estimated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="width: 10%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Amortization</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Year ending  December 31,</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Expense</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2013</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,050,380</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2014</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,046,047</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2015</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,022,651</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2016</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">976,998</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">2017</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">886,927</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Thereafter</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,895,746</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">10,878,749</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div>
</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
<!-- Value of assets sold and leased back -->
<us-gaap:SaleLeasebackTransactionNetBookValue contextRef="c20121231" unitRef="U001" decimals="0"> 250000 </us-gaap:SaleLeasebackTransactionNetBookValue>
<!-- Net sales -->
<us-gaap:SalesRevenueGoodsNet contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 27053773 </us-gaap:SalesRevenueGoodsNet>
<!-- Net sales -->
<us-gaap:SalesRevenueGoodsNet contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 7760446 </us-gaap:SalesRevenueGoodsNet>
<!-- Unvested Stock Options Roll Forward -->
<us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">A summary of the status of the Company's unvested stock options as of December 31, 2012 and December 31, 2011 is presented below:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Unvested Stock Options</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="width: 10%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number of</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Shares</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="width: 10%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Grant Date Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Unvested at January 1, 2012</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">4,333,086</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.72</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Granted</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,307,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.90</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cancelled/expired</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(387,171</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Vested</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(875,877</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.05</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Unvested at December 31, 2012</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">8,377,538</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">0.96</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div> </div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Unvested Stock Options</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="width: 10%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number of</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Shares</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="width: 10%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Grant Date Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Unvested at January 1, 2011</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">2,679,787</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.87</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Granted</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3,918,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.63</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cancelled/expired</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(1,352,567</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.59</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Vested</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(912,634</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">0.81</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Unvested at December 31, 2011</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">4,333,086</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">0.72</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div></div>
</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
<!-- Stock options activity -->
<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Activity with respect to the stock options is summarized as follows:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number of</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Shares</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Price</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Remaining</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Contractual</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Term</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">(in years)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Aggregate</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Intrinsic</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Outstanding at January 1, 2011</div></td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">8,257,650</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.20</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Granted</div></td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">3,918,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Exercised</div></td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">(490,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">0.60</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Unvested options forfeited</div></td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">(217,252</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.10</td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Vested options expired</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(1,135,315</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.70</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Outstanding at December 31, 2011</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">10,333,583</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">7.1</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,457,218</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Vested or expected to vest at December 31, 2011</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">10,283,583</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5.7</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,395,223</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 52%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Outstanding at January 1, 2012</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">10,333,583</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Granted</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,307,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.90</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Exercised</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(843,862</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.25</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Unvested options forfeited</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(387,171</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Vested options expired</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(795,915</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.55</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Outstanding at December 31, 2012</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">13,614,135</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.42</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">8.0</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">32,924,881</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Vested or expected to vest at December 31, 2012</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">13,367,278</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.41</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">7.9</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">32,490,930</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div>
</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
<!-- Fair value of options valuation assumptions -->
<us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The assumptions used in calculating the fair value of options using the Black-Scholes-Merton option-pricing model are set forth in the following table:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" nowrap="nowrap" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Year ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Expected volatility</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">45.7-64.3</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">57.3-58.1</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Expected life (in years)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">6</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">6</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Expected dividend yield</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Risk-free interest rate</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">.62%-1.77</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.86% - 2.24</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td></tr></table></div></div>
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
<!-- Computation of basic and diluted net loss per share -->
<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The following table sets forth the computation of basic and diluted net loss per share for the fiscal years ended December 31, 2012 and 2011:</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="6" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Year ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Net loss</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(7,662,376</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(10,193,986</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Denominator for basic earnings per share - weighted </font><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">average shares</font></div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">81,646,295</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">72,450,337</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Effect of dilutive securities: Stock options and warrants outstanding and convertible debt (a)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Denominator for diluted earnings per share - weighted average shares adjusted for dilutive securities</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">81,646,295</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">72,450,337</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Loss per common share - basic and diluted</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(0.09</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(0.14</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr></table></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(a) Securities outstanding that were excluded from the computation, prior to the use of the treasury stock method, because they would have been anti-dilutive are as follows:</div></div>
</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
<!-- Schedule of Inventory, Current [Table Text Block] -->
<us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c20120101to20121231">
<div><div> Inventories consisted of the following items as of December 31, 2012 and 2011: <div style="text-align: center; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="6" valign="bottom" style="text-align: right; width: 21%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: right;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: right;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Raw materials</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">233,747</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">95,288</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Work in process</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,598,537</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">308,763</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Finished goods</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,349,121</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">361,007</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Inventory, gross</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3,181,405</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">765,058</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Reserve for obsolescence</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(158,621</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(52,456</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Inventory, net</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">3,022,784</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">712,602</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div></div>
</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
<!-- Summary of antidilutive securities -->
<us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(a) Securities outstanding that were excluded from the computation, prior to the use of the treasury stock method, because they would have been anti-dilutive are as follows:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: right; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: right; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">December 31, 2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Outstanding Stock Options</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">13,614,135</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">10,333,583</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Outstanding Warrants</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3,129,168</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">9,388,817</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Convertible Debt, promissory notes</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,313,645</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,007,732</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Convertible Line of Credit with Related Party</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,342,726</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Convertible Debt, Acquisition</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,299,315</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 4px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">22,056,948</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">27,372,173</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div></div>
</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
<!-- Reconciliation of the Federal statutory income tax -->
<us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; display: block; font: 10pt 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The reconciliation of the Federal statutory income tax rate of 34% to the effective rate is as follows:</div><div style="text-transform: none; text-indent: 0pt; display: block; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0px; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">12/31/2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">12/31/2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-left: 0pt; width: 76%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Federal statutory rate</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">34.00</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">34.00</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-left: 0pt; width: 76%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">State taxes, net of federal benefit</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3.40</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5.34</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-left: 0pt; width: 76%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Permanent items & other</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">6.51</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(11.30</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%)</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; padding-left: 0pt; width: 76%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Valuation allowance</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(43.91</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(28.04</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%)</td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="padding-bottom: 4px; width: 76%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">%</td></tr></table></div></div>
</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
<!-- Schedule of Accrued Liabilities [Table Text Block] -->
<us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Accrued Expenses consist of the following as of December 31, 2012 and December 31, 2011:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="6" valign="bottom" style="width: 22%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Accrued Personnel Related Costs</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,761,760</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">311,849</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Accrued Commissions</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,469,925</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">112,905</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Other Accrued Expenses</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">512,249</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">358,435</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Total Accrued Expenses</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">3,743,934</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">783,189</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div>
</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
<!-- Schedule of Related Party Transactions [Table Text Block] -->
<us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company has related party expense as described in the following table:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Office space lease (a)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">48,182</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">41,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Aircraft use (b)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,100</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Hybrid debt instrument (c)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3,232</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Line of credit (d)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">103,630</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">42,726</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Convertible senior secured promissory notes (e)</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">50,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">4,507</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 4px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">201,812</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">92,565</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(a) payments related to the lease of office space from an entity owned by the Chairman of the Board and CEO for $48,182 for 2012 and $41,000 for 2011, respectively</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(b) payments related to aircraft use from an entity owned by the former Chairman of the Board and current member of the Board of Directors</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(c) interest of $3,232 related to convertible promissory notes issued in October 2010 to the Chairman of the Board and CEO and two other members of the Board of Directors</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(d) interest of $103,630 for 2012 and $42,726 for 2011, respectively related to a revolving secured line of credit with the Chairman of the Board and CEO dated March 31, 2011</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(e) interest of $50,000 for 2012 and $4,507 for 2011, respectively related to the convertible senior secured promissory notes with the Chairman of the Board and CEO during the fourth quarter of 2011</div></div>
</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
<!-- Purchase price allocation -->
<us-gaap:ScheduleOfPurchasePriceAllocationTableTextBlock contextRef="c20120101to20121231">
<div><div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The actual purchase price was based on cash paid, the fair value of our stock on the date of the Surgical Biologics acquisition, and direct costs associated with the combination.  The actual purchase price was allocated as follows:</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Value of 5,250,000 shares issued at $1.35 per share</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">7,087,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cash paid at closing</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">350,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cash retained for working capital</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">150,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Assumed Debt</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">182,777</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Convertible Secured Promissory Note</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,250,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Fair value of earn-out</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">7,404,700</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Total fair value of purchase price</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">16,424,977</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Assets purchased:</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Tangible assets:</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Debt-free working capital</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">671,880</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Other assets, net</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">385</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Property, plant and equipment</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">72,866</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">745,131</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Intangible assets:</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Customer relationships</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3,520,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Supplier relationships</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">241,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Patents and know-how</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,530,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Trade names and trademarks</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,008,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">In-process research and development – liquid</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">2,160,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">In-process research and development – other</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">25,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Licenses and permits</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">13,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">12,497,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Goodwill</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">3,182,846</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Total Assets Purchased</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">16,424,977</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Working capital and other assets were composed of the following:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Working capital:</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Cash</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">33,583</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Prepaid Expenses</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">2,738</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Accounts Receivable</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">181,087</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">License Receivable</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">340,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Inventory</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">347,106</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Accounts payable and accrued expenses</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(196,101</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Deferred rent and customer deposits</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(36,533</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Debt-free working capital</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">671,880</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Current portion of debt</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(62,590</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Long-term debt</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(21,187</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Line of credit</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(99,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 27pt; font-size: 10pt; margin-right: 0pt;">Net working capital</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">489,103</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 68%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Deposits</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">16,582</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 68%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Deferred rent (non-current)</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(16,197</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="padding-bottom: 4px; width: 68%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">385</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div></div>
</us-gaap:ScheduleOfPurchasePriceAllocationTableTextBlock>
<!-- Deferred tax assets and liabilities -->
<us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; display: block; font: 10pt 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Significant components of the Company's deferred tax assets and liabilities are as follows:</div><div style="text-transform: none; text-indent: 0pt; display: block; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="6" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center; width: 184px;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 16px; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td align="left" valign="bottom"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Deferred tax assets and liabilities:</div></td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 184px; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 16px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff" style="height: 17px;"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Accrued liabilities</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">(73,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">131,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Beneficial conversion feature on convertible financial instruments</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"><font style="font-weight: normal;">(449,000)</font></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"><font style="font-weight: normal;"> </font></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(927,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff" style="height: 12px;"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Intangible assets</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">1,117,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">249,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Property and equipment</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">89,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(18,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="#cceeff" style="height: 14px;"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">R&D Credit Carryforward</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">1,407,356</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">494,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white" style="height: 18px;"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Stock Compensation</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">213,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Adjust accrued earn-out liability</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">567,947</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"><font style="display: inline; font-weight: bold;">—</font></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Charitable Contributions</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">3,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Patent fees</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">6,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Net operating loss</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; width: 166px; font-family: 'times new roman'; font-size: 10pt;">15,487,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">15,524,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Net deferred tax assets</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;">18,368,303</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">15,453,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 76%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9.13%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Valuation allowance</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; width: 166px; font-family: 'times new roman'; font-size: 10pt;">(18,368,303</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(15,453,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 4px; width: 76%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; width: 166px; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; display: block; font: 13px 'Times New Roman'; white-space: normal; letter-spacing: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div></div>
</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
<!-- Long-term Debt -->
<us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The following table summarizes our long-term debt:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="6" valign="bottom"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; text-indent: 0pt; width: 76%; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">$5M Convertible Senior Secured Promissory Notes including  interest at 5% per annum payable quarterly through December 31, 2013, and an additional one time 5% interest charge payable on January 15, 2013 if not repaid by December 31, 2012, collateralized by a first priority lien shared equally with holder of the Convertible Line of Credit with Related Party in all of the patents and intellectual property owned by the Company subordinated to the Convertible Debt related to acquisition for Surgical Biologics intellectual property until repaid. (a)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,313,645</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,007,732</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 76%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; text-indent: 0pt; width: 76%; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Convertible Line of Credit with Related Party with 5% interest; principal and interest payable in full December 31, 2012 collateralized by a first priority lien shared equally with holders of Convertible Senior Secured Promissory Notes in all patents and intellectual property of the Company subordinated to the Convertible debt related to the acquisition for Surgical Biologics intellectual property until repaid. (b)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,342,726</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 76%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; text-indent: 0pt; width: 76%; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Convertible debt related to acquisition with 4% interest; principal and interest payable in full on July 5, 2012, collateralized by a first priority lien in all the intellectual property owned by Surgical Biologics immediately after the closing. (c)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,299,315</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 2px; width: 76%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Total debt</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,313,645</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">7,649,773</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 76%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Less unamortized debt discount</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(1,301,203</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(2,480,400</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td valign="bottom" style="width: 76%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Less current portion</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(2,424,786</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td valign="bottom" style="width: 76%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 76%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Long-term portion</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">4,012,442</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">2,744,587</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">(a) </font><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Investors received First Contingent Warrants (25% of amount invested) and Second Contingent Warrants (25% of amount invested) at an exercise price of $.01 per share. In March 2012 a total of 1,250,000 First Contingent Warrants were vested. In July 2012, a total of 1,250,000 Second Contingent Warrants were voided due to the Company share price trading at or above $1.75 for ten consecutive trading days. The additional interest resulting from the beneficial conversion feature, inclusive of the First Contingent Warrants, totaled $2,278,052 which has been recorded as a debt discount that has been and will continue to be charged to interest expense using the effective interest rate over the life of the note.</font></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">(b) </font><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">The same terms offered to the Senior Secured Promissory note with regard to Contingent Warrants applied to the Convertible Line of Credit. In March 2012 a total of 325,000 First Contingent Warrants vested. In July 2012, a total of 325,000 Second Contingent Warrants were voided. The additional interest related to the beneficial conversion feature totaled $594,456 and was recorded as a debt discount and charged to interest expense using the effective interest rate over the life of the note. On December 7, 2012, the Chairman and CEO elected to convert his note and accrued interest resulting in the issuance of 1,403,630 shares of MiMedx common stock.</font></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">(c) </font><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Additional financing expense of $437,500 was recorded for the beneficial conversion feature of the convertible notes over the term of the note. In July, 2012, the Company settled the Convertible Promissory Notes by paying approximately $177,000 in cash and issuing 893,267 shares of MiMedx common stock.</font></div></div>
</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
<!-- Allocation of Share-based Compensation -->
<us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Share-based compensation for the years ended December 31, 2012 and 2011, was approximately $2,539,000 and $1,659,000, respectively, an increase of approximately $880,000 or 53.0%. Increased employee stock option grants reflecting management's philosophy of aligning employee compensation with investor objectives and the increase in the market price of MiMedx common stock was the primary reason for the increase in expense.  The following table shows the allocation of share-based compensation for the years ended December 31, 2012 and 2011, to operating departments:</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" valign="bottom" style="width: 22%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Share-based compensation included in:</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cost of products sold</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">97,970</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">98,366</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Research and development</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">289,341</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">254,997</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Selling, General and administrative</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">2,151,410</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,305,720</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">2,538,721</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,659,083</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div>
</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
<!-- Estimated useful lives of acquired intangible assets -->
<us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The values assigned to intangible assets are subject to amortization.  The intangible assets were assigned the following lives for amortization purposes:</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 70%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="top" style="width: 40%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="top" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Estimated useful</div></td></tr><tr><td align="left" valign="middle" style="padding-bottom: 2px; width: 40%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Intangible asset:</div></td><td valign="top" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">     life (in years)</div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Customer relationships</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14</div></td></tr><tr bgcolor="white"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Supplier relationships</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14</div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Patents and know-how</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14</div></td></tr><tr bgcolor="white"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Trade names and trademarks</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">indefinite</div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">In-process research and development – liquid</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">indefinite(a)</div></td></tr><tr bgcolor="white"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">In-process research and development – other</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">indefinite</div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="top" style="padding-left: 0pt; width: 40%; margin-left: 9pt;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Licenses and permits</div></td><td valign="middle" style="width: 30%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">3</div></td></tr></table></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(a)AmnioFix<font style="display: inline; font-size: 10pt;">®</font> injectable was launched in 2012 with amortization recorded over its expected useful life.</div></div>
</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
<!-- Summary of stock options outstanding and exercisable -->
<us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The following is a summary of stock options outstanding for years ended December 31, 2012 and 2011, respectively:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><div style="text-align: left;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 30%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="10" valign="bottom" style="width: 42%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 11%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 30%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="10" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Options Outstanding</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Options Exercisable</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Range of Exercise Prices</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number outstanding</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Remaining</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Contractual</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Term</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">(in years)</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise Price</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number Exercisable</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise Price</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$0.50 - $0.76</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2,372,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">5.3</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">0.66</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2,372,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.66</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$0.87 - $1.35</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">7,048,668</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">8.6</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1.15</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1,674,638</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.15</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$1.40 - $2.18</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1,958,467</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">6.8</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1.68</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1,189,459</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.68</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$2.29 - $3.47</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2,177,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">9.7</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$3.49 - $3.85</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">57,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 15%; font-family: 'times new roman'; font-size: 10pt;">10.0</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 10%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 9%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 30%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">13,614,135</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 15%; font-family: 'times new roman'; font-size: 10pt;">8.0</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1.42</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">5,236,597</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.05</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div> </div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr bgcolor="white"><td valign="bottom" style="text-align: right; width: 30%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 10%;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 15%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">2011</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="10" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Options Outstanding</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Options Exercisable</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="white"><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Range of Exercise Prices</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number outstanding</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Remaining</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Contractual</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Term</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">(in years)</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise Price</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="3" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number Exercisable</div></td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise Price</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$0.50</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">587,250</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">2.9</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">0.50</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">513,268</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.50</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$0.65 - $1.00</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2,967,500</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">5.7</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">0.79</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2,730,224</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.79</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: left; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$1.04 - $1.80</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">6,228,833</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 15%; font-family: 'times new roman'; font-size: 10pt;">8.8</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1.30</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2,207,005</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.45</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 30%; font-family: 'times new roman'; font-size: 10pt;">$2.40</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">550,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 15%; font-family: 'times new roman'; font-size: 10pt;">0.7</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 10%; font-family: 'times new roman'; font-size: 10pt;">2.40</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">550,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 9%; font-family: 'times new roman'; font-size: 10pt;">2.40</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 30%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">10,333,583</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 15%; font-family: 'times new roman'; font-size: 10pt;">7.1</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 10%; font-family: 'times new roman'; font-size: 10pt;">1.17</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">6,000,497</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; padding-bottom: 4px; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.16</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div></div>
</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
<!-- Summary of warrants outstanding -->
<us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Common Stock warrants activity and resulting balances for the years ended December 31, 2012 and 2011, are as follows:</div><div style="text-align: center; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number of</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Warrants</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise Price per Warrant</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Number of</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Contingent Warrants</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Weighted-</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Average</div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Exercise Price per Contingent Warrant</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants outstanding at January 1, 2011</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">6,003,924</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.21</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,252,990</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Issued in connection with private placement of common stock</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,889,161</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.50</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,889,162</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Issued in connection with convertible promissory notes</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">203,332</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.50</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">203,332</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Issued in connection with line of credit with related party</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">650,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Issued in connection with Senior Secured Promissory Notes</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,250,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,250,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Placement agent</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">42,400</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.09</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants outstanding at December 31, 2011</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">9,388,817</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.00</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">5,245,484</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants issued:</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Vested contingent warrants related to private placement of common stock</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,672,743</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(1,672,743</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Vested contingent warrants related to line of credit with related party</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">325,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(325,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Contingent warrants voided</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(3,247,741</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants exercised:</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Contingent warrants related to convertible note</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(1,249,750</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Contingent warrants related to private placement of common stock</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(1,608,802</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Contingent warrants related to line of credit with related party</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(325,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.01</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Callable warrants</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(3,288,733</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.50</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 18pt; font-size: 10pt; margin-right: 0pt;">Other</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(1,703,568</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.63</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants expired</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(10,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1.00</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants redeemed for cashless exercises</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(14,789</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">0.53</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Repurchased callable warrants (a)</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(56,750</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.50</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 52%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Warrants outstanding at December 31, 2012</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">3,129,168</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1.04</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"><div style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"> </div></td><td style="width: 18pt;"><div style="text-indent: 0pt; font-family: 'Times New Roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">(a)</div></td><td><div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Company repurchased the callable warrants at $0.01 per share.</div></td></tr></table></div></div>
</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
<!-- Security deposit-Subsequent Event [Member] -->
<us-gaap:SecurityDeposit contextRef="c20130131_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="0"> 499087 </us-gaap:SecurityDeposit>
<!-- Security deposit-Subsequent Event [Member] -->
<us-gaap:SecurityDeposit contextRef="c20121231_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="0"> 250000 </us-gaap:SecurityDeposit>
<!-- Segment Reporting, Policy [Policy Text Block] -->
<us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Segment Reporting</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">ASC 280, "Segment Reporting" requires use of the "management approach" model for segment reporting.  The management approach model is based on the way a company's management organizes segments within the company for making operating decisions and assessing performance. The Company determined it has one operating segment.  Disaggregation of the Company's operating results is impracticable, because the Company's research and development activities and its assets overlap, and management reviews its business as a single operating segment.  Thus, discrete financial information is not available by more than one operating segment<font style="font-style: italic; display: inline;">.</font></div></div>
</us-gaap:SegmentReportingPolicyPolicyTextBlock>
<!-- Selling, general and administrative expenses -->
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 20970687 </us-gaap:SellingGeneralAndAdministrativeExpense>
<!-- Selling, general and administrative expenses -->
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 11181437 </us-gaap:SellingGeneralAndAdministrativeExpense>
<!-- Employee share-based compensation expense -->
<us-gaap:ShareBasedCompensation contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 2075680 </us-gaap:ShareBasedCompensation>
<!-- Employee share-based compensation expense -->
<us-gaap:ShareBasedCompensation contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 1307869 </us-gaap:ShareBasedCompensation>
<!-- Expected volatility, maximum (in hundredths) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c20120101to20121231" unitRef="U005" decimals="3"> 0.643 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
<!-- Expected volatility, maximum (in hundredths) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c20110101to20111231" unitRef="U005" decimals="3"> 0.581 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
<!-- Expected volatility, minimum (in hundredths) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c20120101to20121231" unitRef="U005" decimals="3"> 0.457 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
<!-- Expected volatility, minimum (in hundredths) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c20110101to20111231" unitRef="U005" decimals="3"> 0.573 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
<!-- Risk-free interest rate, maximum (in hundredths) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c20120101to20121231" unitRef="U005" decimals="5"> 0.00177 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
<!-- Risk-free interest rate, maximum (in hundredths) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c20110101to20111231" unitRef="U005" decimals="4"> 0.0224 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
<!-- Granted (in shares) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c20110101to20111231" unitRef="U002" decimals="0"> 3918500 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<!-- Granted (in shares) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 5307500 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<!-- Share issue price (in dollars per share)-First Contingent Warrants [Member] -->
<us-gaap:SharePrice contextRef="c20120630_StatementEquityComponentsAxis_FirstContingentWarrantsMember" unitRef="U003" decimals="2"> 0.01 </us-gaap:SharePrice>
<!-- Share issue price (in dollars per share)-Chairman and CEO [Member]-Callable Warrants [Member] -->
<us-gaap:SharePrice contextRef="c20111231_SaleOfStockAndWarrantsEntityAxis_BoardOfDirectorsChairmanMember_StatementEquityComponentsAxis_WarrantMember" unitRef="U003" decimals="2"> 1.50 </us-gaap:SharePrice>
<!-- Granted, weighted average exercise price (in dollars per share) -->
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="c20110101to20111231" unitRef="U003" decimals="2"> 1.17 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
<!-- Granted, weighted average exercise price (in dollars per share) -->
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="c20120101to20121231" unitRef="U003" decimals="2"> 1.90 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
<!-- Vested options expired weighted-average exercise price (in dollars per share) -->
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="c20110101to20111231" unitRef="U003" decimals="2"> 1.70 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
<!-- Vested options expired weighted-average exercise price (in dollars per share) -->
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="c20120101to20121231" unitRef="U003" decimals="2"> 1.55 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
<!-- Risk-free interest rate, minimum (in hundredths) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c20120101to20121231" unitRef="U005" decimals="4"> 0.0062 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
<!-- Risk-free interest rate, minimum (in hundredths) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c20110101to20111231" unitRef="U005" decimals="4"> 0.0086 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
<!-- Exercised, weighted average exercise price (in dollars per share) -->
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="c20110101to20111231" unitRef="U003" decimals="2"> 0.60 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
<!-- Exercised, weighted average exercise price (in dollars per share) -->
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="c20120101to20121231" unitRef="U003" decimals="2"> 1.25 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
<!-- Unvested options forfeited weighted-average exercise price (in dollars per share) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="c20110101to20111231" unitRef="U003" decimals="2"> 1.10 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
<!-- Unvested options forfeited weighted-average exercise price (in dollars per share) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="c20120101to20121231" unitRef="U003" decimals="2"> 1.17 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
<!-- Expected dividend yield (in hundredths) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c20120101to20121231" unitRef="U005" decimals="0"> 0 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<!-- Expected dividend yield (in hundredths) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c20110101to20111231" unitRef="U005" decimals="0"> 0 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="c20120101to20121231" unitRef="U003" decimals="2"> 1.07 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="c20110101to20111231" unitRef="U003" decimals="2"> 0.63 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
<!-- Exercised options, intrinsic value -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 718978 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
<!-- Exercised options, intrinsic value -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 258000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
<!-- Shares authorized (in shares) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="c20121231" unitRef="U002" decimals="0"> 16500000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
<!-- Shares authorized (in shares) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="c20111231" unitRef="U002" decimals="0"> 12500000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="c20110101to20111231" unitRef="U002" decimals="0"> 217252 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 387171 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
<!-- Vested or expected to vest at end of period (in shares) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c20111231" unitRef="U002" decimals="0"> 10283583 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
<!-- Vested or expected to vest at end of period (in shares) -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c20121231" unitRef="U002" decimals="0"> 13367278 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
<!-- Number of exercisable options (in shares)-Price Range 0.50 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050Member" unitRef="U002" decimals="0"> 513268 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
<!-- Number of exercisable options (in shares)-Price Range 0.65 to 1.00 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange065To100Member" unitRef="U002" decimals="0"> 2730224 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
<!-- Number of exercisable options (in shares)-Price Range 1.04 to 1.80 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange104To180Member" unitRef="U002" decimals="0"> 2207005 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
<!-- Number of exercisable options (in shares)-Price Range 2.40 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange240Member" unitRef="U002" decimals="0"> 550000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
<!-- Number of exercisable options (in shares) -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c20111231" unitRef="U002" decimals="0"> 6000497 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
<!-- Number of exercisable options (in shares)-Price Range050 To076 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050To076Member" unitRef="U002" decimals="0"> 2372500 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
<!-- Number of exercisable options (in shares)-$0.87-$1.35 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange087To135Member" unitRef="U002" decimals="0"> 1674638 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
<!-- Number of exercisable options (in shares)-Price Range140 To218 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange140To218Member" unitRef="U002" decimals="0"> 1189459 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
<!-- Number of exercisable options (in shares)-Price Range229 To347 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange229To347Member" unitRef="U002" decimals="0"> 0 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
<!-- Number of exercisable options (in shares)-Price Range349 To385 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange349To385Member" unitRef="U002" decimals="0"> 0 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
<!-- Number of exercisable options (in shares) -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c20121231" unitRef="U002" decimals="0"> 5236597 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
<!-- Vested and expected to vest, aggregate intrinsic value -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="c20111231" unitRef="U001" decimals="0"> 1395223 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
<!-- Vested and expected to vest, aggregate intrinsic value -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="c20121231" unitRef="U001" decimals="0"> 32490930 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c20101231" unitRef="U003" decimals="2"> 1.20 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c20111231" unitRef="U003" decimals="2"> 1.17 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c20121231" unitRef="U003" decimals="2"> 1.42 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<!-- Outstanding, aggregate intrinsic value -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c20111231" unitRef="U001" decimals="0"> 1457218 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
<!-- Outstanding, aggregate intrinsic value -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c20121231" unitRef="U001" decimals="0"> 32924881 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
<!-- Number of outstanding options (in shares)-Price Range 0.50 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050Member" unitRef="U002" decimals="0"> 587250 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
<!-- Number of outstanding options (in shares)-Price Range 0.65 to 1.00 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange065To100Member" unitRef="U002" decimals="0"> 2967500 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
<!-- Number of outstanding options (in shares)-Price Range 1.04 to 1.80 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange104To180Member" unitRef="U002" decimals="0"> 6228833 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
<!-- Number of outstanding options (in shares)-Price Range 2.40 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange240Member" unitRef="U002" decimals="0"> 550000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
<!-- Number of outstanding options (in shares) -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c20111231" unitRef="U002" decimals="0"> 10333583 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
<!-- Number of outstanding options (in shares)-Price Range050 To076 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050To076Member" unitRef="U002" decimals="0"> 2372500 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
<!-- Number of outstanding options (in shares)-$0.87-$1.35 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange087To135Member" unitRef="U002" decimals="0"> 7048668 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
<!-- Number of outstanding options (in shares)-Price Range140 To218 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange140To218Member" unitRef="U002" decimals="0"> 1958467 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
<!-- Number of outstanding options (in shares)-Price Range229 To347 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange229To347Member" unitRef="U002" decimals="0"> 2177000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
<!-- Number of outstanding options (in shares)-Price Range349 To385 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange349To385Member" unitRef="U002" decimals="0"> 57500 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
<!-- Number of outstanding options (in shares) -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c20121231" unitRef="U002" decimals="0"> 13614135 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
<!-- Exercise Price Range, lower range limit (in dollars per share)-Price Range 0.65 to 1.00 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange065To100Member" unitRef="U003" decimals="2"> 0.65 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
<!-- Exercise Price Range, lower range limit (in dollars per share)-Price Range 1.04 to 1.80 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange104To180Member" unitRef="U003" decimals="2"> 1.04 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
<!-- Exercise Price Range, lower range limit (in dollars per share)-Price Range050 To076 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050To076Member" unitRef="U003" decimals="2"> 0.50 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
<!-- Exercise Price Range, lower range limit (in dollars per share)-$0.87-$1.35 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange087To135Member" unitRef="U003" decimals="2"> 0.87 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
<!-- Exercise Price Range, lower range limit (in dollars per share)-Price Range140 To218 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange140To218Member" unitRef="U003" decimals="2"> 1.40 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
<!-- Exercise Price Range, lower range limit (in dollars per share)-Price Range229 To347 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange229To347Member" unitRef="U003" decimals="2"> 2.29 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
<!-- Exercise Price Range, lower range limit (in dollars per share)-Price Range349 To385 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange349To385Member" unitRef="U003" decimals="2"> 3.49 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="c20111231" unitRef="U003" decimals="2"> 1.17 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="c20121231" unitRef="U003" decimals="2"> 1.41 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c20101231" unitRef="U002" decimals="0"> 8257650 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c20111231" unitRef="U002" decimals="0"> 10333583 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number -->
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c20121231" unitRef="U002" decimals="0"> 13614135 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<!-- Share-based Compensation -->
<us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Share-based Compensation</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company follows the provisions of ASC topic 718 "Compensation — Stock compensation" which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (options and warrants).  All awards are amortized on a straight-line basis over their vesting terms.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div></div>
</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
<!-- Exercise Price Range, upper range limit (in dollars per share)-Price Range 0.50 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050Member" unitRef="U003" decimals="2"> 0.50 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
<!-- Exercise Price Range, upper range limit (in dollars per share)-Price Range 0.65 to 1.00 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange065To100Member" unitRef="U003" decimals="2"> 1.00 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
<!-- Exercise Price Range, upper range limit (in dollars per share)-Price Range 1.04 to 1.80 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange104To180Member" unitRef="U003" decimals="2"> 1.80 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
<!-- Exercise Price Range, upper range limit (in dollars per share)-Price Range 2.40 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="c20110101to20111231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange240Member" unitRef="U003" decimals="2"> 2.40 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
<!-- Exercise Price Range, upper range limit (in dollars per share)-Price Range050 To076 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange050To076Member" unitRef="U003" decimals="2"> 0.76 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
<!-- Exercise Price Range, upper range limit (in dollars per share)-$0.87-$1.35 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange087To135Member" unitRef="U003" decimals="2"> 1.35 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
<!-- Exercise Price Range, upper range limit (in dollars per share)-Price Range140 To218 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange140To218Member" unitRef="U003" decimals="2"> 2.18 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
<!-- Exercise Price Range, upper range limit (in dollars per share)-Price Range229 To347 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange229To347Member" unitRef="U003" decimals="2"> 3.47 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
<!-- Exercise Price Range, upper range limit (in dollars per share)-Price Range349 To385 [Member] -->
<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="c20120101to20121231_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_PriceRange349To385Member" unitRef="U003" decimals="2"> 3.85 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
<!-- Shares, Outstanding-Series A Preferred Stock [Member] -->
<us-gaap:SharesOutstanding contextRef="c20101231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:SharesOutstanding>
<!-- Shares, Outstanding-Series A Preferred Stock [Member] -->
<us-gaap:SharesOutstanding contextRef="c20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:SharesOutstanding>
<!-- Shares, Outstanding-Common Stock [Member] -->
<us-gaap:SharesOutstanding contextRef="c20101231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 64381910 </us-gaap:SharesOutstanding>
<!-- Shares, Outstanding-Common Stock [Member] -->
<us-gaap:SharesOutstanding contextRef="c20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 74306895 </us-gaap:SharesOutstanding>
<!-- Shares, Outstanding-Series A Preferred Stock [Member] -->
<us-gaap:SharesOutstanding contextRef="c20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:SharesOutstanding>
<!-- Shares, Outstanding-Common Stock [Member] -->
<us-gaap:SharesOutstanding contextRef="c20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 88423169 </us-gaap:SharesOutstanding>
<!-- Significant Accounting Policies [Text Block] -->
<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c20120101to20121231">
<div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"><div style="text-indent: 0pt; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2.</div></td><td><div style="text-align: left; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Significant Accounting Policies</div></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div><div style="text-align: left; font-style: italic; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Use of Estimates</div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">  <div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The preparation of financial statements in conformity with generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Principles of Consolidation</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The accompanying financial statements include the accounts of MiMedx Group, Inc. and its wholly-owned subsidiaries MiMedx, Inc., SpineMedica, LLC., and Surgical Biologics, LLC. All significant inter-company balances and transactions have been eliminated</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Reclassifications</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Certain amounts in the prior year financial statements have been reclassified to conform to the current year financial statement presentation.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Historically, the Company has reported depreciation and share-based compensation expense as part of Selling, General and Administrative expense.  The Company decided to report these expenses in each functional area in order to more accurately present all of the costs attributable to each functional area. During the years ended December 31, 2012 and 2011, we recorded a total of approximately $465,000 and $447,000 in depreciation expense allocated to each functional area per the table below.  The overall $19,000 increase in depreciation was attributable to the purchase of additional production and office equipment and leasehold build-out to support our revenue growth and additional staff.  We depreciate our assets on a straight-line basis, principally over five to seven years.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The following table shows the allocation of depreciation for the years ended December 31, 2012 and 2011, to operating departments:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" valign="bottom" style="width: 22%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Depreciation expense included in:</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cost of products sold</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">155,987</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">104,950</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Research and development</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">120,260</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">118,565</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Selling, general and administrative</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">189,120</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">222,987</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">465,367</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">446,502</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Share-based compensation for the years ended December 31, 2012 and 2011, was approximately $2,539,000 and $1,659,000, respectively, an increase of approximately $880,000 or 53.0%. Increased employee stock option grants reflecting management's philosophy of aligning employee compensation with investor objectives and the increase in the market price of MiMedx common stock was the primary reason for the increase in expense.  The following table shows the allocation of share-based compensation for the years ended December 31, 2012 and 2011, to operating departments:</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" valign="bottom" style="width: 22%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Share-based compensation included in:</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cost of products sold</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">97,970</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">98,366</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Research and development</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">289,341</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">254,997</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Selling, General and administrative</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">2,151,410</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,305,720</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">2,538,721</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,659,083</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Segment Reporting</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">ASC 280, "Segment Reporting" requires use of the "management approach" model for segment reporting.  The management approach model is based on the way a company's management organizes segments within the company for making operating decisions and assessing performance. The Company determined it has one operating segment.  Disaggregation of the Company's operating results is impracticable, because the Company's research and development activities and its assets overlap, and management reviews its business as a single operating segment.  Thus, discrete financial information is not available by more than one operating segment<font style="font-style: italic; display: inline;">.</font></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Market Concentrations and Credit Risk</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company places its cash and cash equivalents on deposit with financial institutions in the United States.  In July 2010, the Federal Deposit Insurance Corporation ("FDIC") increased coverage to $250,000 for substantially all depository accounts and temporarily provides unlimited coverage for certain qualifying and participating non-interest bearing transaction accounts.  The temporary unlimited coverage expired on December 31, 2012, at which time the amounts insured by the FDIC returned to $250,000. As of January 1, 2013, the Company had cash and cash equivalents of approximately $6,254,000 in excess of these insured amounts.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company's principal market concentration of risk is related to its limited distribution channels.  Three customers accounted for approximately 68% of revenues for the year ended December 31, 2012, including one customer who represented 40% and another customer which represented 21% of total revenue.  Two customers accounted for approximately 37% of the revenues for the year ended December 31, 2011, including one customer who represented 19% and another customer which represented 18% of total revenue.  The Company's accounts receivable are derived from customers primarily located in the United States of America.  As of December 31, 2012 two customers accounted for 78% of total accounts receivable, 53% and 25% respectively compared to December 31, 2011 when two customers accounted for 43% of total accounts receivable, 33% and 10%, respectively.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Cash and Cash Equivalents</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Cash and cash equivalents include all highly liquid investments with an original maturity of three months or less.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Accounts Receivable</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Accounts receivable represent amounts due from customers for which revenue has been recognized.  Generally, the Company does not require collateral or any other security to support its receivables.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The allowance for doubtful accounts is the Company's best estimate of the amount of probable credit losses in the Company's existing receivables.  The Company determines the allowance based on factors such as historical collection experience, customer's current creditworthiness, customer concentration, age of accounts receivable balance and general economic conditions that may affect the customer's ability to pay.  As of December 31, 2012, and 2011, the Company has $49,400 and $19,500, respectively, in the allowance for doubtful accounts.  Actual customer collections could differ from estimates.  The approximate provision during the year ended December 31, 2012 was $56,900, with charge-offs of approximately $27,000 as compared to the approximate provision during the year ended December 31, 2011 of $57,900 with charge-offs of approximately $60,000.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Inventories</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Inventories are valued at the lower of cost or market, using the first–in, first-out (FIFO) method.  Inventory is tracked through Raw Material, WIP, and Finished Good stages as the product progresses through various production steps and stocking locations.  Within WIP labor and overhead costs are absorbed through the various production processes upon work order closes in our ERP (Enterprise Resource Planning) system.  Historical yields and normal capacities are utilized in the calculation of production overhead rates.  Reserves for inventory obsolescence are utilized to account for slow-moving inventory as well as inventory no longer needed due to diminished market demand.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Goodwill and Purchased Intangible Assets</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Goodwill and purchased intangible assets with indefinite useful lives are not amortized but are tested for impairment at least annually.  The Company reviews goodwill and purchased intangible assets with indefinite lives for impairment annually at the beginning of its fourth fiscal quarter and whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable.  For goodwill, the Company performs a two-step impairment test.  In the first step, the Company compares the fair value of the Company to its carrying value.  The Company determines the fair value utilizing the market approach.  Under the market approach, the Company uses its market capitalization which is calculated by taking the Company's share price times the number of outstanding shares.  If the fair value of the Company exceeds the carrying value of the net assets, goodwill is not impaired, and no further testing is required.  If the fair value of the Company is less than the carrying value, the Company must perform the second step of the impairment test to measure the amount of impairment loss, if any. In the second step, the Company's value is allocated to all of the assets and liabilities, including any unrecognized intangible assets, in a hypothetical analysis that calculates the implied fair value of goodwill in the same manner as if the Company was being acquired in a business combination.  If the implied fair value of the reporting unit's goodwill is less than the carrying value, the difference is recorded as an impairment loss.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company estimates the fair value of indefinite-lived purchased intangible assets using a market approach.  The Company recognizes an impairment loss when the estimated fair value of the indefinite-lived purchased intangible assets is less than the carrying value.  The Company reviews purchased intangible assets with finite lives for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable.  Recoverability of these intangible assets is assessed based on the undiscounted future cash flows expected to result from the use of the asset.  If the undiscounted future cash flows are less than the carrying value, the purchased intangible assets with finite lives are considered to be impaired.  The amount of the impairment loss, if any, is measured as the difference between the carrying amount of these assets and the fair value based on a discounted cash flow approach or, when available and appropriate, to comparable market values.  The Company amortizes purchased intangible assets with finite lives using the straight-line method over the estimated economic lives of the assets.  Intangible assets with finite useful lives are amortized into Selling, General and Administrative Expenses in the consolidated statement of operations using the straight-line method over various periods depending upon the specific asset.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Impairment of Goodwill</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">We tested for impairment of the Intangible Assets related to the Licenses for SaluMedica LLC, Spine Repair and Polyvinyl Alcohol Cryogel as of September 30, 2012 using an undiscounted cash flow methodology.  The impairment was the result of the HydroFix® product line experiencing slower than projected growth in each of its markets.  Our test indicated that the carrying value of the assets related to HydroFix® exceeded its fair value, an impairment loss of approximately $1,798,000 was recognized and the intangible asset carrying amount was adjusted to its new basis.  The impairment was reported as a separate line item in the Consolidated Statement of Operations and included in the Loss From Operations.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Property and Equipment</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Property and equipment are recorded at cost and depreciated on a straight-line basis over their estimated useful lives, principally five to seven years.  Leasehold improvements are depreciated on a straight-line basis over the lesser of the estimated useful lives or the life of the lease.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Impairment of Long-<font style="font-weight: normal;">lived</font> Assets</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company evaluates the recoverability of its long-lived assets (property and equipment) whenever adverse events or changes in business climate indicate that the expected undiscounted future cash flows from the related assets may be less than previously anticipated.  If the net book value of the related assets exceeds the expected undiscounted future cash flows of the assets, the carrying amount would be reduced to the present value of their expected future cash flows and an impairment loss would be recognized.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Deferred Grant Income</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company received a Regional Economic Business Assistance ("REBA") grant in the amount of $250,000 from the State of Georgia to help the Company defray certain expenses and capital expenditures related to the Company's expansion of manufacturing activities in the State.  To retain the grant monies the Company must add a certain number of full time positions and spend a certain amount on capital and operations expenditures by December 31, 2014.  The Company recorded the grant monies received as Deferred Grant Income which is included in the Other Liabilities section of the balance sheet per ASC 450-30 Gain Contingencies where an existing condition, situation, or set of circumstances involving uncertainty as to possible gain will ultimately be resolved when one or more future events occur or fail to occur.  A contingency that might result in a gain should not be reflected in the financial statements because to do so might be to recognize the gain before its realization.  As part of the transaction, the Company sold and is leasing back $250,000 of the assets from the State for $100 payable at the time the performance standards are achieved or at the termination date of the lease whichever is earlier.  Once the Company has met the headcount and expenditure goals of the project the Company shall notify the State and pay the fixed rent amount of $100 at which time ownership of the equipment will transfer back to the Company.  The Company also entered into a Performance and Accountability Agreement with the State of Georgia which defines the performance standard that if the Company fails to reach by no later than December 31, 2014, the Company shall repay a portion of the Grant amount.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Debt Instruments with Detachable Warrants and Beneficial Conversion Features</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">According to ASC-470 Debt Instruments with Detachable Warrants, proceeds from the sale of convertible debt instruments with stock purchase warrants (detachable call options) shall be allocated to the two elements based upon the relative fair values of the debt instrument without the warrants and of the warrants themselves at the time of issuance.  The portion of the proceeds so allocated to the warrants shall be accounted for as paid-in capital.  The remainder of the proceeds shall be allocated to the debt instrument portion of the transaction.  Also, the embedded beneficial conversion feature present in the convertible instrument shall be recognized separately at issuance by allocating a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Revenue Recognition</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company sells its products primarily through a combination of independent stocking distributors and representatives in the U.S. and independent distributors in international markets.  The Company recognizes revenue when title to the goods and risk of loss transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance.  In cases where the Company utilized distributors or ships products directly to the end user, it recognizes revenue according to the shipping terms of the agreement provided all revenue recognition criteria have been met.  A portion of the Company's revenue is generated from inventory maintained at hospitals or with field representatives.  For these products, revenue is recognized at the time the product has been used or implanted.  The Company records estimated sales returns, discounts and allowances as a reduction of net sales in the same period revenue is recognized.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Research and Development Costs</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Research and development costs consist of direct and indirect costs associated with the development of the Company's technologies.  These costs are expensed as incurred.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Income Taxes</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that included the enactment date.  Valuation allowances are recorded for deferred tax assets when the recoverability of such assets is not deemed more likely than not.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Uncertain Tax Positions</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Tax positions are evaluated in a two-step process.  The Company first determines whether it is more likely than not that a tax position will be sustained upon examination.  If a tax position meets the more-likely-than-not recognition threshold it is then measured to determine the amount of benefit to recognize in the financial statements.  The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.  The Company classifies gross interest and penalties and unrecognized tax benefits that are not expected to result in payment or receipt of cash within one year as non-current liabilities in the Consolidated Balance Sheets.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Share-based Compensation</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company follows the provisions of ASC topic 718 "Compensation — Stock compensation" which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (options and warrants).  All awards are amortized on a straight-line basis over their vesting terms.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Fair Value of Financial Instruments</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The carrying value of accounts payable and accrued expenses approximate their fair value due to the short-term nature of these liabilities.  The fair value of our convertible debt approximates $4,012,000 which represents the face value less the unamortized discount of any beneficial conversion feature plus accrued but unpaid interest at December 31, 2012, as compared to the fair value of our short term and long term convertible debt of approximately $5,169,000 which represented the face value less the unamortized discount of any beneficial conversion feature plus accrued but unpaid interest at December 31, 2011.  As of December 31, 2012, and December 31, 2011, the fair value of warrants issued in conjunction with placement fees was approximately $20,500  and $15,000, respectively, which represents the face value less the unamortized discount of any beneficial conversion feature.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Fair Value Measurements</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company records certain financial instruments at fair value, including: cash equivalents and contingent consideration.  The Company may make an irrevocable election to measure other financial instruments at fair value on an instrument-by-instrument basis; although as of December 31, 2012 the Company has not chosen to make any such elections.  Fair value financial instruments are recorded in accordance with the fair value measurement framework.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The Company also measures certain non-financial assets at fair value on a non-recurring basis.  These non-recurring valuations include evaluating assets such as long-lived assets, and non-amortizing intangible assets for impairment; allocating value to assets in an acquired asset group; and applying accounting for business combinations.  The Company uses the fair value measurement framework to value these assets and reports these fair values in the periods in which they are recorded or written down.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The fair value measurement framework includes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair values in their broad levels.  These levels from highest to lowest priority are as follows:</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"> </td><td align="right" style="width: 18pt;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: Symbol, serif; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">·</div></td><td align="left"><div style="text-align: left; font-style: italic; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: normal; margin-right: 0pt;">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities;</div></td></tr></table></div><div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"> </td><td align="right" style="width: 18pt;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: Symbol, serif; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">·</div></td><td align="left"><div style="text-align: left; font-style: italic; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: normal; margin-right: 0pt;">Level 2: Quoted prices in active markets for similar assets or liabilities or observable prices that are based on inputs not quoted on active markets, but corroborated by market data; and</div></td></tr></table></div><div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"> </td><td align="right" style="width: 18pt;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: Symbol, serif; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">·</div></td><td align="left"><div style="text-align: left; font-style: italic; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: normal; margin-right: 0pt;">Level 3: Unobservable inputs or valuation techniques that are used when little or no market data is available.</div></td></tr></table></div></div></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The determination of fair value and the assessment of a measurement's placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity.  Level 3 valuations may require the use of various cost, market, or income valuation methodologies applied to unobservable management estimates and assumptions.  Management's assumptions could vary depending on the asset or liability valued and the valuation method used.  Such assumptions could include: estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods.  The Company may also engage external advisors to assist it in determining fair value, as appropriate.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Although the Company believes that the recorded fair value of its financial instruments is appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: italic 10pt 'times new roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Net loss Per Share</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Basic net loss per common share is computed using the weighted-average number of common shares outstanding during the period.</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">For all periods presented, diluted net loss per share is the same as basic net loss per share, as the inclusion of equivalent shares from outstanding common stock options, warrants, and convertible debt would be anti-dilutive.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The following table sets forth the computation of basic and diluted net loss per share for the fiscal years ended December 31, 2012 and 2011:</div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="6" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Year ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Net loss</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(7,662,376</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(10,193,986</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Denominator for basic earnings per share - weighted </font><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">average shares</font></div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">81,646,295</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">72,450,337</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Effect of dilutive securities: Stock options and warrants outstanding and convertible debt (a)</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Denominator for diluted earnings per share - weighted average shares adjusted for dilutive securities</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">81,646,295</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">72,450,337</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Loss per common share - basic and diluted</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(0.09</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">(0.14</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td></tr></table></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(a) Securities outstanding that were excluded from the computation, prior to the use of the treasury stock method, because they would have been anti-dilutive are as follows:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: right; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td align="right" colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: right; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">December 31, 2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Outstanding Stock Options</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">13,614,135</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">10,333,583</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Outstanding Warrants</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">3,129,168</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">9,388,817</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Convertible Debt, promissory notes</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,313,645</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,007,732</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Convertible Line of Credit with Related Party</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,342,726</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Convertible Debt, Acquisition</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">1,299,315</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 4px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">22,056,948</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">27,372,173</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The table above excludes all securities with contingencies including the earnout liability and contingent warrants.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: bold 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Recently Adopted Accounting Pronouncements</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">In January 2012 the Company adopted Accounting Standards Update ("ASU") 2011-04, Fair Value Measurement (Topic 820): <font style="font-style: italic; display: inline;"><font style="font-weight: bold;">Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs</font>,</font> which clarifies some existing concepts and expands the disclosures for fair value measurements that are estimated using significant unobservable (Level 3) inputs.  The adoption of ASU 2011-04 did not have a material effect on the Company's financial condition, profitability, and cash flows.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">In January 2012 the Company adopted ASU 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income.  The amendments to the Codification in this ASU will require companies to present the components of net income and other comprehensive income either as one continuous statement or as two consecutive statements.  It eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders' equity.  The standard does not change the items which must be reported in other comprehensive income, how such items are measured or when they must be reclassified to net income.  This standard is effective for interim and annual periods beginning after December 15, 2011.  Because this ASU impacts presentation only, it had no effect on our financial condition, results of operations or cash flows.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">In January 2012 the Company adopted ASU 2011-08, Intangibles-Goodwill and Other (Topic 350): <font style="font-style: italic; display: inline;"><font style="font-weight: bold;">Testing Goodwill for Impairment</font>,</font> which gives entities testing goodwill for impairment the option of performing a qualitative assessment before calculating the fair value of a reporting unit in step 1 of the goodwill impairment test.  The adoption of ASU 2011-08 did not have a material effect on the Company's financial condition, profitability, and cash flows.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">In July 2012, the FASB issued ASU No. 2012-02, which amends the guidance in ASC 350-30 on testing indefinite-lived intangible assets, other than goodwill, for impairment. Under the revised guidance, companies testing an indefinite-lived intangible asset for impairment have the option of performing a qualitative assessment before calculating the fair value of the asset (i.e. step 1 of the impairment test). If companies determine, on the basis of qualitative factors, that the fair value of the indefinite-lived intangible asset is more likely than not less than the carrying amount, the two-step impairment test would be required. This update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012, with early adoption permitted. The Company adopted the revised guidance, and it did not have a material impact on the Company's Consolidated Financial Statements.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: bold 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Recently Issued Accounting Pronouncements Not Yet Adopted</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><font style="display: inline; font-weight: bold;">Disclosures about offsetting assets and liabilities – </font>In December 2011, the FASB issued accounting guidance on disclosures about offsetting assets and liabilities.  The guidance requires entities to disclose both gross and net information about instruments and transactions that are offset in the statement of financial position, as well as instruments and transactions that are subject to an enforceable master netting arrangement or similar agreement.  In January 2013, the FASB issued guidance clarifying the scope of the disclosures to apply only to derivatives, including bifurcated embedded derivatives, repurchase and reverse repurchase agreements, and securities lending and securities borrowing transactions.  This guidance is effective January 1, 2013, with retrospective application required.  We do not expect the adoption to have a material impact on our financial statements.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><font style="display: inline; font-weight: bold;">Reporting of amounts reclassified out of accumulated other comprehensive income – </font>In February 2013, the FASB issued accounting guidance on the reporting of reclassifications out of accumulated other comprehensive income. The guidance requires an entity to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income if the amount is reclassified to net income in its entirety in the same reporting period. For other amounts not required to be reclassified in their entirety to net income in the same reporting period, a cross reference to other disclosures that provide additional detail about the reclassification amounts is required. This guidance is effective January 1, 2013. We do not expect the adoption to have a material impact on our financial statements.</div><br class="Apple-interchange-newline" /></div></div></div>
</us-gaap:SignificantAccountingPoliciesTextBlock>
<!-- Placement fee, warrants issued (in shares) -->
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 1120000 </us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<!-- Placement fee, warrants issued (in shares)-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="c20120101to20121231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U002" decimals="0"> 42400 </us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<!-- Common stock issued for acquisition note (in shares)-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
<!-- Common stock issued for acquisition note (in shares)-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 893267 </us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
<!-- Stock Issued During Period, Value, Stock Options Exercised-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<!-- Stock Issued During Period, Value, Stock Options Exercised-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<!-- Stock Issued During Period, Value, Stock Options Exercised-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 490 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<!-- Stock Issued During Period, Value, Stock Options Exercised-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 844 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<!-- Stock Issued During Period, Value, Stock Options Exercised-Additional Paid-in Capital [Member] -->
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c20110101to20111231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 295263 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<!-- Stock Issued During Period, Value, Stock Options Exercised-Additional Paid-in Capital [Member] -->
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c20120101to20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 1051824 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<!-- Stock Issued During Period, Value, Stock Options Exercised-Treasury Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c20110101to20111231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<!-- Stock Issued During Period, Value, Stock Options Exercised-Treasury Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c20120101to20121231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<!-- Stock Issued During Period, Value, Stock Options Exercised-Accumulated Deficit [Member] -->
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c20110101to20111231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<!-- Stock Issued During Period, Value, Stock Options Exercised-Accumulated Deficit [Member] -->
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c20120101to20121231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<!-- Stock Issued During Period, Value, Stock Options Exercised -->
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 295753 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<!-- Stock Issued During Period, Value, Stock Options Exercised -->
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 1052668 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<!-- Common stock issued for acquisition note-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueAcquisitions>
<!-- Common stock issued for acquisition note-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 893 </us-gaap:StockIssuedDuringPeriodValueAcquisitions>
<!-- Common stock issued for acquisition note-Additional Paid-in Capital [Member] -->
<us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c20120101to20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 892374 </us-gaap:StockIssuedDuringPeriodValueAcquisitions>
<!-- Common stock issued for acquisition note-Treasury Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c20120101to20121231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueAcquisitions>
<!-- Common stock issued for acquisition note-Accumulated Deficit [Member] -->
<us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c20120101to20121231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueAcquisitions>
<!-- Common stock issued for acquisition note -->
<us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 893267 </us-gaap:StockIssuedDuringPeriodValueAcquisitions>
<!-- Sale of common stock and warrants (net of $47,333 of offering costs)-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<!-- Sale of common stock and warrants (net of $47,333 of offering costs)-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 3779 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<!-- Sale of common stock and warrants (net of $47,333 of offering costs)-Additional Paid-in Capital [Member] -->
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c20110101to20111231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 3726808 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<!-- Sale of common stock and warrants (net of $47,333 of offering costs)-Treasury Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c20110101to20111231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<!-- Sale of common stock and warrants (net of $47,333 of offering costs)-Accumulated Deficit [Member] -->
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c20110101to20111231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<!-- Sale of common stock and warrants (net of $47,333 of offering costs) -->
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 3730587 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<!-- Value of shares issued for intangibles -->
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 896000 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<!-- Other share-based compensation expense (in shares)-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Warrants Issued in Connection with Private Placement [Member]-Callable Warrants [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember" unitRef="U002" decimals="0"> 1889161 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Contingent Warrants [Member]-Warrants Issued in Connection with Private Placement [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember" unitRef="U002" decimals="0"> 1889162 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Warrants issued in connection with convertible promissory notes [Member]-Callable Warrants [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithConvertiblePromissoryNotesMember" unitRef="U002" decimals="0"> 203332 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Warrants issued in connection with convertible promissory notes [Member]-Contingent Warrants [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithConvertiblePromissoryNotesMember" unitRef="U002" decimals="0"> 203332 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Warrants Issued In Connection With Line of Credit with Related Party [Member]-Callable Warrants [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Warrants Issued In Connection With Line of Credit with Related Party [Member]-Contingent Warrants [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember" unitRef="U002" decimals="0"> 650000 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Warrants issued in connection with Senior Secured Promissory Notes. [Member]-Callable Warrants [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithSeniorSecuredPromissoryNotesMember" unitRef="U002" decimals="0"> 1250000 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Contingent Warrants [Member]-Warrants issued in connection with Senior Secured Promissory Notes. [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithSeniorSecuredPromissoryNotesMember" unitRef="U002" decimals="0"> 1250000 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Placement Agent [Member]-Callable Warrants [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_PrivatePlacementMember" unitRef="U002" decimals="0"> 42400 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Placement Agent [Member]-Contingent Warrants [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_PrivatePlacementMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Warrants Issued in Connection with Private Placement [Member]-Callable Warrants [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember" unitRef="U002" decimals="0"> 1672743 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Contingent Warrants [Member]-Warrants Issued in Connection with Private Placement [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember" unitRef="U002" decimals="0"> -1672743 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Warrants Issued In Connection With Line of Credit with Related Party [Member]-Callable Warrants [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember" unitRef="U002" decimals="0"> 325000 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Other share-based compensation expense (in shares)-Warrants Issued In Connection With Line of Credit with Related Party [Member]-Contingent Warrants [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember" unitRef="U002" decimals="0"> -325000 </us-gaap:StockIssuedDuringPeriodSharesOther>
<!-- Shares issued in conjunction with conversion of convertible debt-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<!-- Shares issued in conjunction with conversion of convertible debt-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 406 </us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<!-- Shares issued in conjunction with conversion of convertible debt-Additional Paid-in Capital [Member] -->
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c20110101to20111231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 406257 </us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<!-- Shares issued in conjunction with conversion of convertible debt-Treasury Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c20110101to20111231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<!-- Shares issued in conjunction with conversion of convertible debt-Accumulated Deficit [Member] -->
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c20110101to20111231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<!-- Shares issued in conjunction with conversion of convertible debt -->
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 406663 </us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<!-- Employee share-based compensation expense (in shares)-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
<!-- Employee share-based compensation expense (in shares)-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
<!-- Employee share-based compensation expense (in shares)-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
<!-- Employee share-based compensation expense (in shares)-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
<!-- Stock valued in conjunction with the acquisition of Surgical Biologics, LLC -->
<us-gaap:StockIssued1 contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 7087500 </us-gaap:StockIssued1>
<!-- Sale of common stock and warrants (net of $47,333 of offering costs) (in shares)-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<!-- Sale of common stock and warrants (net of $47,333 of offering costs) (in shares)-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 3778321 </us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<!-- Sale of common stock and warrants (net of $47,333 of offering costs) (in shares)-Common Stock [Member] --> <!-- Sale of common stock and warrants (net of $47,333 of offering costs) (in shares)-Callable Warrants [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c20110101to20111231_StatementEquityComponentsAxis_WarrantMember" unitRef="U002" decimals="0"> 1889161 </us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<!-- Sale of common stock and warrants (net of $47,333 of offering costs) (in shares)-First Contingent Warrants [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c20120101to20120630_StatementEquityComponentsAxis_FirstContingentWarrantsMember" unitRef="U002" decimals="0"> 1673000 </us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 490000 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 843863 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period -->
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c20110101to20111231" unitRef="U002" decimals="0"> 490000 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<!-- Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period -->
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 843862 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<!-- Shares issued in conjunction with conversion of convertible debt (in shares)-Series A Preferred Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<!-- Shares issued in conjunction with conversion of convertible debt (in shares)-Common Stock [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 406664 </us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<!-- Shares issued in conjunction with conversion of convertible debt (in shares)-Revolving Credit Facility [Member]-Chairman and CEO [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c20120101to20121231_CreditFacilityAxis_RevolvingCreditFacilityMember_LineOfCreditFacilityAxis_BoardOfDirectorsChairmanMember" unitRef="U002" decimals="0"> 1403630 </us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<!-- Shares issued in conjunction with conversion of convertible debt (in shares)-Revolving Credit Facility [Member] -->
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c20120101to20121231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="0"> 893267 </us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<!-- Stockholders' Equity Attributable to Parent -->
<us-gaap:StockholdersEquity contextRef="c20121231" unitRef="U001" decimals="0"> 20007302 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent -->
<us-gaap:StockholdersEquity contextRef="c20111231" unitRef="U001" decimals="0"> 11896565 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Series A Preferred Stock [Member] -->
<us-gaap:StockholdersEquity contextRef="c20101231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Common Stock [Member] -->
<us-gaap:StockholdersEquity contextRef="c20101231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 64382 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Additional Paid-in Capital [Member] -->
<us-gaap:StockholdersEquity contextRef="c20101231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 57888506 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Treasury Stock [Member] -->
<us-gaap:StockholdersEquity contextRef="c20101231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> -25000 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Accumulated Deficit [Member] -->
<us-gaap:StockholdersEquity contextRef="c20101231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> -51827360 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent -->
<us-gaap:StockholdersEquity contextRef="c20101231" unitRef="U001" decimals="0"> 6100528 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Series A Preferred Stock [Member] -->
<us-gaap:StockholdersEquity contextRef="c20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Common Stock [Member] -->
<us-gaap:StockholdersEquity contextRef="c20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 74307 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Additional Paid-in Capital [Member] -->
<us-gaap:StockholdersEquity contextRef="c20111231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 73868604 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Treasury Stock [Member] -->
<us-gaap:StockholdersEquity contextRef="c20111231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> -25000 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Accumulated Deficit [Member] -->
<us-gaap:StockholdersEquity contextRef="c20111231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> -62021346 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Series A Preferred Stock [Member] -->
<us-gaap:StockholdersEquity contextRef="c20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Common Stock [Member] -->
<us-gaap:StockholdersEquity contextRef="c20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 88423 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Additional Paid-in Capital [Member] -->
<us-gaap:StockholdersEquity contextRef="c20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 89627602 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Treasury Stock [Member] -->
<us-gaap:StockholdersEquity contextRef="c20121231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> -25000 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent-Accumulated Deficit [Member] -->
<us-gaap:StockholdersEquity contextRef="c20121231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> -69683722 </us-gaap:StockholdersEquity>
<!-- Stockholders' Equity Attributable to Parent --> <!-- Stockholders' Equity Note Disclosure [Text Block] -->
<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">10. Common Stock Placements</div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-align: left; font-style: italic; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">October 2010 Private Placement</div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;"> In October 2010, the Company commenced a private placement to sell common stock and warrants.  For the year ended December 31, 2011, the Company sold 3,778,321 shares of Common Stock and issued 1,889,161 warrants and received cash proceeds of $3,730,587 net of $47,733 in offering costs.  Under the terms of the offering, for each share purchased, the investor received one 5-year warrant to purchase the common stock of the Company at an exercise price of $1.50 per share.  The terms of the warrant, (the "Callable Warrant") are that for every two shares of common stock purchased, the holder is issued a 5-year warrant to purchase one share of the Company's Common Stock at an exercise price of $1.50 per share.  The Callable Warrant was callable by the Company at any time after the issuance if the closing sale price of the Stock exceeds $1.75 for fifteen (15) or more consecutive trading days. Upon written notice, the Company may redeem the Callable Warrant at a price of $0.01 per share. In July 2012, the Company decided to exercise its right to call approximately 3,345,000 warrants.  The Company raised approximately $4,900,000 and issued approximately 3,289,000 shares of MiMedx common stock including a total of 503,332 Callable Warrants exercised by the Company's Chairman and CEO.  The balance of 56,750 warrants were repurchased at $0.01 per share. <div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Additionally, under the terms of the offering the Company issued a First Contingent Warrant ("First Contingent Warrant") and a Second Contingent Warrant ("Second Contingent Warrant") to Purchase Common Stock.  These warrants vested assuming certain revenue targets were not achieved and could be voided if the closing trading price of the Company's stock achieved a certain level for a specified number of consecutive trading days.  The First Contingent Warrant vested during the second quarter of 2012 resulting in the issuance of approximately 1,673,000 warrants including approximately 252,000 to the Company's Chairman and CEO, at an exercise price of $0.01 per share. On July 3, 2012, 1,672,742 Second Contingent Warrants were voided which represented the tenth consecutive trading day of the closing trading price of the Company stock being at least $1.75. As of December 31, 2012 approximately 1,609,000 First Contingent Warrants have been exercised.</div><br class="Apple-interchange-newline" /></div></div>
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
<!-- Subsequent Events [Text Block] -->
<us-gaap:SubsequentEventsTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">16.   Subsequent Events</div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">  <div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">On January 31, 2013, the Company entered into a lease agreement (the "Lease") under which the Company will lease approximately 80,000 square feet of office, laboratory and warehouse space in Marietta, Georgia.  This building will become the Company's new corporate headquarters.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The initial term of the lease is sixty-nine (69) months commencing on May 1, 2013. Base rental payments over the term of the lease total approximately $7,100,000.  Under the Lease, the Company is obligated to post a security deposit in the amount of $499,087.  As of the date of this report approximately $250,000 of this obligation has been deposited.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">During the months of January and February 2013, all holders of the Convertible Senior Secured Promissory Notes converted their interest in this obligation to shares of MiMedx common stock.  The total amount of debt plus accrued interest that was exchanged was $5,271,963.  In conjunction with this exchange 5,271,963 shares of the Company's common stock were issued in full satisfaction of this obligation.  Included in this total are 532,260 shares representing Mr. Petit's conversion of his note.</div><br /></div></div>
</us-gaap:SubsequentEventsTextBlock>
<!-- Tax Credit Carryforward, Amount -->
<us-gaap:TaxCreditCarryforwardAmount contextRef="c20121231" unitRef="U001" decimals="0"> 1400000 </us-gaap:TaxCreditCarryforwardAmount>
<!-- Treasury Stock, Value -->
<us-gaap:TreasuryStockValue contextRef="c20121231" unitRef="U001" decimals="0"> 25000 </us-gaap:TreasuryStockValue>
<!-- Treasury Stock, Value -->
<us-gaap:TreasuryStockValue contextRef="c20111231" unitRef="U001" decimals="0"> 25000 </us-gaap:TreasuryStockValue>
<!-- Treasury stock, shares (in shares) -->
<us-gaap:TreasuryStockShares contextRef="c20121231" unitRef="U002" decimals="0"> 50000 </us-gaap:TreasuryStockShares>
<!-- Treasury stock, shares (in shares) -->
<us-gaap:TreasuryStockShares contextRef="c20111231" unitRef="U002" decimals="0"> 50000 </us-gaap:TreasuryStockShares>
<!-- Unrecognized tax benefits -->
<us-gaap:UnrecognizedTaxBenefits contextRef="c20121231" unitRef="U001" decimals="0"> 18817000 </us-gaap:UnrecognizedTaxBenefits>
<!-- Unrecognized tax benefits -->
<us-gaap:UnrecognizedTaxBenefits contextRef="c20111231" unitRef="U001" decimals="0"> 15453000 </us-gaap:UnrecognizedTaxBenefits>
<!-- Use of Estimates -->
<us-gaap:UseOfEstimates contextRef="c20120101to20121231">
<div><div style="text-align: left; font-style: italic; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Use of Estimates</div><div style="text-indent: 0pt; display: block;"><br /></div><div>  <div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The preparation of financial statements in conformity with generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.</div></div></div>
</us-gaap:UseOfEstimates>
<!-- Warrants and Rights Outstanding -->
<us-gaap:WarrantsAndRightsOutstanding contextRef="c20121231" unitRef="U001" decimals="0"> 20500 </us-gaap:WarrantsAndRightsOutstanding>
<!-- Warrants and Rights Outstanding -->
<us-gaap:WarrantsAndRightsOutstanding contextRef="c20111231" unitRef="U001" decimals="0"> 15000 </us-gaap:WarrantsAndRightsOutstanding>
<!-- Warrants Not Settleable in Cash, Fair Value Disclosure-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<us-gaap:WarrantsNotSettleableInCashFairValueDisclosure contextRef="c20121231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U001" decimals="0"> 15000 </us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
<!-- Weighted Average Number of Shares Outstanding, Basic -->
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 81646295 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<!-- Weighted Average Number of Shares Outstanding, Basic -->
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c20110101to20111231" unitRef="U002" decimals="0"> 72450337 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<!-- Weighted Average Number of Shares Outstanding, Diluted -->
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 81646295 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<!-- Weighted Average Number of Shares Outstanding, Diluted -->
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c20110101to20111231" unitRef="U002" decimals="0"> 72450337 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<!-- Basic and diluted (in shares) -->
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 81646295 </us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<!-- Basic and diluted (in shares) -->
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="c20110101to20111231" unitRef="U002" decimals="0"> 72450337 </us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<!-- Weighted Average Number Diluted Shares Outstanding Adjustment -->
<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c20120101to20121231" unitRef="U002" decimals="0" id="Item-15"> 0 </us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
<!-- Weighted Average Number Diluted Shares Outstanding Adjustment -->
<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c20110101to20111231" unitRef="U002" decimals="0" id="Item-16"> 0 </us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
<!-- Earn out liability payable in MiMedx stock -->
<mdxg:EarnOutLiabilityPayableInMimedxStock contextRef="c20121231" unitRef="U001" decimals="0"> 5792330 </mdxg:EarnOutLiabilityPayableInMimedxStock>
<!-- Earn out liability payable in MiMedx stock -->
<mdxg:EarnOutLiabilityPayableInMimedxStock contextRef="c20111231" unitRef="U001" decimals="0"> 7410503 </mdxg:EarnOutLiabilityPayableInMimedxStock>
<!-- Intangible assets, net of accumulated amortization -->
<mdxg:Finite-LivedIntangibleAssetsAccumulatedAmortization contextRef="c20121231" unitRef="U001" decimals="0"> 4848756 </mdxg:Finite-LivedIntangibleAssetsAccumulatedAmortization>
<!-- Intangible assets, net of accumulated amortization -->
<mdxg:Finite-LivedIntangibleAssetsAccumulatedAmortization contextRef="c20111231" unitRef="U001" decimals="0"> 3468515 </mdxg:Finite-LivedIntangibleAssetsAccumulatedAmortization>
<!-- Long term debt including related party, current maturities -->
<mdxg:LongTermDebtIncludingRelatedPartyExcludingCurrentMaturities contextRef="c20121231" unitRef="U001" decimals="0"> 0 </mdxg:LongTermDebtIncludingRelatedPartyExcludingCurrentMaturities>
<!-- Long term debt including related party, current maturities -->
<mdxg:LongTermDebtIncludingRelatedPartyExcludingCurrentMaturities contextRef="c20111231" unitRef="U001" decimals="0"> 2424786 </mdxg:LongTermDebtIncludingRelatedPartyExcludingCurrentMaturities>
<!-- Impairment of Intangible Assets -->
<mdxg:ImpairmentOfIntangibleAssets contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 1798495 </mdxg:ImpairmentOfIntangibleAssets>
<!-- Impairment of Intangible Assets -->
<mdxg:ImpairmentOfIntangibleAssets contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 0 </mdxg:ImpairmentOfIntangibleAssets>
<!-- Warrants vested-First Contingent Warrants [Member]-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<mdxg:WarrantsVested contextRef="c20120301to20120331_ClassOfWarrantOrRightAxis_FirstContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U002" decimals="0"> -1250000 </mdxg:WarrantsVested>
<!-- Warrants vested-First Contingent Warrants [Member]-Revolving Credit Facility [Member] -->
<mdxg:WarrantsVested contextRef="c20120301to20120331_ClassOfWarrantOrRightAxis_FirstContingentWarrantsMember_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="0"> -325000 </mdxg:WarrantsVested>
<!-- Closing Trading Price Of Company Stock-Five Percent Convertible Senior Secured Promissory Note [Member]-Second Contingent Warrants [Member] -->
<mdxg:ClosingTradingPriceOfCompanyStock contextRef="c20120702to20120703_ClassOfWarrantOrRightAxis_SecondContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U003" decimals="2"> 1.75 </mdxg:ClosingTradingPriceOfCompanyStock>
<!-- Number Of Consecutive Trading Days-Five Percent Convertible Senior Secured Promissory Note [Member]-Second Contingent Warrants [Member] -->
<mdxg:NumberOfConsecutiveTradingDays contextRef="c20120701to20120731_ClassOfWarrantOrRightAxis_SecondContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember"> P10D </mdxg:NumberOfConsecutiveTradingDays>
<!-- Deferred tax assets, intangible assets -->
<mdxg:DeferredTaxAssetsIntangibleAssets contextRef="c20121231" unitRef="U001" decimals="0"> 6000 </mdxg:DeferredTaxAssetsIntangibleAssets>
<!-- Deferred tax assets, intangible assets -->
<mdxg:DeferredTaxAssetsIntangibleAssets contextRef="c20111231" unitRef="U001" decimals="0"> 0 </mdxg:DeferredTaxAssetsIntangibleAssets>
<!-- Deferred tax liabilities, accrued liabilities -->
<mdxg:DeferredTaxLiabilitiesAccruedLiabilities contextRef="c20121231" unitRef="U001" decimals="0"> 73000 </mdxg:DeferredTaxLiabilitiesAccruedLiabilities>
<!-- Other share-based compensation expense-Series A Preferred Stock [Member] -->
<mdxg:OtherShare-BasedCompensationExpense contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </mdxg:OtherShare-BasedCompensationExpense>
<!-- Other share-based compensation expense-Series A Preferred Stock [Member] -->
<mdxg:OtherShare-BasedCompensationExpense contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </mdxg:OtherShare-BasedCompensationExpense>
<!-- Other share-based compensation expense-Common Stock [Member] -->
<mdxg:OtherShare-BasedCompensationExpense contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 0 </mdxg:OtherShare-BasedCompensationExpense>
<!-- Other share-based compensation expense-Common Stock [Member] -->
<mdxg:OtherShare-BasedCompensationExpense contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 0 </mdxg:OtherShare-BasedCompensationExpense>
<!-- Other share-based compensation expense-Additional Paid-in Capital [Member] -->
<mdxg:OtherShare-BasedCompensationExpense contextRef="c20110101to20111231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 351214 </mdxg:OtherShare-BasedCompensationExpense>
<!-- Other share-based compensation expense-Additional Paid-in Capital [Member] -->
<mdxg:OtherShare-BasedCompensationExpense contextRef="c20120101to20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 463041 </mdxg:OtherShare-BasedCompensationExpense>
<!-- Other share-based compensation expense-Treasury Stock [Member] -->
<mdxg:OtherShare-BasedCompensationExpense contextRef="c20110101to20111231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </mdxg:OtherShare-BasedCompensationExpense>
<!-- Other share-based compensation expense-Treasury Stock [Member] -->
<mdxg:OtherShare-BasedCompensationExpense contextRef="c20120101to20121231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </mdxg:OtherShare-BasedCompensationExpense>
<!-- Other share-based compensation expense-Accumulated Deficit [Member] -->
<mdxg:OtherShare-BasedCompensationExpense contextRef="c20110101to20111231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </mdxg:OtherShare-BasedCompensationExpense>
<!-- Other share-based compensation expense-Accumulated Deficit [Member] -->
<mdxg:OtherShare-BasedCompensationExpense contextRef="c20120101to20121231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </mdxg:OtherShare-BasedCompensationExpense>
<!-- Other share-based compensation expense -->
<mdxg:OtherShare-BasedCompensationExpense contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 351214 </mdxg:OtherShare-BasedCompensationExpense>
<!-- Other share-based compensation expense -->
<mdxg:OtherShare-BasedCompensationExpense contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 463041 </mdxg:OtherShare-BasedCompensationExpense>
<!-- Stock Issued During Period, Value, Exercise of Warrants-Series A Preferred Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueExerciseOfWarrants>
<!-- Stock Issued During Period, Value, Exercise of Warrants-Common Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 7960 </mdxg:StockIssuedDuringPeriodValueExerciseOfWarrants>
<!-- Stock Issued During Period, Value, Exercise of Warrants-Additional Paid-in Capital [Member] -->
<mdxg:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 5993103 </mdxg:StockIssuedDuringPeriodValueExerciseOfWarrants>
<!-- Stock Issued During Period, Value, Exercise of Warrants-Treasury Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueExerciseOfWarrants>
<!-- Stock Issued During Period, Value, Exercise of Warrants-Accumulated Deficit [Member] -->
<mdxg:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueExerciseOfWarrants>
<!-- Stock Issued During Period, Value, Exercise of Warrants -->
<mdxg:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 6001063 </mdxg:StockIssuedDuringPeriodValueExerciseOfWarrants>
<!-- Stock Issued During Period, Shares, Exercise of Warrants-Series A Preferred Stock [Member] -->
<mdxg:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodSharesExerciseOfWarrants>
<!-- Stock Issued During Period, Shares, Exercise of Warrants-Common Stock [Member] -->
<mdxg:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 7959767 </mdxg:StockIssuedDuringPeriodSharesExerciseOfWarrants>
<!-- Fair value adjustment of earn out liability -->
<mdxg:FairValueAdjustmentOfEarnOutLiability contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 1567050 </mdxg:FairValueAdjustmentOfEarnOutLiability>
<!-- Fair value adjustment of earn out liability -->
<mdxg:FairValueAdjustmentOfEarnOutLiability contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 5803 </mdxg:FairValueAdjustmentOfEarnOutLiability>
<!-- Proceeds From Reba Grant -->
<mdxg:ProceedsFromRebaGrant contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 0 </mdxg:ProceedsFromRebaGrant>
<!-- Proceeds From Reba Grant -->
<mdxg:ProceedsFromRebaGrant contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 250000 </mdxg:ProceedsFromRebaGrant>
<!-- Shares Issued In Conjunction With Its Acquisition Of Company -->
<mdxg:SharesIssuedInConjunctionWithItsAcquisitionOfCompany contextRef="c20110101to20111231" unitRef="U002" decimals="0"> 5250000 </mdxg:SharesIssuedInConjunctionWithItsAcquisitionOfCompany>
<!-- Convertible Debt Issued In Acquisition Of Company -->
<mdxg:ConvertibleDebtIssuedInAcquisitionOfCompany contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 437500 </mdxg:ConvertibleDebtIssuedInAcquisitionOfCompany>
<!-- Convertible Debt Issued In Acquisition Of Company -->
<mdxg:ConvertibleDebtIssuedInAcquisitionOfCompany contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 893267 </mdxg:ConvertibleDebtIssuedInAcquisitionOfCompany>
<!-- Beneficial Conversion Feature Value Related To Convertible Debt Issued With Regard To Senior Secured Promissory Notes -->
<mdxg:BeneficialConversionFeatureValueRelatedToConvertibleDebtIssuedWithRegardToSeniorSecuredPromissoryNotes contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 2278052 </mdxg:BeneficialConversionFeatureValueRelatedToConvertibleDebtIssuedWithRegardToSeniorSecuredPromissoryNotes>
<!-- Beneficial Conversion Feature Value Related To Convertible Debt Issued With Regard To Senior Secured Promissory Notes-First Contingent Warrants [Member]-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<mdxg:BeneficialConversionFeatureValueRelatedToConvertibleDebtIssuedWithRegardToSeniorSecuredPromissoryNotes contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_FirstContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U001" decimals="0"> 2278052 </mdxg:BeneficialConversionFeatureValueRelatedToConvertibleDebtIssuedWithRegardToSeniorSecuredPromissoryNotes>
<!-- Beneficial Conversion Feature Value Related To Convertible Debt Issued With Regard To Senior Secured Promissory Notes-First Contingent Warrants [Member]-Revolving Credit Facility [Member] -->
<mdxg:BeneficialConversionFeatureValueRelatedToConvertibleDebtIssuedWithRegardToSeniorSecuredPromissoryNotes contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_FirstContingentWarrantsMember_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="0"> 594456 </mdxg:BeneficialConversionFeatureValueRelatedToConvertibleDebtIssuedWithRegardToSeniorSecuredPromissoryNotes>
<!-- Adjustments to Additional Paid in Capital, Related Party-Series A Preferred Stock [Member] -->
<mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty>
<!-- Adjustments to Additional Paid in Capital, Related Party-Series A Preferred Stock [Member] -->
<mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty>
<!-- Adjustments to Additional Paid in Capital, Related Party-Common Stock [Member] -->
<mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 0 </mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty>
<!-- Adjustments to Additional Paid in Capital, Related Party-Common Stock [Member] -->
<mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 0 </mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty>
<!-- Adjustments to Additional Paid in Capital, Related Party-Additional Paid-in Capital [Member] -->
<mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty contextRef="c20110101to20111231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 80000 </mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty>
<!-- Adjustments to Additional Paid in Capital, Related Party-Additional Paid-in Capital [Member] -->
<mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty contextRef="c20120101to20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 514456 </mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty>
<!-- Adjustments to Additional Paid in Capital, Related Party-Treasury Stock [Member] -->
<mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty contextRef="c20110101to20111231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty>
<!-- Adjustments to Additional Paid in Capital, Related Party-Treasury Stock [Member] -->
<mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty contextRef="c20120101to20121231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty>
<!-- Adjustments to Additional Paid in Capital, Related Party-Accumulated Deficit [Member] -->
<mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty contextRef="c20110101to20111231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty>
<!-- Adjustments to Additional Paid in Capital, Related Party-Accumulated Deficit [Member] -->
<mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty contextRef="c20120101to20121231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty>
<!-- Adjustments to Additional Paid in Capital, Related Party -->
<mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 80000 </mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty>
<!-- Adjustments to Additional Paid in Capital, Related Party -->
<mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 514456 </mdxg:AdjustmentsToAdditionalPaidInCapitalRelatedParty>
<!-- Beneficial Conversion Feature Related To Warrants Issued With Regard To Senior Secured Promissory Notes -->
<mdxg:BeneficialConversionFeatureRelatedToWarrantsIssuedWithRegardToSeniorSecuredPromissoryNotes contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 14885 </mdxg:BeneficialConversionFeatureRelatedToWarrantsIssuedWithRegardToSeniorSecuredPromissoryNotes>
<!-- Fair value adjustment of earn-out liability -->
<mdxg:FairValueAdjustmentOfEarn-OutLiability contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 1567050 </mdxg:FairValueAdjustmentOfEarn-OutLiability>
<!-- Fair value adjustment of earn-out liability -->
<mdxg:FairValueAdjustmentOfEarn-OutLiability contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 5803 </mdxg:FairValueAdjustmentOfEarn-OutLiability>
<!-- Repurchase of warrants-Series A Preferred Stock [Member] -->
<mdxg:RepurchaseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </mdxg:RepurchaseOfWarrants>
<!-- Repurchase of warrants-Common Stock [Member] -->
<mdxg:RepurchaseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 0 </mdxg:RepurchaseOfWarrants>
<!-- Repurchase of warrants-Additional Paid-in Capital [Member] -->
<mdxg:RepurchaseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 568 </mdxg:RepurchaseOfWarrants>
<!-- Repurchase of warrants-Treasury Stock [Member] -->
<mdxg:RepurchaseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </mdxg:RepurchaseOfWarrants>
<!-- Repurchase of warrants-Accumulated Deficit [Member] -->
<mdxg:RepurchaseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </mdxg:RepurchaseOfWarrants>
<!-- Repurchase of warrants -->
<mdxg:RepurchaseOfWarrants contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 568 </mdxg:RepurchaseOfWarrants>
<!-- Repurchase of warrants, Shares-Series A Preferred Stock [Member] -->
<mdxg:RepurchaseOfWarrantsShares contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </mdxg:RepurchaseOfWarrantsShares>
<!-- Repurchase of warrants, Shares-Common Stock [Member] -->
<mdxg:RepurchaseOfWarrantsShares contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 0 </mdxg:RepurchaseOfWarrantsShares>
<!-- Stock Issued During Period Value Cashless Exercise Of Warrants-Series A Preferred Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants>
<!-- Stock Issued During Period Value Cashless Exercise Of Warrants-Common Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 216 </mdxg:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants>
<!-- Stock Issued During Period Value Cashless Exercise Of Warrants-Additional Paid-in Capital [Member] -->
<mdxg:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> -216 </mdxg:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants>
<!-- Stock Issued During Period Value Cashless Exercise Of Warrants-Treasury Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants>
<!-- Stock Issued During Period Value Cashless Exercise Of Warrants-Accumulated Deficit [Member] -->
<mdxg:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants>
<!-- Stock Issued During Period Value Cashless Exercise Of Warrants -->
<mdxg:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants>
<!-- Stock Issued During Period Shares Cashless Exercise Of Warrants-Series A Preferred Stock [Member] -->
<mdxg:StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants>
<!-- Stock Issued During Period Shares Cashless Exercise Of Warrants-Common Stock [Member] -->
<mdxg:StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 216085 </mdxg:StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants>
<!-- Stock Issued During Period Value For Accrued Director Fees-Series A Preferred Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueForAccruedDirectorFees contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueForAccruedDirectorFees>
<!-- Stock Issued During Period Value For Accrued Director Fees-Common Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueForAccruedDirectorFees contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 167 </mdxg:StockIssuedDuringPeriodValueForAccruedDirectorFees>
<!-- Stock Issued During Period Value For Accrued Director Fees-Additional Paid-in Capital [Member] -->
<mdxg:StockIssuedDuringPeriodValueForAccruedDirectorFees contextRef="c20120101to20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 184486 </mdxg:StockIssuedDuringPeriodValueForAccruedDirectorFees>
<!-- Stock Issued During Period Value For Accrued Director Fees-Treasury Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueForAccruedDirectorFees contextRef="c20120101to20121231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueForAccruedDirectorFees>
<!-- Stock Issued During Period Value For Accrued Director Fees-Accumulated Deficit [Member] -->
<mdxg:StockIssuedDuringPeriodValueForAccruedDirectorFees contextRef="c20120101to20121231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueForAccruedDirectorFees>
<!-- Stock Issued During Period Value For Accrued Director Fees -->
<mdxg:StockIssuedDuringPeriodValueForAccruedDirectorFees contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 184653 </mdxg:StockIssuedDuringPeriodValueForAccruedDirectorFees>
<!-- Stock Issued During Period Shares For Accrued Director Fees-Series A Preferred Stock [Member] -->
<mdxg:StockIssuedDuringPeriodSharesForAccruedDirectorFees contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodSharesForAccruedDirectorFees>
<!-- Stock Issued During Period Shares For Accrued Director Fees-Common Stock [Member] -->
<mdxg:StockIssuedDuringPeriodSharesForAccruedDirectorFees contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 167086 </mdxg:StockIssuedDuringPeriodSharesForAccruedDirectorFees>
<!-- Stock Issued During Period Shares For Accrued Director Fees -->
<mdxg:StockIssuedDuringPeriodSharesForAccruedDirectorFees contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 167086 </mdxg:StockIssuedDuringPeriodSharesForAccruedDirectorFees>
<!-- Stock Issued During Period Value For Earn out liability-Series A Preferred Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueForEarnOutLiability contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueForEarnOutLiability>
<!-- Stock Issued During Period Value For Earn out liability-Common Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueForEarnOutLiability contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 2632 </mdxg:StockIssuedDuringPeriodValueForEarnOutLiability>
<!-- Stock Issued During Period Value For Earn out liability-Additional Paid-in Capital [Member] -->
<mdxg:StockIssuedDuringPeriodValueForEarnOutLiability contextRef="c20120101to20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 3182591 </mdxg:StockIssuedDuringPeriodValueForEarnOutLiability>
<!-- Stock Issued During Period Value For Earn out liability-Treasury Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueForEarnOutLiability contextRef="c20120101to20121231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueForEarnOutLiability>
<!-- Stock Issued During Period Value For Earn out liability-Accumulated Deficit [Member] -->
<mdxg:StockIssuedDuringPeriodValueForEarnOutLiability contextRef="c20120101to20121231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueForEarnOutLiability>
<!-- Stock Issued During Period Value For Earn out liability -->
<mdxg:StockIssuedDuringPeriodValueForEarnOutLiability contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 3185223 </mdxg:StockIssuedDuringPeriodValueForEarnOutLiability>
<!-- Stock Issued During Period Value For Earn out liability -->
<mdxg:StockIssuedDuringPeriodValueForEarnOutLiability contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueForEarnOutLiability>
<!-- Stock Issued During Period Shares For Earn Out Liability-Series A Preferred Stock [Member] -->
<mdxg:StockIssuedDuringPeriodSharesForEarnOutLiability contextRef="c20120101to20121231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodSharesForEarnOutLiability>
<!-- Stock Issued During Period Shares For Earn Out Liability-Common Stock [Member] -->
<mdxg:StockIssuedDuringPeriodSharesForEarnOutLiability contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 2632576 </mdxg:StockIssuedDuringPeriodSharesForEarnOutLiability>
<!-- Stock Issued During Period Shares For Earn Out Liability -->
<mdxg:StockIssuedDuringPeriodSharesForEarnOutLiability contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 2632576 </mdxg:StockIssuedDuringPeriodSharesForEarnOutLiability>
<!-- Liquidity and Management's Plans [Text Block] -->
<mdxg:LiquidityAndManagementSPlansTextBlock contextRef="c20120101to20121231">
<div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"><div style="text-indent: 0pt; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;"> <font style="display: inline; font-weight: bold;">3.</font></div></td><td><div style="text-align: left; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Liquidity and Management's Plans</div></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">As of December 31, 2012, the Company had approximately $6,754,000 of cash and cash equivalents.  The Company reported total current assets of approximately $18,089,000 and current liabilities of approximately $5,071,000.  The Company believes that its anticipated cash from operating and financing activities and existing cash and cash equivalents will enable the Company to meet its operational liquidity needs, fund its planned investing activities and pay its debt when due for the next year.</div></div>
</mdxg:LiquidityAndManagementSPlansTextBlock>
<!-- Business Acquisition, Cost of Acquired Entity, Convertible Secured Promissory Note -->
<mdxg:BusinessAcquisitionCostOfAcquiredEntityConvertibleSecuredPromissoryNote contextRef="c20110105" unitRef="U001" decimals="0"> 1250000 </mdxg:BusinessAcquisitionCostOfAcquiredEntityConvertibleSecuredPromissoryNote>
<!-- Total current liabilities, net of short term earn-out liability -->
<mdxg:TotalCurrentLiabilitiesNetOfShortTermEarn-OutLiability contextRef="c20121231" unitRef="U001" decimals="0"> 5071000 </mdxg:TotalCurrentLiabilitiesNetOfShortTermEarn-OutLiability>
<!-- Debt Instrument, Current, Fair Value Disclosure -->
<mdxg:DebtInstrumentCurrentFairValueDisclosure contextRef="c20121231" unitRef="U001" decimals="0"> 3762000 </mdxg:DebtInstrumentCurrentFairValueDisclosure>
<!-- Share based Compensation Arrangement by Share based Payment Award, Stock Options, Nonvested, Number -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedNumber contextRef="c20111231" unitRef="U002" decimals="0"> 4333086 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedNumber>
<!-- Share based Compensation Arrangement by Share based Payment Award, Stock Options, Nonvested, Number -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedNumber contextRef="c20101231" unitRef="U002" decimals="0"> 2679787 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedNumber>
<!-- Share based Compensation Arrangement by Share based Payment Award, Stock Options, Nonvested, Number -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedNumber contextRef="c20121231" unitRef="U002" decimals="0"> 8377538 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedNumber>
<!-- Share based Compensation Arrangement by Share based Payment Award, Stock Options, Grants in Period -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantsInPeriod contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 5307500 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantsInPeriod>
<!-- Share based Compensation Arrangement by Share based Payment Award, Stock Options, Grants in Period -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantsInPeriod contextRef="c20110101to20111231" unitRef="U002" decimals="0"> 3918500 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantsInPeriod>
<!-- Share based Compensation Arrangement by Share based Payment Award, Stock Options, Cancelled or Expired in Period -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsCancelledOrExpiredInPeriod contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 387171 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsCancelledOrExpiredInPeriod>
<!-- Share based Compensation Arrangement by Share based Payment Award, Stock Options, Cancelled or Expired in Period -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsCancelledOrExpiredInPeriod contextRef="c20110101to20111231" unitRef="U002" decimals="0"> 1352567 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsCancelledOrExpiredInPeriod>
<!-- Share based Compensation Arrangement by Share based Payment Award, Stock Options, Vested in Period -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedInPeriod contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 875877 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedInPeriod>
<!-- Share based Compensation Arrangement by Share based Payment Award, Stock Options, Vested in Period -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedInPeriod contextRef="c20110101to20111231" unitRef="U002" decimals="0"> 912634 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedInPeriod>
<!-- Share Based Compensation Arrangement By Share Based Payment Award Stock Options Nonvested Weighted Average Grant Date Fair Value -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="c20111231" unitRef="U003" decimals="2"> 0.72 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedWeightedAverageGrantDateFairValue>
<!-- Share Based Compensation Arrangement By Share Based Payment Award Stock Options Nonvested Weighted Average Grant Date Fair Value -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="c20101231" unitRef="U003" decimals="2"> 0.87 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedWeightedAverageGrantDateFairValue>
<!-- Share Based Compensation Arrangement By Share Based Payment Award Stock Options Nonvested Weighted Average Grant Date Fair Value -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="c20121231" unitRef="U003" decimals="2"> 0.96 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedWeightedAverageGrantDateFairValue>
<!-- Share Based Compensation Arrangement By Share Based Payment Award Stock Options Grants In Period Weighted Average Grant Date Fair Value -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="c20120101to20121231" unitRef="U003" decimals="2"> 1.90 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
<!-- Share Based Compensation Arrangement By Share Based Payment Award Stock Options Grants In Period Weighted Average Grant Date Fair Value -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="c20110101to20111231" unitRef="U003" decimals="2"> 0.63 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
<!-- Minimum age require to qualify for pension plan -->
<mdxg:MinimumAgeRequireToQualifyForPensionPlan contextRef="c20120101to20121231"> P21Y </mdxg:MinimumAgeRequireToQualifyForPensionPlan>
<!-- Minimum service period require to qualify for pension plan -->
<mdxg:MinimumServicePeriodRequireToQualifyForPensionPlan contextRef="c20120101to20121231"> P3M </mdxg:MinimumServicePeriodRequireToQualifyForPensionPlan>
<!-- Defined contribution plan maximum percentage of eligible wages deferred by participants -->
<mdxg:DefinedContributionPlanMaximumPercentageOfEligibleWagesDeferredByParticipants contextRef="c20120101to20121231" unitRef="U005" decimals="0"> 1 </mdxg:DefinedContributionPlanMaximumPercentageOfEligibleWagesDeferredByParticipants>
<!-- Maximum eligible wages deferred by participants per year -->
<mdxg:MaximumEligibleWagesDeferredByParticipantsPerYear contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 17000 </mdxg:MaximumEligibleWagesDeferredByParticipantsPerYear>
<!-- Minimum age for additional contribution beyond normal plan -->
<mdxg:MinimumAgeForAdditionalContributionBeyondNormalPlan contextRef="c20120101to20121231"> P50Y </mdxg:MinimumAgeForAdditionalContributionBeyondNormalPlan>
<!-- Defined Benefit Plan, Maximum pre tax Contributions by Plan Participants -->
<mdxg:DefinedBenefitPlanMaximumPreTaxContributionsByPlanParticipants contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 5500 </mdxg:DefinedBenefitPlanMaximumPreTaxContributionsByPlanParticipants>
<!-- Proceeds from Line of Credit with Related Party -->
<mdxg:ProceedsFromLineOfCreditWithRelatedParty contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 0 </mdxg:ProceedsFromLineOfCreditWithRelatedParty>
<!-- Proceeds from Line of Credit with Related Party -->
<mdxg:ProceedsFromLineOfCreditWithRelatedParty contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 1300000 </mdxg:ProceedsFromLineOfCreditWithRelatedParty>
<!-- Minimum number of consecutive trading days considered for closing trading price -->
<mdxg:MinimumNumberOfConsecutiveTradingDaysConsideredForClosingTradingPrice contextRef="c20120101to20121231"> P20D </mdxg:MinimumNumberOfConsecutiveTradingDaysConsideredForClosingTradingPrice>
<!-- Minimum number of consecutive trading days considered for closing trading price-Callable Warrants [Member] -->
<mdxg:MinimumNumberOfConsecutiveTradingDaysConsideredForClosingTradingPrice contextRef="c20110101to20111231_StatementEquityComponentsAxis_WarrantMember"> P15D </mdxg:MinimumNumberOfConsecutiveTradingDaysConsideredForClosingTradingPrice>
<!-- Schedule of Intangible assets activity [Table Text Block] -->
<mdxg:ScheduleOfIntangibleAssetsActivityTableTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Intangible assets activity is summarized as follows:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 23%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="16" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="10" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">December 31, 2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="text-align: center; width: 23%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Average</div></td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Gross</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Net</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Gross</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Net</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="text-align: center; width: 23%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Amortization</div></td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Carrying</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Impairment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Accumulated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Carrying</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Carrying</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Accumulated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="text-align: center; width: 8%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Carrying</div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="text-align: center; padding-bottom: 2px; width: 23%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Lives</div></td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Adjustment</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Amortization</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Amortization</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: center; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="width: 23%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 7%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 8%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">License-Shriners Hsp for Children & USF Research (a)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">10 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">996,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(587,633</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">408,367</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">996,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(488,033</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">507,967</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">License - SaluMedica LLC Spine Repair (b)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">10 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,399,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(851,676</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(1,547,324</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,399,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(1,313,573</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">1,085,427</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">License - Polyvinyl Alcohol Cryogel (c)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">10 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,667,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(946,819</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(1,223,561</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">496,620</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,667,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(998,932</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">1,668,068</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" nowrap="nowrap" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Customer Relationships (d)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">3,520,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(502,857</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">3,017,143</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">3,520,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(251,429</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">3,268,571</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Supplier Relationships (d)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">241,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(34,429</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">206,571</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">241,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(17,215</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">223,785</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Patents & Know-How (d)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">5,530,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(790,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">4,740,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">5,530,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(395,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">5,135,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Micronized Processing Know-How (d)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">14 years</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,160,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(154,286</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,005,714</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,160,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">2,160,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Licenses/Permits (d)</div></td><td valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">3 years</div></td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">13,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(8,667</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">4,333</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">13,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(4,333</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">8,667</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="width: 23%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 7%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">17,526,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(1,798,495</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(4,848,756</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">10,878,749</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">17,526,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">(3,468,515</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">14,057,485</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="width: 23%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 7%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Trade Names/Trademarks (d)</div></td><td valign="bottom" style="width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">indefinite</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">1,008,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">1,008,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">1,008,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 7%; font-family: 'times new roman'; font-size: 10pt;">1,008,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 23%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">In-process Research & Development-Other (d)</div></td><td valign="bottom" style="padding-bottom: 2px; width: 7%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">indefinite</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">25,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">25,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">25,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">—</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">25,000</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td valign="bottom" style="padding-bottom: 4px; width: 23%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 4px; width: 7%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">18,559,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(1,798,495</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(4,848,756</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">11,911,749</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">18,559,000</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(3,468,515</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">15,090,485</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(a)    On January 29, 2007, the Company acquired a license from Shriners Hospitals for Children and University of South Florida Research Foundation, Inc.  Within 30 days after the receipt by the Company of approval by the FDA allowing the sale of the first licensed product, the Company is required to pay an additional $200,000 to the licensor.  Due to its contingent nature, this amount is not recorded as a liability. The Company will also be required to pay a royalty of 3% on all commercial sales revenue from the licensed products. The Company is also obligated to pay a $50,000 minimum annual royalty payment over the life of the license.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(b)    License from SaluMedica, LLC (SaluMedica) for the use of certain developed technologies related to spine repair. This license was acquired through the acquisition of SpineMedica Corp.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(c)    On March 31, 2008, the Company entered into a license agreement for the use of certain developed technologies related to surgical sheets made of polyvinyl alcohol cryogel.  The agreement also provides for the issuance of an additional 600,000 shares upon the Company meeting certain milestones related to future sales. On December 31, 2009 the Company completed the sale of its first commercial product and met its first milestone under this agreement. As a result the Company issued 100,000 shares of common stock to the licensor valued at $71,000. At December 31, 2012 or 2011, there are no additional amounts accrued for this obligation due to its contingent nature.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">(d)    On January 5, 2011, the Company acquired Surgical Biologics, LLC.  As a result, the Company recorded intangible assets for customer and supplier relationships, patents and know-how, licenses/permits, trade names and trademarks and in-process research and development.</div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div></div>
</mdxg:ScheduleOfIntangibleAssetsActivityTableTextBlock>
<!-- Contingent royalty to be paid to licensor -->
<mdxg:ContingentRoyaltyToBePaidToLicensor contextRef="c20121231" unitRef="U005" decimals="2"> 0.03 </mdxg:ContingentRoyaltyToBePaidToLicensor>
<!-- Milestone Stock Issued During Period, Value -->
<mdxg:MilestoneStockIssuedDuringPeriodValue contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 71000 </mdxg:MilestoneStockIssuedDuringPeriodValue>
<!-- Weighted average useful life Indefinite lived-Trade names and trademarks [Member] -->
<mdxg:WeightedAverageUsefulLifeIndefiniteLived contextRef="c20120101to20121231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesAndTrademarksMember"> indefinite </mdxg:WeightedAverageUsefulLifeIndefiniteLived>
<!-- Weighted average useful life Indefinite lived-In process research and development, liquid [Member] -->
<mdxg:WeightedAverageUsefulLifeIndefiniteLived contextRef="c20120101to20121231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentLiquidMember" id="Item-17"> indefinite </mdxg:WeightedAverageUsefulLifeIndefiniteLived>
<!-- Weighted average useful life Indefinite lived-In process research and development, other [Member] -->
<mdxg:WeightedAverageUsefulLifeIndefiniteLived contextRef="c20120101to20121231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentOtherMember"> indefinite </mdxg:WeightedAverageUsefulLifeIndefiniteLived>
<!-- Weighted average useful life Indefinite lived-Trade names and trademarks [Member] --> <!-- Weighted average useful life Indefinite lived-In process research and development, other [Member] --> <!-- Finite-Lived Intangible Assets, Impairment Adjustment-License-Shriners Hsp for Children & USF Research [Member] -->
<mdxg:Finite-LivedIntangibleAssetsImpairmentAdjustment contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-ShrinersHspForChildrenUsfResearchMember" unitRef="U001" decimals="0"> 0 </mdxg:Finite-LivedIntangibleAssetsImpairmentAdjustment>
<!-- Finite-Lived Intangible Assets, Impairment Adjustment-License - SaluMedica LLC Spine Repair [Member] -->
<mdxg:Finite-LivedIntangibleAssetsImpairmentAdjustment contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-SalumedicaLlcSpineRepairMember" unitRef="U001" decimals="0"> 851676 </mdxg:Finite-LivedIntangibleAssetsImpairmentAdjustment>
<!-- Finite-Lived Intangible Assets, Impairment Adjustment-License - Polyvinyl Alcohol Cryogel [Member] -->
<mdxg:Finite-LivedIntangibleAssetsImpairmentAdjustment contextRef="c20121231_FiniteLivedIntangibleAssetsByMajorClassAxis_License-PolyvinylAlcoholCryogelMember" unitRef="U001" decimals="0"> 946819 </mdxg:Finite-LivedIntangibleAssetsImpairmentAdjustment>
<!-- Finite-Lived Intangible Assets, Impairment Adjustment -->
<mdxg:Finite-LivedIntangibleAssetsImpairmentAdjustment contextRef="c20121231" unitRef="U001" decimals="0"> 1798495 </mdxg:Finite-LivedIntangibleAssetsImpairmentAdjustment>
<!-- Intangible Assets, Impairment Adjustment -->
<mdxg:IntangibleAssetsImpairmentAdjustment contextRef="c20121231" unitRef="U001" decimals="0"> -1798495 </mdxg:IntangibleAssetsImpairmentAdjustment>
<!-- Intangible Assets, Accumulated Amortization-In process research and development, other [Member] -->
<mdxg:IntangibleAssetsAccumulatedAmortization contextRef="c20111231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentOtherMember" unitRef="U001" decimals="0"> 0 </mdxg:IntangibleAssetsAccumulatedAmortization>
<!-- Intangible Assets, Accumulated Amortization-In process research and development, other [Member] -->
<mdxg:IntangibleAssetsAccumulatedAmortization contextRef="c20121231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_InProcessResearchAndDevelopmentOtherMember" unitRef="U001" decimals="0"> 0 </mdxg:IntangibleAssetsAccumulatedAmortization>
<!-- Intangible Assets, Accumulated Amortization-Trade names and trademarks [Member] -->
<mdxg:IntangibleAssetsAccumulatedAmortization contextRef="c20111231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesAndTrademarksMember" unitRef="U001" decimals="0"> 0 </mdxg:IntangibleAssetsAccumulatedAmortization>
<!-- Intangible Assets, Accumulated Amortization-Trade names and trademarks [Member] -->
<mdxg:IntangibleAssetsAccumulatedAmortization contextRef="c20121231_IndefiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesAndTrademarksMember" unitRef="U001" decimals="0"> 0 </mdxg:IntangibleAssetsAccumulatedAmortization>
<!-- Tax credit carryforwards expiration period -->
<mdxg:TaxCreditCarryforwardsExpirationPeriod contextRef="c20120101to20121231"> 2025 through 2032 </mdxg:TaxCreditCarryforwardsExpirationPeriod>
<!-- Number of share based compensation plans -->
<mdxg:NumberOfShareBasedCompensationPlans contextRef="c20120101to20121231" unitRef="U006" decimals="0"> 3 </mdxg:NumberOfShareBasedCompensationPlans>
<!-- Outstanding assumed options -->
<mdxg:OutstandingAssumedOptions contextRef="c20121231" unitRef="U002" decimals="0"> 375000 </mdxg:OutstandingAssumedOptions>
<!-- Share Based Compensation Arrangement By Share Based Payment Award Stock Options Cancelled or Expired Weighted Average Grant Date Fair Value -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsCancelledOrExpiredWeightedAverageGrantDateFairValue contextRef="c20120101to20121231" unitRef="U003" decimals="2"> 1.17 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsCancelledOrExpiredWeightedAverageGrantDateFairValue>
<!-- Share Based Compensation Arrangement By Share Based Payment Award Stock Options Cancelled or Expired Weighted Average Grant Date Fair Value -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsCancelledOrExpiredWeightedAverageGrantDateFairValue contextRef="c20110101to20111231" unitRef="U003" decimals="2"> 0.59 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsCancelledOrExpiredWeightedAverageGrantDateFairValue>
<!-- Warrants term-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<mdxg:WarrantsTerm contextRef="c20120101to20121231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember"> P5Y </mdxg:WarrantsTerm>
<!-- Warrants term -->
<mdxg:WarrantsTerm contextRef="c20120101to20121231"> P5Y </mdxg:WarrantsTerm>
<!-- Warrants term-Callable Warrants [Member] -->
<mdxg:WarrantsTerm contextRef="c20110101to20111231_StatementEquityComponentsAxis_WarrantMember"> P5Y </mdxg:WarrantsTerm>
<!-- Warrants Expired-Warrants expired [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExpired contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsExpiredMember" unitRef="U002" decimals="0"> 10000 </mdxg:WarrantsExpired>
<!-- Warrants Expired-Warrants expired [Member]-Contingent Warrants [Member] -->
<mdxg:WarrantsExpired contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsExpiredMember" unitRef="U002" decimals="0"> 0 </mdxg:WarrantsExpired>
<!-- Warrants exercised, shares-Contingent warrants related to convertible note [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_ContingentWarrantsRelatedToConvertibleNoteMember" unitRef="U002" decimals="0"> 1249750 </mdxg:WarrantsExercisedShares>
<!-- Warrants exercised, shares-Contingent Warrants [Member]-Contingent warrants related to convertible note [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_ContingentWarrantsRelatedToConvertibleNoteMember" unitRef="U002" decimals="0"> 0 </mdxg:WarrantsExercisedShares>
<!-- Warrants exercised, shares-Warrants Issued in Connection with Private Placement [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember" unitRef="U002" decimals="0"> 1608802 </mdxg:WarrantsExercisedShares>
<!-- Warrants exercised, shares-Contingent Warrants [Member]-Warrants Issued in Connection with Private Placement [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember" unitRef="U002" decimals="0"> 0 </mdxg:WarrantsExercisedShares>
<!-- Warrants exercised, shares-Warrants Issued In Connection With Line of Credit with Related Party [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember" unitRef="U002" decimals="0"> 325000 </mdxg:WarrantsExercisedShares>
<!-- Warrants exercised, shares-Warrants Issued In Connection With Line of Credit with Related Party [Member]-Contingent Warrants [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember" unitRef="U002" decimals="0"> 0 </mdxg:WarrantsExercisedShares>
<!-- Warrants exercised, shares-Callable warrants [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_CallableWarrantsMember" unitRef="U002" decimals="0"> 3288733 </mdxg:WarrantsExercisedShares>
<!-- Warrants exercised, shares-Contingent Warrants [Member]-Callable warrants [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_CallableWarrantsMember" unitRef="U002" decimals="0"> 0 </mdxg:WarrantsExercisedShares>
<!-- Warrants exercised, shares-Other [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_EquitySecuritiesOtherMember" unitRef="U002" decimals="0"> 1703568 </mdxg:WarrantsExercisedShares>
<!-- Warrants exercised, shares-Contingent Warrants [Member]-Other [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_EquitySecuritiesOtherMember" unitRef="U002" decimals="0"> 0 </mdxg:WarrantsExercisedShares>
<!-- Warrants exercised, shares-Warrants Redeemed for Cashless Exercises [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsRedeemedForCashlessExercisesMember" unitRef="U002" decimals="0"> 14789 </mdxg:WarrantsExercisedShares>
<!-- Warrants exercised, shares-Repurchase of callable warrants [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_RepurchaseOfCallableWarrantsMember" unitRef="U002" decimals="0"> 56750 </mdxg:WarrantsExercisedShares>
<!-- Warrants exercised, shares-Contingent Warrants [Member]-Warrants Redeemed for Cashless Exercises [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsRedeemedForCashlessExercisesMember" unitRef="U002" decimals="0"> 0 </mdxg:WarrantsExercisedShares>
<!-- Warrants exercised, shares-Contingent Warrants [Member]-Repurchase of callable warrants [Member] -->
<mdxg:WarrantsExercisedShares contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_RepurchaseOfCallableWarrantsMember" unitRef="U002" decimals="0"> 0 </mdxg:WarrantsExercisedShares>
<!-- Warrants issued, weighted average exercise price-Warrants Issued in Connection with Private Placement [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember" unitRef="U003" decimals="2"> 1.50 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Contingent Warrants [Member]-Warrants Issued in Connection with Private Placement [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Warrants issued in connection with convertible promissory notes [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithConvertiblePromissoryNotesMember" unitRef="U003" decimals="2"> 1.50 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Warrants issued in connection with convertible promissory notes [Member]-Contingent Warrants [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithConvertiblePromissoryNotesMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Warrants Issued In Connection With Line of Credit with Related Party [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember" unitRef="U003" decimals="0"> 0 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Warrants Issued In Connection With Line of Credit with Related Party [Member]-Contingent Warrants [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Warrants issued in connection with Senior Secured Promissory Notes. [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithSeniorSecuredPromissoryNotesMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Contingent Warrants [Member]-Warrants issued in connection with Senior Secured Promissory Notes. [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithSeniorSecuredPromissoryNotesMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Placement Agent [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_PrivatePlacementMember" unitRef="U003" decimals="2"> 1.09 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Placement Agent [Member]-Contingent Warrants [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20110101to20111231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_PrivatePlacementMember" unitRef="U003" decimals="0"> 0 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Warrants Issued in Connection with Private Placement [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Contingent Warrants [Member]-Warrants Issued in Connection with Private Placement [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Warrants Issued In Connection With Line of Credit with Related Party [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Warrants Issued In Connection With Line of Credit with Related Party [Member]-Contingent Warrants [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Callable Warrants [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember" unitRef="U003" decimals="0"> 0 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants issued, weighted average exercise price-Contingent Warrants [Member] -->
<mdxg:WarrantsIssuedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantsIssuedWeightedAverageExercisePrice>
<!-- Warrants Expired Weighted Average Exercise Price-Warrants expired [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExpiredWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsExpiredMember" unitRef="U003" decimals="2"> 1.00 </mdxg:WarrantsExpiredWeightedAverageExercisePrice>
<!-- Warrants Expired Weighted Average Exercise Price-Warrants expired [Member]-Contingent Warrants [Member] -->
<mdxg:WarrantsExpiredWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsExpiredMember" unitRef="U003" decimals="0"> 0 </mdxg:WarrantsExpiredWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Warrants Redeemed for Cashless Exercises [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsRedeemedForCashlessExercisesMember" unitRef="U003" decimals="2"> 0.53 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Repurchase of callable warrants [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_RepurchaseOfCallableWarrantsMember" unitRef="U003" decimals="2"> 1.50 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Contingent warrants related to convertible note [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_ContingentWarrantsRelatedToConvertibleNoteMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Contingent Warrants [Member]-Contingent warrants related to convertible note [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_ContingentWarrantsRelatedToConvertibleNoteMember" unitRef="U003" decimals="0"> 0 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Warrants Issued in Connection with Private Placement [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Contingent Warrants [Member]-Warrants Issued in Connection with Private Placement [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithPrivatePlacementMember" unitRef="U003" decimals="0"> 0 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Warrants Issued In Connection With Line of Credit with Related Party [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Warrants Issued In Connection With Line of Credit with Related Party [Member]-Contingent Warrants [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsIssuedInConnectionWithLineOfCreditWithRelatedPartyMember" unitRef="U003" decimals="0"> 0 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Callable warrants [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_CallableWarrantsMember" unitRef="U003" decimals="2"> 1.50 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Contingent Warrants [Member]-Callable warrants [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_CallableWarrantsMember" unitRef="U003" decimals="0"> 0 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Other [Member]-Callable Warrants [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember_WarrantEventAxis_EquitySecuritiesOtherMember" unitRef="U003" decimals="2"> 0.63 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Contingent Warrants [Member]-Other [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_EquitySecuritiesOtherMember" unitRef="U003" decimals="0"> 0 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Contingent Warrants [Member]-Warrants Redeemed for Cashless Exercises [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_WarrantsRedeemedForCashlessExercisesMember" unitRef="U003" decimals="0"> 0 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Warrants exercised, weighted average exercise price-Contingent Warrants [Member]-Repurchase of callable warrants [Member] -->
<mdxg:WarrantsExercisedWeightedAverageExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember_WarrantEventAxis_RepurchaseOfCallableWarrantsMember" unitRef="U003" decimals="0"> 0 </mdxg:WarrantsExercisedWeightedAverageExercisePrice>
<!-- Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding, Vested, Number -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingVestedNumber contextRef="c20110101to20111231" unitRef="U002" decimals="0"> 1135315 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingVestedNumber>
<!-- Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding, Vested, Number -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingVestedNumber contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 795915 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingVestedNumber>
<!-- Share Based Compensation Arrangement By Share Based Payment Award Stock Options Vested In Period Weighted Average Grant Date Fair Value -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="c20120101to20121231" unitRef="U003" decimals="2"> 1.05 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
<!-- Share Based Compensation Arrangement By Share Based Payment Award Stock Options Vested In Period Weighted Average Grant Date Fair Value -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="c20110101to20111231" unitRef="U003" decimals="2"> 0.81 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
<!-- Increase (decrease) in depreciation -->
<mdxg:IncreaseDecreaseInDepreciation contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 19000 </mdxg:IncreaseDecreaseInDepreciation>
<!-- Increase (decrease) in share based compensation expense -->
<mdxg:IncreaseDecreaseInShareBasedCompensationExpense contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 880000 </mdxg:IncreaseDecreaseInShareBasedCompensationExpense>
<!-- Percentage increase (decrease) in share based compensation expense -->
<mdxg:PercentageIncreaseDecreaseInShareBasedCompensationExpense contextRef="c20120101to20121231" unitRef="U005" decimals="2"> 0.53 </mdxg:PercentageIncreaseDecreaseInShareBasedCompensationExpense>
<!-- Deferred Tax liability Debt Instrument, Convertible, Beneficial Conversion Feature -->
<mdxg:DeferredTaxLiabilityDebtInstrumentConvertibleBeneficialConversionFeature contextRef="c20121231" unitRef="U001" decimals="0"> 449000 </mdxg:DeferredTaxLiabilityDebtInstrumentConvertibleBeneficialConversionFeature>
<!-- Deferred Tax liability Debt Instrument, Convertible, Beneficial Conversion Feature -->
<mdxg:DeferredTaxLiabilityDebtInstrumentConvertibleBeneficialConversionFeature contextRef="c20111231" unitRef="U001" decimals="0"> 927000 </mdxg:DeferredTaxLiabilityDebtInstrumentConvertibleBeneficialConversionFeature>
<!-- Warrants Voided-Five Percent Convertible Senior Secured Promissory Note [Member]-Second Contingent Warrants [Member] -->
<mdxg:WarrantsVoided contextRef="c20120701to20120731_ClassOfWarrantOrRightAxis_SecondContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U002" decimals="0"> -1250000 </mdxg:WarrantsVoided>
<!-- Warrants Voided-Revolving Credit Facility [Member]-Second Contingent Warrants [Member] -->
<mdxg:WarrantsVoided contextRef="c20120701to20120731_ClassOfWarrantOrRightAxis_SecondContingentWarrantsMember_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="0"> -325000 </mdxg:WarrantsVoided>
<!-- Warrants Voided-Second Contingent Warrants [Member] -->
<mdxg:WarrantsVoided contextRef="c20120702to20120703_StatementEquityComponentsAxis_SecondContingentWarrantsMember" unitRef="U002" decimals="0"> 1672742 </mdxg:WarrantsVoided>
<!-- Warrants Voided-Callable Warrants [Member] -->
<mdxg:WarrantsVoided contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_WarrantMember" unitRef="U002" decimals="0"> 0 </mdxg:WarrantsVoided>
<!-- Warrants Voided-Contingent Warrants [Member] -->
<mdxg:WarrantsVoided contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_ContingentWarrantsMember" unitRef="U002" decimals="0"> -3247741 </mdxg:WarrantsVoided>
<!-- Number of shares to be purchased to receive one warrant-Callable Warrants [Member] -->
<mdxg:NumberOfSharesToBePurchasedToReceiveOneWarrant contextRef="c20110101to20111231_StatementEquityComponentsAxis_WarrantMember" unitRef="U002" decimals="0"> 2 </mdxg:NumberOfSharesToBePurchasedToReceiveOneWarrant>
<!-- Number of shares covered under each warrant-Callable Warrants [Member] -->
<mdxg:NumberOfSharesCoveredUnderEachWarrant contextRef="c20110101to20111231_StatementEquityComponentsAxis_WarrantMember" unitRef="U002" decimals="0"> 1 </mdxg:NumberOfSharesCoveredUnderEachWarrant>
<!-- Minimum closing price to exercise callable rights-Callable Warrants [Member] -->
<mdxg:MinimumClosingPriceToExerciseCallableRights contextRef="c20110101to20111231_StatementEquityComponentsAxis_WarrantMember" unitRef="U003" decimals="2"> 1.75 </mdxg:MinimumClosingPriceToExerciseCallableRights>
<!-- Redemption price of callable warrant-Callable Warrants [Member] -->
<mdxg:RedemptionPriceOfCallableWarrant contextRef="c20120101to20121231_StatementEquityComponentsAxis_WarrantMember" unitRef="U003" decimals="2"> 0.01 </mdxg:RedemptionPriceOfCallableWarrant>
<!-- Private placement offering costs-Common Stock [Member] -->
<mdxg:PrivatePlacementOfferingCosts contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 47733 </mdxg:PrivatePlacementOfferingCosts>
<!-- Stock Issued During Period, Value, Acquisitions, Company-Series A Preferred Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueAcquisitionsCompany contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueAcquisitionsCompany>
<!-- Stock Issued During Period, Value, Acquisitions, Company-Common Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueAcquisitionsCompany contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 5250 </mdxg:StockIssuedDuringPeriodValueAcquisitionsCompany>
<!-- Stock Issued During Period, Value, Acquisitions, Company-Additional Paid-in Capital [Member] -->
<mdxg:StockIssuedDuringPeriodValueAcquisitionsCompany contextRef="c20110101to20111231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 7082250 </mdxg:StockIssuedDuringPeriodValueAcquisitionsCompany>
<!-- Stock Issued During Period, Value, Acquisitions, Company-Treasury Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueAcquisitionsCompany contextRef="c20110101to20111231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueAcquisitionsCompany>
<!-- Stock Issued During Period, Value, Acquisitions, Company-Accumulated Deficit [Member] -->
<mdxg:StockIssuedDuringPeriodValueAcquisitionsCompany contextRef="c20110101to20111231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodValueAcquisitionsCompany>
<!-- Stock Issued During Period, Value, Acquisitions, Company -->
<mdxg:StockIssuedDuringPeriodValueAcquisitionsCompany contextRef="c20110101to20111231" unitRef="U001" decimals="0"> 7087500 </mdxg:StockIssuedDuringPeriodValueAcquisitionsCompany>
<!-- Stock Issued During Period, Shares, Acquisitions, Company-Series A Preferred Stock [Member] -->
<mdxg:StockIssuedDuringPeriodSharesAcquisitionsCompany contextRef="c20110101to20111231_StatementEquityComponentsAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0"> 0 </mdxg:StockIssuedDuringPeriodSharesAcquisitionsCompany>
<!-- Stock Issued During Period, Shares, Acquisitions, Company-Common Stock [Member] -->
<mdxg:StockIssuedDuringPeriodSharesAcquisitionsCompany contextRef="c20110101to20111231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 5250000 </mdxg:StockIssuedDuringPeriodSharesAcquisitionsCompany>
<!-- Finite-Lived and Infinite Lived Intangible Assets, Gross -->
<mdxg:Finite-LivedAndInfiniteLivedIntangibleAssetsGross contextRef="c20121231" unitRef="U001" decimals="0"> 18559000 </mdxg:Finite-LivedAndInfiniteLivedIntangibleAssetsGross>
<!-- Finite-Lived and Infinite Lived Intangible Assets, Gross -->
<mdxg:Finite-LivedAndInfiniteLivedIntangibleAssetsGross contextRef="c20111231" unitRef="U001" decimals="0"> 18559000 </mdxg:Finite-LivedAndInfiniteLivedIntangibleAssetsGross>
<!-- Debt Instrument, Maturity period -->
<mdxg:DebtInstrumentMaturityPeriod contextRef="c20120101to20121231"> P18M </mdxg:DebtInstrumentMaturityPeriod>
<!-- Percentage of equity securities to be sold for conversion of notes-First Contingent Warrants [Member]-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<mdxg:PercentageOfEquitySecuritiesToBeSoldForConversionOfNotes contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_FirstContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U005" decimals="2"> 0.25 </mdxg:PercentageOfEquitySecuritiesToBeSoldForConversionOfNotes>
<!-- Percentage of equity securities to be sold for conversion of notes-Five Percent Convertible Senior Secured Promissory Note [Member]-Second Contingent Warrants [Member] -->
<mdxg:PercentageOfEquitySecuritiesToBeSoldForConversionOfNotes contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_SecondContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U005" decimals="2"> 0.25 </mdxg:PercentageOfEquitySecuritiesToBeSoldForConversionOfNotes>
<!-- Finite-Lived and infinite lived Intangible Assets, Accumulated Amortization -->
<mdxg:Finite-LivedAndInfiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20111231" unitRef="U001" decimals="0"> 3468515 </mdxg:Finite-LivedAndInfiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Finite-Lived and infinite lived Intangible Assets, Accumulated Amortization -->
<mdxg:Finite-LivedAndInfiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20121231" unitRef="U001" decimals="0"> 4848756 </mdxg:Finite-LivedAndInfiniteLivedIntangibleAssetsAccumulatedAmortization>
<!-- Number of warrants exercised-Chairman and CEO [Member]-Callable Warrants [Member] -->
<mdxg:NumberOfWarrantsExercised contextRef="c20120731_SaleOfStockAndWarrantsEntityAxis_BoardOfDirectorsChairmanMember_StatementEquityComponentsAxis_WarrantMember" unitRef="U002" decimals="0"> 503332 </mdxg:NumberOfWarrantsExercised>
<!-- Number of warrants exercised-First Contingent Warrants [Member] -->
<mdxg:NumberOfWarrantsExercised contextRef="c20121231_StatementEquityComponentsAxis_FirstContingentWarrantsMember" unitRef="U002" decimals="0"> 1609000 </mdxg:NumberOfWarrantsExercised>
<!-- Additional interest payment, Percentage-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<mdxg:AdditionalInterestPaymentPercentage contextRef="c20121231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U005" decimals="2"> 0.05 </mdxg:AdditionalInterestPaymentPercentage>
<!-- Rollforward of Earn Out Liability [Table Text Block] -->
<mdxg:RollforwardOfEarnOutLiabilityTableTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">Accrued Earn - Out Acquisition Consideration</div><div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> </div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td colspan="2" valign="bottom" style="width: 10%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Beginning balance at January 1,</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">7,410,503</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Valuation at acquisition date</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;"> </td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">7,404,700</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Remeasurement adjustments</div></td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">1,567,050</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">5,803</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Common stock issued on earn - out</div></td><td align="right" valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">(3,185,223</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">)</td><td align="right" valign="bottom" style="border-bottom: black 2px solid; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 4px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Ending balance at December 31,</div></td><td align="right" valign="bottom" style="padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">5,792,330</td><td nowrap="nowrap" valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td align="right" valign="bottom" style="border-bottom: black 4px double; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 4px double; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 4px double; text-align: right; font-family: 'times new roman'; font-size: 10pt;">7,410,503</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div><div style="text-align: justify; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"> </div></div>
</mdxg:RollforwardOfEarnOutLiabilityTableTextBlock>
<!-- Business Acquisition, Equity Interest Issued or Issuable, Value Per Share -->
<mdxg:BusinessAcquisitionEquityInterestIssuedOrIssuableValuePerShare contextRef="c20110105" unitRef="U003" decimals="2"> 1.35 </mdxg:BusinessAcquisitionEquityInterestIssuedOrIssuableValuePerShare>
<!-- Placement fee-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<mdxg:PlacementFee contextRef="c20120101to20121231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U001" decimals="0"> 32800 </mdxg:PlacementFee>
<!-- Warrant Exercise Price-First Contingent Warrants [Member]-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<mdxg:WarrantExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_FirstContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantExercisePrice>
<!-- Warrant Exercise Price-Five Percent Convertible Senior Secured Promissory Note [Member] -->
<mdxg:WarrantExercisePrice contextRef="c20120101to20121231_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U003" decimals="2"> 1.09 </mdxg:WarrantExercisePrice>
<!-- Warrant Exercise Price-Five Percent Convertible Senior Secured Promissory Note [Member]-Second Contingent Warrants [Member] -->
<mdxg:WarrantExercisePrice contextRef="c20120101to20121231_ClassOfWarrantOrRightAxis_SecondContingentWarrantsMember_DebtInstrumentAxis_FivePercentConvertibleSeniorSecuredPromissoryNoteMember" unitRef="U003" decimals="2"> 0.01 </mdxg:WarrantExercisePrice>
<!-- Warrant Exercise Price-Revolving Credit Facility [Member] -->
<mdxg:WarrantExercisePrice contextRef="c20110101to20111231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U003" decimals="2"> 1.00 </mdxg:WarrantExercisePrice>
<!-- Number of callable warrants repurchased-Callable Warrants [Member] -->
<mdxg:NumberOfCallableWarrantsRepurchased contextRef="c20120701to20120731_StatementEquityComponentsAxis_WarrantMember" unitRef="U002" decimals="0"> 56750 </mdxg:NumberOfCallableWarrantsRepurchased>
<!-- Number of Major Customers-Revenue [Member] -->
<mdxg:NumberOfMajorCustomers contextRef="c20121231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember" unitRef="U005" decimals="0"> 3 </mdxg:NumberOfMajorCustomers>
<!-- Number of Major Customers-Revenue [Member] -->
<mdxg:NumberOfMajorCustomers contextRef="c20111231_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember" unitRef="U005" decimals="0"> 2 </mdxg:NumberOfMajorCustomers>
<!-- Number of Major Customers-Accounts Receivable [Member] -->
<mdxg:NumberOfMajorCustomers contextRef="c20121231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember" unitRef="U005" decimals="0"> 2 </mdxg:NumberOfMajorCustomers>
<!-- Number of Major Customers-Accounts Receivable [Member] -->
<mdxg:NumberOfMajorCustomers contextRef="c20111231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember" unitRef="U005" decimals="0"> 2 </mdxg:NumberOfMajorCustomers>
<!-- Proceeds from grant received as regional economic business assistance -->
<mdxg:ProceedsFromGrantReceivedAsRegionalEconomicBusinessAssistance contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 250000 </mdxg:ProceedsFromGrantReceivedAsRegionalEconomicBusinessAssistance>
<!-- Rent payable for use of asset under transaction -->
<mdxg:RentPayableForUseOfAssetUnderTransaction contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 100 </mdxg:RentPayableForUseOfAssetUnderTransaction>
<!-- Common stock held in escrow, shares -->
<mdxg:CommonStockHeldInEscrowShares contextRef="c20110105" unitRef="U002" decimals="0"> 525000 </mdxg:CommonStockHeldInEscrowShares>
<!-- Purchase price of warrants repurchased-Callable Warrants [Member] -->
<mdxg:PurchasePriceOfWarrantsRepurchased contextRef="c20120701to20120731_StatementEquityComponentsAxis_WarrantMember" unitRef="U003" decimals="2"> 0.01 </mdxg:PurchasePriceOfWarrantsRepurchased>
<!-- Business Acquisition Cash retained for working capital -->
<mdxg:BusinessAcquisitionCashRetainedForWorkingCapital contextRef="c20110105" unitRef="U001" decimals="0"> 150000 </mdxg:BusinessAcquisitionCashRetainedForWorkingCapital>
<!-- Number of warrants vested-Chairman and CEO [Member]-First Contingent Warrants [Member] -->
<mdxg:NumberOfWarrantsVested contextRef="c20120101to20120630_SaleOfStockAndWarrantsEntityAxis_BoardOfDirectorsChairmanMember_StatementEquityComponentsAxis_FirstContingentWarrantsMember" unitRef="U002" decimals="0"> 252000 </mdxg:NumberOfWarrantsVested>
<!-- Business Acquisition Purchase Price Allocation, Debt-free working capital -->
<mdxg:BusinessAcquisitionPurchasePriceAllocationDebt-FreeWorkingCapital contextRef="c20110105" unitRef="U001" decimals="0"> 671880 </mdxg:BusinessAcquisitionPurchasePriceAllocationDebt-FreeWorkingCapital>
<!-- Business Acquisition, Purchase Price Allocation, License Receivable -->
<mdxg:BusinessAcquisitionPurchasePriceAllocationLicenseReceivable contextRef="c20110105" unitRef="U001" decimals="0"> 340000 </mdxg:BusinessAcquisitionPurchasePriceAllocationLicenseReceivable>
<!-- Business Acquisition, Purchase Price Allocation, Line of credit -->
<mdxg:BusinessAcquisitionPurchasePriceAllocationLineOfCredit contextRef="c20110105" unitRef="U001" decimals="0"> 99000 </mdxg:BusinessAcquisitionPurchasePriceAllocationLineOfCredit>
<!-- Net working capital -->
<mdxg:NetWorkingCapital contextRef="c20110105" unitRef="U001" decimals="0"> 489103 </mdxg:NetWorkingCapital>
<!-- Business Acquisition, Purchase Price Allocation, Deposits -->
<mdxg:BusinessAcquisitionPurchasePriceAllocationDeposits contextRef="c20110105" unitRef="U001" decimals="0"> 16582 </mdxg:BusinessAcquisitionPurchasePriceAllocationDeposits>
<!-- Business Acquisition, Purchase Price Allocation, Noncurrent Deferred rent -->
<mdxg:BusinessAcquisitionPurchasePriceAllocationNoncurrentDeferredRent contextRef="c20110105" unitRef="U001" decimals="0"> 16197 </mdxg:BusinessAcquisitionPurchasePriceAllocationNoncurrentDeferredRent>
<!-- Deposits net of deferred rent noncurrent -->
<mdxg:DepositsNetOfDeferredRentNoncurrent contextRef="c20110105" unitRef="U001" decimals="0"> 385 </mdxg:DepositsNetOfDeferredRentNoncurrent>
<!-- Stock issued during period, value, issued for payment of Line of Credit with related party-Common Stock [Member] -->
<mdxg:StockIssuedDuringPeriodValueIssuedForPaymentOfLineOfCreditWithRelatedParty contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0"> 1404 </mdxg:StockIssuedDuringPeriodValueIssuedForPaymentOfLineOfCreditWithRelatedParty>
<!-- Stock issued during period, value, issued for payment of Line of Credit with related party-Additional Paid-in Capital [Member] -->
<mdxg:StockIssuedDuringPeriodValueIssuedForPaymentOfLineOfCreditWithRelatedParty contextRef="c20120101to20121231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="0"> 1402226 </mdxg:StockIssuedDuringPeriodValueIssuedForPaymentOfLineOfCreditWithRelatedParty>
<!-- Stock issued during period, value, issued for payment of Line of Credit with related party -->
<mdxg:StockIssuedDuringPeriodValueIssuedForPaymentOfLineOfCreditWithRelatedParty contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 1403630 </mdxg:StockIssuedDuringPeriodValueIssuedForPaymentOfLineOfCreditWithRelatedParty>
<!-- Stock issued during period, shares, issued for payment of Line of Credit with related party-Common Stock [Member] -->
<mdxg:StockIssuedDuringPeriodSharesIssuedForPaymentOfLineOfCreditWithRelatedParty contextRef="c20120101to20121231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0"> 1403630 </mdxg:StockIssuedDuringPeriodSharesIssuedForPaymentOfLineOfCreditWithRelatedParty>
<!-- Stock issued during period, shares, issued for payment of Line of Credit with related party -->
<mdxg:StockIssuedDuringPeriodSharesIssuedForPaymentOfLineOfCreditWithRelatedParty contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 1403630 </mdxg:StockIssuedDuringPeriodSharesIssuedForPaymentOfLineOfCreditWithRelatedParty>
<!-- Initial term of lease-Subsequent Event [Member] -->
<mdxg:InitialTermOfLease contextRef="c20120101to20121231_SubsequentEventTypeAxis_SubsequentEventMember"> P69M </mdxg:InitialTermOfLease>
<!-- Stock issued during period, shares, issued for purchase of surgical sheets -->
<mdxg:StockIssuedDuringPeriodSharesIssuedForPurchaseOfSurgicalSheets contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 400000 </mdxg:StockIssuedDuringPeriodSharesIssuedForPurchaseOfSurgicalSheets>
<!-- Stock issued during period, value, issued for purchase of surgical sheets -->
<mdxg:StockIssuedDuringPeriodValueIssuedForPurchaseOfSurgicalSheets contextRef="c20120101to20121231" unitRef="U001" decimals="0"> 2596000 </mdxg:StockIssuedDuringPeriodValueIssuedForPurchaseOfSurgicalSheets>
<!-- Period of approval, maximum -->
<mdxg:PeriodOfApprovalMaximum contextRef="c20120101to20121231"> P30D </mdxg:PeriodOfApprovalMaximum>
<!-- Deferred tax assets, contingent consideration -->
<mdxg:DeferredTaxAssetsContingentConsideration contextRef="c20121231" unitRef="U001" decimals="0"> 567947 </mdxg:DeferredTaxAssetsContingentConsideration>
<!-- Deferred tax assets, contingent consideration -->
<mdxg:DeferredTaxAssetsContingentConsideration contextRef="c20111231" unitRef="U001" decimals="0"> 0 </mdxg:DeferredTaxAssetsContingentConsideration>
<!-- Share based Compensation Arrangement by Share based Payment Award, Stock Options, Other -->
<mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsOther contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 4000000 </mdxg:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsOther>
<!-- Contractual Obligation, Due after Second Year -->
<mdxg:ContractualObligationDueAfterSecondYear contextRef="c20121231" unitRef="U001" decimals="0"> 542021 </mdxg:ContractualObligationDueAfterSecondYear>
<!-- Stock Issued During Period, Exercise of Warrants -->
<mdxg:StockIssuedDuringPeriodExerciseOfWarrants contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 216085 </mdxg:StockIssuedDuringPeriodExerciseOfWarrants>
<!-- Contingent payments to licensor, shares issued -->
<mdxg:ContingentPaymentsToLicensorSharesIssued contextRef="c20120101to20121231" unitRef="U002" decimals="0"> 100000 </mdxg:ContingentPaymentsToLicensorSharesIssued>
<!-- Recently Issued Accounting Pronouncements Not Yet Adopted [Policy Text Block] -->
<mdxg:RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: bold 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">Recently Issued Accounting Pronouncements Not Yet Adopted</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><font style="display: inline; font-weight: bold;">Disclosures about offsetting assets and liabilities – </font>In December 2011, the FASB issued accounting guidance on disclosures about offsetting assets and liabilities.  The guidance requires entities to disclose both gross and net information about instruments and transactions that are offset in the statement of financial position, as well as instruments and transactions that are subject to an enforceable master netting arrangement or similar agreement.  In January 2013, the FASB issued guidance clarifying the scope of the disclosures to apply only to derivatives, including bifurcated embedded derivatives, repurchase and reverse repurchase agreements, and securities lending and securities borrowing transactions.  This guidance is effective January 1, 2013, with retrospective application required.  We do not expect the adoption to have a material impact on our financial statements.</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><font style="display: inline; font-weight: bold;">Reporting of amounts reclassified out of accumulated other comprehensive income – </font>In February 2013, the FASB issued accounting guidance on the reporting of reclassifications out of accumulated other comprehensive income. The guidance requires an entity to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income if the amount is reclassified to net income in its entirety in the same reporting period. For other amounts not required to be reclassified in their entirety to net income in the same reporting period, a cross reference to other disclosures that provide additional detail about the reclassification amounts is required. This guidance is effective January 1, 2013. We do not expect the adoption to have a material impact on our financial statements.</div><br class="Apple-interchange-newline" /></div>
</mdxg:RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock>
<!-- Schedule of Depreciation, Allocation to Operating Departments [Table Text Block] -->
<mdxg:ScheduleOfDepreciationAllocationToOperatingDepartmentsTableTextBlock contextRef="c20120101to20121231">
<div><div style="text-align: left; text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 10pt 'Times New Roman'; white-space: normal; color: rgb(0,0,0); margin-left: 0pt; margin-right: 0pt; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;">The following table shows the allocation of depreciation for the years ended December 31, 2012 and 2011, to operating departments:</div><div style="text-transform: none; text-indent: 0pt; letter-spacing: normal; display: block; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><br /></div><div style="text-align: center; text-transform: none; text-indent: 0px; letter-spacing: normal; font: 13px 'Times New Roman'; white-space: normal; color: rgb(0,0,0); word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px;"><table cellpadding="0" cellspacing="0" style="width: 80%; font-family: 'times new roman'; font-size: 10pt;"><tr><td valign="bottom" style="width: 56%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="6" valign="bottom" style="width: 22%;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Depreciation expense included in:</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div style="text-align: center; text-indent: 0pt; display: block; font-family: 'times new roman'; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Cost of products sold</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">155,987</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">104,950</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td align="left" valign="bottom" style="width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Research and development</div></td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">120,260</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="width: 1%; display: inline; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="text-align: right; width: 9%; font-family: 'times new roman'; font-size: 10pt;">118,565</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" style="padding-bottom: 2px; width: 56%;"><div style="text-align: left; text-indent: -9pt; display: block; font-family: 'times new roman'; margin-left: 9pt; font-size: 10pt; margin-right: 0pt;">Selling, general and administrative</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">189,120</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">222,987</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr><tr bgcolor="white"><td valign="bottom" style="padding-bottom: 2px; width: 56%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">465,367</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td><td valign="bottom" style="border-bottom: black 2px solid; text-align: left; font-family: 'times new roman'; font-size: 10pt;">$</td><td valign="bottom" style="border-bottom: black 2px solid; text-align: right; font-family: 'times new roman'; font-size: 10pt;">446,502</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; font-family: 'times new roman'; font-size: 10pt;"> </td></tr></table></div></div>
</mdxg:ScheduleOfDepreciationAllocationToOperatingDepartmentsTableTextBlock>
<link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:footnote xlink:label="Footnote-Item-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> Investors received First Contingent Warrants (25% of amount invested) and Second Contingent Warrants (25% of amount invested) at an exercise price of $.01 per share. The warrants vest depending upon reported Company revenues for the Years ended December 31, 2011 and 2012. In March 2012 a total of 1,250,000 First Contingent Warrants were vested. In July 2012, a total of 1,250,000 Second Contingent Warrants were voided due to the Company share price trading at or above $1.75 for ten consecutive trading days. The amount of the warrants (i.e. the exercisable First Contingent Warrants) and beneficial conversion feature totaled $2,278,052 which has been recorded as a debt discount that has been and will continue to be charged to interest expense using the effective interest rate over the life of the note. </link:footnote>
<link:loc xlink:href="#Item-1" xlink:label="Item-1_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-1_lbl" xlink:to="Footnote-Item-1" xlink:type="arc"/>
<link:loc xlink:href="#Item-2" xlink:label="Item-2_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-2_lbl" xlink:to="Footnote-Item-1" xlink:type="arc"/>
<link:footnote xlink:label="Footnote-Item-2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> The same terms offerred to the Senior Secured Promissory note with regard to Contingent Warrants applied to the Convertible Line of Credit. In March 2012 a total of 325,000 First Contingent Warrants vested. In July 2012, a total of 325,000 Second Contingent Warrants were voided. The amount of the warrants (i.e. the exercisable First Contingent Warrants) and beneficial conversion feature totaled $594,456 which has been recorded as a debt discount that has been charged to interest expense using the effective interest rate over the life of the note. </link:footnote>
<link:loc xlink:href="#Item-3" xlink:label="Item-3_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-3_lbl" xlink:to="Footnote-Item-2" xlink:type="arc"/>
<link:loc xlink:href="#Item-4" xlink:label="Item-4_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-4_lbl" xlink:to="Footnote-Item-2" xlink:type="arc"/>
<link:footnote xlink:label="Footnote-Item-3" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> interest of $3,232 related to convertible promissory notes issued in October 2010 to the Chairman of the Board and CEO and two other members of the Board of Directors </link:footnote>
<link:loc xlink:href="#Item-5" xlink:label="Item-5_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-5_lbl" xlink:to="Footnote-Item-3" xlink:type="arc"/>
<link:loc xlink:href="#Item-6" xlink:label="Item-6_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-6_lbl" xlink:to="Footnote-Item-3" xlink:type="arc"/>
<link:footnote xlink:label="Footnote-Item-4" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> interest of $103,630 for 2012 and $42,726 for 2011, respectively related to a revolving secured line of credit with the Chairman of the Board and CEO dated March 31, 2011 </link:footnote>
<link:loc xlink:href="#Item-7" xlink:label="Item-7_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-7_lbl" xlink:to="Footnote-Item-4" xlink:type="arc"/>
<link:loc xlink:href="#Item-8" xlink:label="Item-8_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-8_lbl" xlink:to="Footnote-Item-4" xlink:type="arc"/>
<link:footnote xlink:label="Footnote-Item-5" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> interest of $50,000 for 2012 and $4,507 for 2011, respectively related to the convertible senior secured promissory notes with the Chairman of the Board and CEO during the fourth quarter of 2011 </link:footnote>
<link:loc xlink:href="#Item-9" xlink:label="Item-9_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-9_lbl" xlink:to="Footnote-Item-5" xlink:type="arc"/>
<link:loc xlink:href="#Item-10" xlink:label="Item-10_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-10_lbl" xlink:to="Footnote-Item-5" xlink:type="arc"/>
<link:footnote xlink:label="Footnote-Item-6" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> payments related to the lease of office space from an entity owned by the Chairman of the Board and CEO for $48,182 for 2012 and $41,000 for 2011, respectively </link:footnote>
<link:loc xlink:href="#Item-11" xlink:label="Item-11_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-11_lbl" xlink:to="Footnote-Item-6" xlink:type="arc"/>
<link:loc xlink:href="#Item-12" xlink:label="Item-12_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-12_lbl" xlink:to="Footnote-Item-6" xlink:type="arc"/>
<link:footnote xlink:label="Footnote-Item-7" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> payments related to aircraft use from an entity owned by the former Chairman of the Board and current member of the Board of Directors </link:footnote>
<link:loc xlink:href="#Item-13" xlink:label="Item-13_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-13_lbl" xlink:to="Footnote-Item-7" xlink:type="arc"/>
<link:loc xlink:href="#Item-14" xlink:label="Item-14_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-14_lbl" xlink:to="Footnote-Item-7" xlink:type="arc"/>
<link:footnote xlink:label="Footnote-Item-8" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> Securities outstanding that were excluded from the computiation, prior to the use of the treasury stock method, because they would have been anti-dilutive are as follows: </link:footnote>
<link:loc xlink:href="#Item-15" xlink:label="Item-15_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-15_lbl" xlink:to="Footnote-Item-8" xlink:type="arc"/>
<link:loc xlink:href="#Item-16" xlink:label="Item-16_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-16_lbl" xlink:to="Footnote-Item-8" xlink:type="arc"/>
<link:footnote xlink:label="Footnote-Item-9" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> AmnioFix injectable was launched in 2012 with amortization recorded over its expected useful life. </link:footnote>
<link:loc xlink:href="#Item-17" xlink:label="Item-17_lbl" xlink:type="locator"/>
<link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-17_lbl" xlink:to="Footnote-Item-9" xlink:type="arc"/>
</link:footnoteLink>
</xbrl>

↑Top
Filing Submission 0001140361-13-012765   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 23, 8:50:35.3am ET